Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,1505,30,0.31 [0.05-1.92],0.2057478431995096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AAMDC,Mth938 domain-containing protein,1461,30,1.05 [0.55-2.01],0.8913323716023398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,1722,38,0.75 [0.45-1.25],0.2741355080283506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,1439,28,3.45 [1.93-6.16],2.9658061050870112e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABHD14B,Protein ABHD14B,1700,37,1.41 [0.88-2.27],0.1518253897029085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,1722,38,1.58 [1.10-2.26],0.0134312398539339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABO,Histo-blood group ABO system transferase,1502,29,0.98 [0.77-1.25],0.8649906198853335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,1439,28,0.79 [0.45-1.37],0.3997744020841419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1675,38,0.95 [0.69-1.30],0.7484210724421828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1475,30,1.03 [0.60-1.78],0.9109123446539702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1493,29,1.00 [0.67-1.48],0.9975607718872418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,1704,38,3.24 [1.26-8.30],0.0145773299245565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE,Angiotensin-converting enzyme,1502,29,8.01 [2.20-29.12],0.001581401908328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,1692,39,1.16 [0.78-1.74],0.4661247996936276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACHE,Acetylcholinesterase,1471,29,1.06 [0.40-2.76],0.9115446581668846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,1478,29,1.05 [0.77-1.43],0.7727039356432326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1724,39,1.50 [0.92-2.44],0.1045717065253902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,1444,28,0.70 [0.29-1.69],0.4323532598628323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,1732,39,3.97 [1.63-9.66],0.0023758523688444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,1735,39,2.50 [1.44-4.32],0.0010797259632961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRBP,Acrosin-binding protein,1490,30,1.09 [0.50-2.38],0.824912332437893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,1444,28,1.04 [0.36-3.00],0.9392858804101278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,1439,28,1.39 [0.63-3.04],0.4107294450568314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",1692,39,2.24 [1.61-3.11],1.776421808373988e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN2,Alpha-actinin-2,1439,28,1.35 [0.77-2.35],0.29613158587039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,1676,36,1.65 [0.82-3.32],0.1626486473718592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,1705,37,11.45 [5.47-23.96],9.708307798296063e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY1,Aminoacylase-1,1724,39,0.58 [0.39-0.88],0.0109119778250279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1439,28,1.42 [0.82-2.47],0.2156862249758489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACYP1,Acylphosphatase-1,1466,29,1.13 [0.67-1.89],0.6537232413108227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA,Adenosine deaminase,1738,37,2.32 [1.20-4.48],0.0120960312376661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,1719,39,2.31 [1.32-4.02],0.0031774069229863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1444,28,3.21 [1.72-6.00],0.0002469078337389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1692,39,1.64 [0.67-4.02],0.2805548791339022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1708,37,3.56 [1.70-7.47],0.000775357155222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1738,37,4.82 [1.87-12.39],0.0011020098682581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1733,37,3.49 [1.26-9.66],0.0158110219776033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1478,29,3.84 [1.77-8.30],0.0006324157227328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1444,28,2.81 [1.09-7.25],0.0328657462428845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1742,39,0.51 [0.18-1.47],0.2121269529044502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1722,38,1.72 [0.91-3.25],0.0923998405413895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1692,39,2.77 [1.53-5.03],0.0007649790663924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1444,28,3.87 [2.08-7.20],1.921164085619716e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1729,38,1.44 [0.78-2.65],0.2480593456992292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,1499,29,1.29 [0.58-2.87],0.5326246968342776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,1461,30,2.42 [0.62-9.48],0.204503568021638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,1493,29,1.26 [0.52-3.04],0.6063455189788574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1675,38,0.54 [0.18-1.63],0.2732310057618207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,1471,29,0.98 [0.59-1.60],0.921942877235536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,1705,37,2.74 [1.58-4.75],0.0003406843337822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,1471,29,3.56 [1.78-7.14],0.0003377073554986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,1478,29,1.87 [1.10-3.18],0.0202255186426875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,1726,37,4.33 [1.81-10.33],0.0009726401473138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,1735,39,3.93 [2.19-7.06],4.679629473912066e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,1493,29,1.81 [0.53-6.20],0.3430836262343205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,1722,38,1.08 [0.81-1.44],0.5868251143259897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,1724,39,0.57 [0.22-1.48],0.2473311620621555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,1432,28,0.77 [0.41-1.43],0.410206840651045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,1471,29,0.55 [0.35-0.87],0.0114485028772947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1692,39,0.61 [0.44-0.84],0.0027994103977818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADIPOQ,Adiponectin,1505,30,1.52 [1.00-2.32],0.0502192505451726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,1740,39,7.00 [2.54-19.24],0.0001636591367134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,1439,28,1.06 [0.65-1.74],0.8074264007664496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFAP1,Actin filament-associated protein 1,1471,29,1.23 [0.82-1.84],0.3208387963653311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,1505,30,0.17 [0.05-0.55],0.0030149432088361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,1701,37,0.55 [0.34-0.89],0.0144644480594194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,1432,28,1.04 [0.71-1.53],0.8420396218131694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,1713,37,1.99 [1.07-3.72],0.0306339268979307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,1652,36,2.01 [1.58-2.54],8.962215662596855e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR3,Anterior gradient protein 3,1673,38,1.81 [1.13-2.91],0.0143868715905474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,1726,37,3.79 [2.25-6.40],6.012488779781205e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,1738,37,2.58 [1.56-4.28],0.0002341163371305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGT,Angiotensinogen,1502,29,3.17 [1.19-8.47],0.0211674085302863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,1724,39,0.72 [0.51-1.03],0.071681671810762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHCY,Adenosylhomocysteinase,1724,39,0.98 [0.64-1.48],0.9159435494701964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,1461,30,2.33 [0.81-6.66],0.1155668223872122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,1461,30,1.69 [0.65-4.40],0.2829367392022174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1490,30,1.04 [0.63-1.71],0.8861010578649686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,1502,29,0.30 [0.12-0.79],0.0146984165670448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,1726,37,0.87 [0.64-1.19],0.3793426050354621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",1456,28,0.70 [0.39-1.25],0.2238224033994431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1,Allograft inflammatory factor 1,1675,38,1.60 [0.95-2.71],0.0797990301034931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,1461,30,1.83 [1.31-2.56],0.0004178121012218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1720,38,1.08 [0.83-1.40],0.5636144037382798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,1724,39,0.98 [0.64-1.51],0.9415505060035798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",1486,27,1.04 [0.73-1.49],0.8219378472940477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKAP12,A-kinase anchor protein 12,1471,29,2.27 [0.85-6.09],0.1029748564339267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,1675,38,0.87 [0.58-1.29],0.4786832509158492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,1456,28,0.96 [0.62-1.51],0.8755279913329986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,1692,39,1.45 [1.09-1.94],0.0116414074363917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,1444,28,1.09 [0.69-1.71],0.7245905460713273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,1661,36,0.99 [0.64-1.52],0.9566183842130824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,1498,30,1.04 [0.79-1.37],0.7890088951687021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,1667,38,1.62 [0.98-2.66],0.0587367745589822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,1742,39,3.34 [1.02-10.91],0.0456632283895436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,1728,37,0.40 [0.23-0.70],0.001260053536614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",1490,30,0.56 [0.21-1.45],0.2319294071666166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1707,35,1.11 [0.80-1.53],0.5505857709625621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1498,30,1.09 [0.53-2.22],0.8213897578364375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,1475,30,1.11 [0.51-2.42],0.7995245882399702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,1444,28,1.20 [0.90-1.59],0.2123646522300142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",1722,38,1.26 [0.97-1.63],0.0831503366111125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBN,Ameloblastin,1676,36,1.21 [0.44-3.32],0.7138156483196738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,1738,39,17.78 [7.07-44.70],9.539961115213014e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1499,29,1.19 [0.29-4.94],0.8099958081494452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,1661,36,1.46 [1.01-2.12],0.0455950628965048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,1456,28,0.76 [0.33-1.74],0.5223694858802329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,1722,38,2.13 [0.64-7.05],0.2163431355061929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,1676,36,1.11 [0.62-1.96],0.7317758394062474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOT,Angiomotin,1471,29,1.26 [0.57-2.76],0.5701609221406911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,1485,30,1.34 [0.77-2.36],0.3034970674449338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMPD3,AMP deaminase 3,1486,27,0.83 [0.50-1.38],0.4828550456179359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1401,28,1.12 [0.56-2.23],0.7494254382457418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,1638,38,1.39 [0.80-2.43],0.2434868061394522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2B,Alpha-amylase 2B,1587,36,1.43 [0.81-2.50],0.2181692109284085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,1727,39,3.46 [1.79-6.67],0.0002186492738038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT1,Angiopoietin-1,1712,36,1.22 [0.85-1.74],0.2859450608914427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,1740,39,2.60 [1.34-5.02],0.0045853498199049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,1697,38,3.11 [1.29-7.53],0.0116014000740086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,1723,37,0.75 [0.38-1.45],0.386317269790296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,1732,39,1.70 [0.84-3.43],0.1378987193099389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,1721,37,2.64 [1.45-4.83],0.0016009323740506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,1740,39,1.90 [1.04-3.46],0.0373971639450464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANK2,Ankyrin-2,1439,28,0.87 [0.51-1.48],0.6065832982598116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1444,28,1.23 [0.79-1.91],0.3631695355409555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,1438,27,1.43 [0.83-2.46],0.1956932850779547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,1675,38,0.95 [0.58-1.54],0.8231375219999608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1461,30,0.47 [0.14-1.65],0.2411214123431997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANPEP,Aminopeptidase N,1730,39,1.29 [0.52-3.19],0.578651833827897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA1,Annexin A1,1467,29,1.62 [0.89-2.93],0.1126051851735282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,1661,36,1.08 [0.79-1.48],0.6158096053108302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA11,Annexin A11,1712,36,0.91 [0.58-1.42],0.6666347808847481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA2,Annexin A2,1446,29,0.99 [0.58-1.70],0.9829150457998096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA3,Annexin A3,1733,37,1.35 [0.91-2.00],0.1419174679142704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA4,Annexin A4,1716,38,1.09 [0.73-1.61],0.6848811991628208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,1657,36,4.93 [2.29-10.62],4.431531786766209e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],1676,36,0.86 [0.50-1.51],0.6064975692237041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,1733,39,6.60 [3.07-14.19],1.3425629731457262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,1490,30,1.06 [0.69-1.62],0.8053476773667536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP2B1,AP-2 complex subunit beta,1456,28,0.85 [0.40-1.82],0.6763845756354033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,1478,29,1.19 [0.75-1.88],0.4545822550989067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,1486,27,1.27 [0.64-2.52],0.5006604095671174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1722,38,1.53 [0.91-2.58],0.1101329386731451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APCS,Serum amyloid P-component,1490,30,0.42 [0.17-1.06],0.0671544802861377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1733,39,1.10 [0.68-1.77],0.7026599551277276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APLP1,Amyloid-like protein 1,1724,39,0.91 [0.53-1.56],0.7245128098438591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,1505,30,0.53 [0.14-2.01],0.3534843285627719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,1502,29,2.98 [1.54-5.75],0.0011519406418639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,1505,30,3.52 [1.96-6.32],2.6615598506555228e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOB,Apolipoprotein B-100,1502,29,2.73 [0.51-14.71],0.2412865197231523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOBR,Apolipoprotein B receptor,1461,30,1.29 [0.53-3.12],0.5745710836920705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,1501,30,0.35 [0.14-0.85],0.020507065425707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOD,Apolipoprotein D,1440,27,1.10 [0.49-2.43],0.8226055709795081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOE,Apolipoprotein E,1505,30,0.96 [0.52-1.75],0.8828755956371547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOF,Apolipoprotein F,1502,29,0.87 [0.36-2.09],0.7517006319691986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,1728,37,1.34 [0.62-2.91],0.4541213582392995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOL1,Apolipoprotein L1,1502,29,0.86 [0.49-1.51],0.6010878274953921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,1732,39,1.00 [0.39-2.56],0.9988245334877912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APP,Amyloid-beta precursor protein,1725,37,1.40 [0.91-2.13],0.1223994670725034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,1471,29,1.00 [0.73-1.38],0.9809792471545126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,1707,37,1.37 [0.73-2.60],0.3302011950843926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,1475,30,0.85 [0.49-1.48],0.5705700507661191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,1722,38,2.63 [1.69-4.08],1.590434779639431e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARF6,ADP-ribosylation factor 6,1478,29,1.15 [0.82-1.62],0.4217007123629198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARFIP1,Arfaptin-1,1498,30,0.94 [0.58-1.55],0.8168946361332122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,1722,39,0.68 [0.41-1.13],0.134739908334949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",1490,30,0.65 [0.25-1.65],0.3598492627813823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,1675,38,0.86 [0.46-1.64],0.6559149994999486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,1675,38,1.33 [0.87-2.05],0.1920009055768539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,1475,30,0.66 [0.19-2.32],0.5118488323948385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,1471,29,0.86 [0.55-1.33],0.4886737184717793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,1438,27,0.68 [0.37-1.24],0.209782893064294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,1486,27,1.00 [0.66-1.52],0.9860420008756338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,1498,30,1.23 [0.86-1.78],0.2602007474671931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,1713,36,1.04 [0.78-1.39],0.7686316376571416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,1432,28,1.44 [0.98-2.11],0.0638419523500195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,1432,28,1.47 [0.65-3.35],0.3539748246652903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,1661,36,0.69 [0.30-1.61],0.3886575363811181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,1439,28,0.90 [0.52-1.53],0.6886040977175143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1439,28,0.97 [0.41-2.31],0.9435765444453036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,1432,28,0.96 [0.52-1.78],0.905082534871862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,1676,36,1.61 [0.93-2.80],0.0897230913997247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1439,28,0.94 [0.49-1.81],0.84980391303375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSA,Arylsulfatase A,1728,37,0.96 [0.53-1.72],0.887212552339439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSB,Arylsulfatase B,1722,38,1.05 [0.64-1.73],0.8413830329591363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,1733,39,7.28 [4.18-12.66],2.163282090718735e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,1432,28,0.92 [0.47-1.77],0.7984650137114998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARTN,Artemin,1676,36,0.59 [0.25-1.39],0.2281420340106087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH1,Acid ceramidase,1490,29,1.38 [0.72-2.62],0.3293147033659587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH2,Neutral ceramidase,1708,37,0.82 [0.50-1.36],0.4463172857228379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,1708,37,4.64 [2.39-8.98],5.429373772718895e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,1502,29,5.38 [2.14-13.53],0.0003476365907489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPN,Asporin,1493,29,1.79 [0.71-4.48],0.2165048880035804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,1498,30,0.88 [0.52-1.48],0.6319628732153679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,1461,30,0.99 [0.70-1.41],0.9678000487782128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASS1,Argininosuccinate synthase,1439,28,0.73 [0.47-1.13],0.159420796971992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,1661,36,0.98 [0.64-1.51],0.9280400276940914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,1438,27,0.44 [0.12-1.59],0.2100233504458581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,1478,29,1.08 [0.71-1.65],0.7060880674932272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG4A,Cysteine protease ATG4A,1675,38,1.11 [0.70-1.76],0.6598091872786798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATOX1,Copper transport protein ATOX1,1729,38,1.40 [0.91-2.16],0.127486470839373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1439,28,1.40 [0.78-2.54],0.2599096115767136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1439,28,1.12 [0.50-2.49],0.7808644761306789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1439,28,1.55 [0.73-3.28],0.2504944968574099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B4,Protein ATP1B4,1438,27,0.75 [0.28-1.99],0.565409635090915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,1439,28,0.84 [0.42-1.67],0.6131416949509094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",1439,28,1.51 [0.92-2.48],0.1040591288005655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",1726,37,1.19 [0.91-1.55],0.216867497375839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",1661,36,1.09 [0.58-2.05],0.7930642004550967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,1675,38,2.00 [1.23-3.25],0.0050534286643681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,1722,38,1.64 [0.74-3.61],0.2201681806860557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,1657,36,1.02 [0.65-1.62],0.9223660015603512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,1461,30,1.13 [0.70-1.81],0.6206182397494429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,1439,28,0.99 [0.66-1.49],0.949727490954568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,1478,29,3.94 [2.30-6.75],5.685456726991277e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRN,"Attractin, Isoform 2",1505,30,0.31 [0.05-1.77],0.1874324971901728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN10,Ataxin-10,1661,36,0.77 [0.51-1.15],0.1950045565063776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2,Ataxin-2,1432,28,1.08 [0.78-1.49],0.6446119894498534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2L,Ataxin-2-like protein,1498,30,1.12 [0.57-2.23],0.7432990474409091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN3,Ataxin-3,1486,27,0.68 [0.38-1.23],0.2070064453920107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXIN1,Axin-1,1713,36,1.06 [0.77-1.45],0.7159379191556997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,1733,39,5.07 [2.20-11.69],0.0001373155751007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,1498,30,1.10 [0.60-2.02],0.746830467242336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZU1,Azurocidin,1675,39,1.07 [0.77-1.50],0.6829741020608927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,1505,30,5.14 [2.57-10.30],3.8638056968241415e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1439,28,1.12 [0.16-7.55],0.91094196564018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1461,30,5.99 [2.49-14.42],6.445362438133696e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",1726,37,8.32 [3.49-19.82],1.7488929605245616e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",1728,37,6.92 [2.20-21.79],0.0009487479964013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,1444,28,0.60 [0.15-2.41],0.4664541853989272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BACH1,Transcription regulator protein BACH1,1713,36,1.05 [0.70-1.57],0.8139265409789169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,1705,37,1.71 [0.87-3.36],0.1207109123589117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,1444,28,1.43 [0.72-2.84],0.3015865068260828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG6,Large proline-rich protein BAG6,1692,39,1.33 [0.63-2.84],0.4544379155613967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1675,38,1.42 [0.99-2.05],0.0565357318910224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,1675,38,5.83 [3.24-10.51],4.282703120713504e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,1713,36,1.03 [0.77-1.37],0.8511461158096932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,1486,27,1.01 [0.62-1.64],0.9718482573013648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,1456,28,0.86 [0.52-1.44],0.5696443571475166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAX,Apoptosis regulator BAX,1660,36,1.20 [0.87-1.66],0.2723364973674344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,1728,37,1.95 [0.64-5.90],0.2392769684602517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAN,Brevican core protein,1708,37,0.70 [0.32-1.51],0.3570721077616606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1493,29,1.81 [0.85-3.87],0.1258796626875864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1432,28,1.13 [0.60-2.10],0.7107256819341626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCHE,Cholinesterase,1480,29,0.59 [0.17-2.01],0.4007301421233031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,1478,29,1.43 [0.92-2.24],0.1120497322209127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,1486,27,1.05 [0.73-1.53],0.7886112056859103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1713,36,1.86 [0.85-4.06],0.1189984886966795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,1444,28,1.83 [1.21-2.76],0.0040389713426161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,1438,27,0.89 [0.48-1.65],0.7148459258349769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,1490,30,0.62 [0.23-1.67],0.3409424462005078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCR,Breakpoint cluster region protein,1713,36,1.05 [0.75-1.45],0.7878349036425008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,1499,29,0.87 [0.58-1.31],0.5039082694389793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BECN1,Beclin-1,1461,30,1.24 [0.72-2.14],0.4390867467142676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BEX3,Protein BEX3,1438,27,0.40 [0.13-1.21],0.1027813422322199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGLAP,Osteocalcin,1499,29,1.01 [0.71-1.44],0.9521678072199624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGN,Biglycan,1673,38,0.80 [0.62-1.04],0.0919294116101187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,1432,28,0.95 [0.57-1.61],0.8594040507428555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1439,28,2.42 [0.57-10.21],0.2304270677016916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BID,BH3-interacting domain death agonist,1713,36,1.10 [0.73-1.67],0.6363428309224051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIN2,Bridging integrator 2,1728,37,1.11 [0.81-1.53],0.5243935075068851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,1675,38,1.33 [0.86-2.06],0.1992161676940336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLMH,Bleomycin hydrolase,1742,39,0.86 [0.38-1.95],0.7235961687128583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLNK,B-cell linker protein,1444,28,0.95 [0.33-2.71],0.9234947780327784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1432,28,1.02 [0.59-1.74],0.9556393264314752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1486,27,1.27 [0.54-2.96],0.5878626028625656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLVRB,Flavin reductase,1728,37,0.86 [0.56-1.32],0.4820895303176719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,1471,29,16.95 [5.22-55.05],2.497987303007441e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,1705,37,1.59 [0.95-2.65],0.0764149217417406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP6,Bone morphogenetic protein 6,1689,39,2.03 [1.00-4.12],0.049020305610196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,1471,29,5.89 [1.48-23.48],0.0118742118525391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1493,29,1.13 [0.41-3.10],0.8165726981659633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1444,28,1.81 [0.90-3.63],0.0966508007981052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,1692,39,6.55 [2.19-19.55],0.0007608757995714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA1,BolA-like protein 1,1432,28,1.54 [0.85-2.79],0.1573329491531451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,1461,30,0.88 [0.47-1.65],0.6996401341702874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,1419,30,1.12 [0.83-1.51],0.461469240986725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,1710,38,1.02 [0.67-1.56],0.917842060533457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,1491,29,0.87 [0.57-1.34],0.5422528428817479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRAP,BRCA1-associated protein,1460,29,1.09 [0.78-1.52],0.6199826548984955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD1,Bromodomain-containing protein 1,1475,30,1.04 [0.37-2.91],0.9383932500475716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD2,Bromodomain-containing protein 2,1432,28,1.06 [0.36-3.10],0.9155534127253752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD3,Bromodomain-containing protein 3,1439,28,0.82 [0.35-1.88],0.6336971700064005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRDT,Bromodomain testis-specific protein,1439,28,1.66 [0.61-4.46],0.3191874604140097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRK1,Protein BRICK1,1661,36,2.11 [1.17-3.79],0.0125955184567283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,1432,28,0.83 [0.30-2.32],0.7293257061159174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,1498,30,1.07 [0.46-2.48],0.8816148909886259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,1736,37,17.18 [7.51-39.28],1.598156405060504e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSND,Barttin,1438,27,0.98 [0.31-3.06],0.9698465314129416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1736,37,0.73 [0.44-1.22],0.2252347960937034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,1736,37,1.19 [0.78-1.82],0.4161750292936279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTC,Probetacellulin,1675,38,1.17 [0.78-1.76],0.4426407818988542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTD,Biotinidase,1505,30,0.43 [0.09-2.08],0.291104592153847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,1438,27,0.98 [0.64-1.49],0.9081213489110472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,1487,30,1.25 [0.59-2.64],0.5577461107661391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,1726,37,6.77 [4.03-11.38],5.243789898703252e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,1713,36,6.70 [3.55-12.64],4.181069315158093e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,1438,27,0.70 [0.24-2.07],0.5186008694898278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C19orf12,Protein C19orf12,1661,36,0.45 [0.26-0.76],0.0032776194405237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,1439,28,1.56 [0.48-5.01],0.4583130459729176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,1730,37,3.96 [1.61-9.77],0.0028043957380354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1498,30,0.87 [0.49-1.54],0.6317962921853877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QL2,Complement C1q-like protein 2,1444,28,0.69 [0.30-1.58],0.3759778871478162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1733,39,1.65 [0.94-2.92],0.0827764182624912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1471,29,1.46 [0.56-3.83],0.4377274001384709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1498,30,0.75 [0.25-2.26],0.6049097955455056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1468,29,1.65 [0.76-3.58],0.2029333208747958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1R,Complement C1r subcomponent,1505,30,0.23 [0.04-1.22],0.0847187857267069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,1503,30,1.78 [0.33-9.51],0.5018558360558861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1S,Complement C1s subcomponent,1505,30,0.57 [0.17-1.92],0.3607847796722356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,1732,39,2.44 [0.59-10.08],0.2177375995865082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,1657,36,1.28 [0.68-2.42],0.4396405236079385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,1456,28,0.94 [0.49-1.79],0.851023906876627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C3,Complement C3,1419,28,1.98 [1.16-3.37],0.0125524844223423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C4BPB,C4b-binding protein beta chain,1729,38,2.09 [1.09-4.04],0.0275784395405177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C5,Complement C5,1505,30,2.37 [0.37-15.14],0.3619079848067724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,1460,30,3.82 [1.68-8.70],0.0014285051509738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,1486,27,0.31 [0.06-1.54],0.1517956783215557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C8B,Complement component C8 beta chain,1505,30,0.38 [0.15-0.96],0.0409211272025313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9,Complement component C9,1502,29,1.22 [0.64-2.33],0.5405148991497333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,1478,29,0.66 [0.42-1.03],0.0654503737850853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,1697,39,0.86 [0.56-1.32],0.4920782442623332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,1675,38,1.25 [0.72-2.16],0.4274178625280465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,1722,38,3.24 [2.27-4.62],1.0667337339004927e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA13,Carbonic anhydrase 13,1705,38,1.08 [0.81-1.45],0.5825453883014207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,1740,39,3.96 [2.42-6.50],4.745931426733702e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,1725,37,0.85 [0.57-1.26],0.4088599086353263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,1740,39,1.27 [0.84-1.92],0.2603647001923771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,1742,39,10.22 [4.43-23.60],5.080983535307778e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",1692,39,1.05 [0.80-1.37],0.7417695994913553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,1719,36,1.14 [0.73-1.78],0.5579586230179812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA7,Carbonic anhydrase 7,1475,30,1.00 [0.35-2.88],0.9996831644475144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA8,Carbonic anhydrase-related protein,1444,28,0.39 [0.06-2.51],0.3205509526666534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,1740,39,2.18 [1.44-3.29],0.0002080165173651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CABP2,Calcium-binding protein 2,1456,28,0.91 [0.50-1.66],0.7543207040712485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1432,28,1.63 [0.71-3.77],0.2495526104585207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1439,28,1.13 [0.70-1.82],0.6187753328298322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1432,28,0.46 [0.20-1.02],0.0570787075805166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1498,30,0.95 [0.63-1.42],0.7924037134394388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACYBP,Calcyclin-binding protein,1467,29,1.02 [0.72-1.46],0.8921131383186451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,1456,28,1.13 [0.58-2.22],0.7231347806090713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,1722,38,2.97 [1.71-5.15],0.0001108533148323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,1661,36,6.36 [3.05-13.29],8.405864909457683e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,1704,37,1.78 [1.32-2.40],0.0001480097680724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,1486,27,1.41 [0.82-2.42],0.2153095148462634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1732,39,1.06 [0.80-1.40],0.6702532820949856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1461,30,1.02 [0.64-1.62],0.9268740380868036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,1439,28,1.06 [0.40-2.76],0.9114566996484572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1675,38,1.47 [0.80-2.68],0.2128870399867578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1456,28,1.04 [0.55-1.96],0.9143574915439584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1498,30,1.21 [0.88-1.68],0.2443789490394965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,1718,38,9.47 [2.74-32.79],0.0003861263696681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,1714,39,1.90 [1.27-2.83],0.0017732602448576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPN3,Calpain-3,1490,30,1.06 [0.38-2.91],0.9136984343572074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPS,Calcyphosin,1486,27,1.23 [0.94-1.61],0.1235660647865038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,1661,36,1.16 [0.69-1.95],0.5844213983808684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASC3,Protein CASC3,1456,28,1.38 [0.65-2.94],0.4057858884570026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP1,Caspase-1,1661,36,1.12 [0.78-1.62],0.539869331663256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP10,Caspase-10,1661,36,1.33 [0.88-2.00],0.1725345607990291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP2,Caspase-2,1713,36,1.01 [0.67-1.52],0.9564441253680774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP3,Caspase-3,1742,39,1.06 [0.77-1.48],0.7109126869150522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP4,Caspase-4,1475,30,0.85 [0.66-1.09],0.1922811154390653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP7,Caspase-7,1486,27,1.03 [0.66-1.60],0.903434070943827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP8,Caspase-8,1733,39,1.11 [0.72-1.71],0.6371365320040362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP9,Caspase-9,1444,28,0.59 [0.31-1.11],0.0995282381297905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASQ2,Calsequestrin-2,1439,28,0.58 [0.21-1.64],0.3063547305841332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,1476,29,0.65 [0.32-1.32],0.2347852239103166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,1724,39,1.50 [1.11-2.03],0.0084462600503429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN1,Cerebellin-1,1432,28,0.98 [0.66-1.45],0.9212694521167863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN4,Cerebellin-4,1740,39,0.32 [0.15-0.71],0.0050891583570584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBS,Cystathionine beta-synthase,1461,30,0.87 [0.47-1.62],0.66016818021526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBX2,Chromobox protein homolog 2,1439,28,0.90 [0.33-2.47],0.8377985662609124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1708,37,1.23 [0.85-1.79],0.2655429186966322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,1486,27,0.78 [0.33-1.84],0.5772751054053944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,1490,30,1.24 [0.63-2.43],0.5339308869537693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,1456,28,0.99 [0.29-3.37],0.9874662257683076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,1498,30,0.74 [0.42-1.30],0.2942567173107165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,1724,39,2.91 [1.81-4.69],1.1231279068830276e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1461,30,1.43 [0.92-2.23],0.1165218965546088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,1738,37,3.85 [1.97-7.55],8.481823809465083e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL13,C-C motif chemokine 13,1736,37,1.19 [0.79-1.80],0.3972009884424867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,1727,39,3.73 [1.97-7.08],5.544761686235677e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,1742,39,3.25 [2.06-5.13],4.104032611368638e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,1742,39,1.77 [1.12-2.79],0.0148456380235815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL17,C-C motif chemokine 17,1713,37,1.29 [0.94-1.76],0.1135228276739635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL18,C-C motif chemokine 18,1711,39,0.92 [0.60-1.41],0.6940114087845235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL19,C-C motif chemokine 19,1736,37,1.05 [0.87-1.27],0.6182478399535312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,1705,37,1.38 [0.84-2.28],0.2091957190017741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,1738,37,1.08 [0.83-1.43],0.5605035394111879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,1726,37,1.15 [0.72-1.82],0.5639421636009364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL22,C-C motif chemokine 22,1702,37,1.11 [0.64-1.94],0.7011990890859081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,1726,37,2.34 [1.31-4.20],0.0042155019046851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL24,C-C motif chemokine 24,1721,37,1.10 [0.78-1.56],0.5699762122525507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,1738,37,3.73 [2.07-6.73],1.2586593697484534e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL26,C-C motif chemokine 26,1713,36,0.96 [0.69-1.32],0.7871165276514648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,1724,39,2.32 [1.48-3.62],0.0002158954535708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL28,C-C motif chemokine 28,1703,35,1.32 [0.87-2.00],0.1860264344912789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,1713,36,1.13 [0.87-1.47],0.3455369977758169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL4,C-C motif chemokine 4,1721,37,0.88 [0.55-1.40],0.583551180535548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL5,C-C motif chemokine 5,1733,39,1.06 [0.80-1.41],0.6737724988994589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,1713,36,1.38 [0.87-2.18],0.1692069161574467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,1738,39,0.91 [0.58-1.43],0.6863890784256916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN1,CCN family member 1,1720,38,1.59 [1.05-2.39],0.0283052381016833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN2,CCN family member 2,1718,37,1.78 [1.08-2.96],0.0244601250336753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,1734,39,5.15 [3.17-8.35],3.262082421773097e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,1740,39,5.20 [3.11-8.68],2.8835483631896676e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,1728,37,3.52 [1.97-6.29],2.1999842849697097e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,1475,30,1.95 [0.73-5.18],0.1808173202313897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,1444,28,0.76 [0.39-1.49],0.4252287750774911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,1708,37,0.84 [0.47-1.51],0.5684259687565307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,1675,38,1.07 [0.58-1.99],0.8232083143211529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,1478,29,0.97 [0.42-2.25],0.9378951025663016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,1728,37,3.90 [1.69-9.02],0.0014640803670562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,1703,39,3.89 [2.45-6.18],9.187586483418488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,1738,37,3.91 [2.49-6.15],3.402738742184401e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,1733,39,1.87 [1.05-3.33],0.0343375863307379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,1728,37,1.75 [1.30-2.36],0.0002197509386662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,1456,28,0.70 [0.25-1.99],0.5087271918671666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD177,CD177 antigen,1724,37,0.98 [0.79-1.22],0.8906004645322196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,1729,38,0.55 [0.18-1.64],0.2807248245031963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2,T-cell surface antigen CD2,1439,28,0.94 [0.39-2.26],0.8827998410679875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,1713,36,4.70 [2.54-8.70],8.10023390871146e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,1708,36,2.16 [0.91-5.08],0.0793037173752521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,1698,37,4.04 [2.20-7.41],6.930600604674568e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,1723,39,1.70 [0.81-3.54],0.1584863411277177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD22,B-cell receptor CD22,1738,37,0.64 [0.34-1.22],0.1778491580750677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD226,CD226 antigen,1444,28,1.92 [0.84-4.37],0.1207511290686824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,1738,37,2.44 [1.06-5.63],0.0367877816469753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,1499,29,2.16 [0.94-4.93],0.0690333751713816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,1729,38,4.80 [3.20-7.19],3.3715586351292105e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,1708,37,3.88 [2.01-7.49],5.273517033642682e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,1714,37,4.24 [2.46-7.31],1.9909598229989777e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,1675,38,2.98 [1.77-5.01],3.943593723181594e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2AP,CD2-associated protein,1724,39,1.29 [0.85-1.94],0.2282049661753122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,1471,29,10.51 [4.13-26.73],7.768865674844209e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,1736,37,4.95 [2.48-9.87],5.499743248813265e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,1733,39,4.15 [2.52-6.83],2.2100722814155964e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,1740,39,2.51 [1.54-4.08],0.0002178602178826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,1728,37,7.64 [4.18-13.94],3.604479698427273e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,1722,38,8.76 [5.05-15.19],1.0520790542172507e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,1729,38,1.30 [0.87-1.93],0.2018780678793946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,1731,37,3.75 [1.26-11.12],0.0171627171444163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD36,Platelet glycoprotein 4,1444,28,0.98 [0.45-2.12],0.9496655835664104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1722,38,5.51 [3.15-9.62],2.012157964990393e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,1432,28,1.54 [0.57-4.18],0.3947278614190574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,1475,30,0.38 [0.10-1.48],0.164884763483253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,1444,28,0.92 [0.57-1.50],0.7363337129664966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,1709,36,2.57 [1.45-4.54],0.0011753974547713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,1716,37,2.32 [1.44-3.74],0.0005156307888969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40LG,CD40 ligand,1738,37,1.31 [0.89-1.93],0.169430758407196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,1720,39,12.32 [6.05-25.10],4.547772539517703e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,1721,37,3.79 [1.65-8.74],0.0017362103057106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,1738,39,6.90 [3.39-14.03],9.803180975865044e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,1659,37,10.81 [5.82-20.08],5.1272309196972326e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,1713,37,5.59 [1.08-28.86],0.0399964249609688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,1659,39,11.43 [6.37-20.51],2.9950637324889876e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,1498,30,0.89 [0.44-1.82],0.7493731180654395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD6,T-cell differentiation antigen CD6,1736,37,0.71 [0.41-1.22],0.2127617848146931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD63,CD63 antigen,1705,37,1.55 [0.84-2.84],0.1584319257654826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD69,Early activation antigen CD69,1716,39,1.05 [0.75-1.47],0.7636602280625947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,1440,28,2.32 [1.27-4.24],0.0062492678083251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,1713,36,4.46 [2.30-8.65],9.464630701503637e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,1471,29,1.61 [0.77-3.35],0.2064484905590356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,1736,37,5.73 [3.01-10.92],1.0646323578506285e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,1738,37,3.72 [2.50-5.51],6.843831228464856e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,1493,29,1.91 [0.82-4.45],0.1334054445583675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD82,CD82 antigen,1475,30,1.05 [0.50-2.20],0.8908097748725952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,1713,36,4.46 [2.38-8.39],3.321814040243764e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD84,SLAM family member 5,1713,36,1.51 [0.58-3.92],0.3938083243250797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,1478,29,1.95 [0.63-6.08],0.2493412826744922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,1736,37,1.05 [0.61-1.82],0.8637577583782579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,1663,38,7.12 [3.67-13.80],6.138649896789279e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,1728,37,20.45 [7.26-57.62],1.1153532866743265e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,1728,37,6.34 [2.21-18.15],0.0005775468348489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDA,Cytidine deaminase,1492,29,1.21 [0.63-2.33],0.5732348560729746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDAN1,Codanin-1,1486,27,0.25 [0.06-1.00],0.0508073003443468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,1438,27,0.87 [0.47-1.62],0.6568328405297776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,1438,27,1.11 [0.43-2.86],0.8272294063055882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,1476,29,1.72 [1.05-2.81],0.0303475735444091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,1675,38,1.32 [0.85-2.05],0.214037831655763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,1729,38,1.13 [0.81-1.58],0.4790635164441922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,1478,29,1.15 [0.82-1.62],0.4123274197634154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDCP1,CUB domain-containing protein 1,1708,37,1.21 [0.74-1.98],0.4530291742331468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,1659,39,3.06 [2.20-4.24],2.3073003817890075e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,1732,37,1.44 [0.93-2.21],0.1014496117204211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,1724,39,2.05 [1.49-2.82],1.1812103597496804e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,1724,39,1.32 [0.66-2.67],0.4333324223357577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH22,Cadherin-22,1475,30,0.91 [0.27-3.09],0.8804217051336933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH23,Cadherin-23,1486,27,2.16 [0.60-7.75],0.2382837615157435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,1736,37,4.43 [2.49-7.86],3.838799159913453e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH4,Cadherin-4,1432,28,1.17 [0.69-1.99],0.5582577529451067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,1742,39,2.92 [1.34-6.36],0.0071268720546339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,1724,39,2.39 [1.36-4.22],0.0025026192461286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR1,Cadherin-related family member 1,1661,36,1.12 [0.55-2.27],0.7498071296071707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR2,Cadherin-related family member 2,1722,38,0.55 [0.40-0.77],0.0004826298249107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR5,Cadherin-related family member 5,1724,39,0.35 [0.22-0.57],2.332420523372557e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,1438,27,2.27 [0.93-5.54],0.0704379326406997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1498,30,1.16 [0.67-2.02],0.5945598968006739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,1432,28,0.91 [0.46-1.83],0.8011061500288111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,1722,38,1.26 [0.97-1.65],0.0832714300982267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1722,38,1.09 [0.79-1.49],0.6093537299778665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,1722,38,6.82 [3.79-12.28],1.5022682209098467e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1718,37,1.31 [0.46-3.78],0.6158540963145331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,1729,37,4.02 [2.40-6.72],1.222342846697757e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1724,38,0.74 [0.33-1.65],0.4565693499938431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1478,29,0.86 [0.55-1.34],0.5113693261254182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1475,30,1.14 [0.76-1.70],0.526697989145892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1478,29,2.46 [1.07-5.66],0.0345674422440495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1475,30,2.07 [1.25-3.43],0.0049593993034154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1713,36,1.48 [1.09-2.02],0.0120545860732938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1675,38,0.87 [0.47-1.62],0.6589889805432193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1656,38,1.69 [1.20-2.38],0.0024747012917211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1499,29,3.32 [1.44-7.63],0.0047500025944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1692,39,2.59 [1.69-3.96],1.2254014230417104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,1444,28,0.75 [0.20-2.81],0.6659965878600713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,1692,39,0.83 [0.38-1.79],0.6298422178237422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,1499,29,0.63 [0.41-0.98],0.0387010926152798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,1740,39,0.74 [0.49-1.11],0.1434576371045012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1471,29,8.60 [3.45-21.40],3.810587097084715e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,1444,28,0.81 [0.26-2.52],0.7185882560430126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,1432,28,1.45 [0.99-2.13],0.0559269252728261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,1475,30,0.73 [0.38-1.38],0.3295164417224678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPJ,Centromere protein J,1475,30,0.79 [0.43-1.43],0.4292141110263991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,1439,28,0.85 [0.34-2.10],0.7214330778930582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,1438,27,2.07 [1.27-3.35],0.0032299275982098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,1676,36,1.16 [0.81-1.67],0.4075031999409022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,1461,30,1.25 [0.79-1.95],0.3396603151449158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP20,Centrosomal protein 20,1675,38,1.25 [0.88-1.77],0.2150233000066305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,1475,30,0.45 [0.19-1.08],0.07455602681936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP350,Centrosome-associated protein 350,1438,27,1.87 [1.25-2.79],0.002293366498753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP43,Centrosomal protein 43,1682,39,1.12 [0.74-1.70],0.5842003531057718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,1675,38,1.16 [0.76-1.78],0.488314135718552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CERT,Ceramide transfer protein,1661,36,1.13 [0.68-1.85],0.6417314707890217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES1,Liver carboxylesterase 1,1722,39,0.70 [0.52-0.93],0.012684321550639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES2,Cocaine esterase,1722,38,1.90 [1.24-2.92],0.003179396432287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES3,Carboxylesterase 3,1722,38,1.18 [0.83-1.67],0.3630744993022837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN2,Centrin-2,1661,36,1.28 [0.83-1.97],0.2624651805406285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN3,Centrin-3,1478,29,1.33 [0.84-2.10],0.2214018620160245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFB,Complement factor B,1473,28,0.38 [0.15-0.94],0.0367879872119988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,1675,38,1.05 [0.58-1.92],0.8614376024517998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,1505,30,4.89 [1.40-17.15],0.013123260248933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFH,Complement factor H,1400,28,0.37 [0.10-1.40],0.1427482126870501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR2,Complement factor H-related protein 2,1494,30,1.09 [0.60-1.98],0.7719640811076455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR4,Complement factor H-related protein 4,1501,30,0.76 [0.49-1.18],0.2185692529150243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR5,Complement factor H-related protein 5,1481,29,3.42 [1.56-7.52],0.0021685809788678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFI,Complement factor I,1505,30,0.35 [0.08-1.58],0.1711798371500486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,1505,30,0.20 [0.06-0.67],0.0095424092726045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,1728,37,1.60 [1.18-2.17],0.0023717410739276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1502,29,1.32 [0.96-1.81],0.0838722360704596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGN,Cingulin,1456,28,1.14 [0.53-2.46],0.7317427705697479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,1724,39,3.79 [2.40-6.00],1.2015975582627413e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1675,38,0.97 [0.62-1.54],0.9137767405336163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAD,Chondroadherin,1471,29,0.63 [0.35-1.16],0.1382521733594601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1486,27,4.26 [2.48-7.31],1.5504660962114473e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,1490,30,2.32 [1.22-4.43],0.0104827849707449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,1692,39,0.94 [0.40-2.17],0.8794862696862875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,1499,29,1.25 [0.98-1.61],0.0753319067307335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,1729,37,3.55 [2.29-5.52],1.692988584811876e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,1681,38,1.88 [1.41-2.50],1.7098093216765535e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHIT1,Chitotriosidase-1,1724,39,1.01 [0.85-1.19],0.9539344698386104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,1731,39,2.64 [1.26-5.50],0.0097263444796577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,1456,28,0.68 [0.36-1.29],0.2392749315085764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,1708,37,1.15 [0.79-1.67],0.4775174921570037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,1493,29,0.97 [0.52-1.82],0.9268504745380302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,1432,28,0.89 [0.51-1.55],0.6764898956154637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,1721,37,5.49 [2.61-11.56],7.229636554989847e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL2,Chordin-like protein 2,1724,39,0.93 [0.57-1.52],0.7668425395719136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,1456,28,0.89 [0.32-2.49],0.819648035771324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIAPIN1,Anamorsin,1729,38,1.26 [0.80-1.97],0.3121253025347525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,1499,29,1.11 [0.59-2.07],0.7536786875095922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,1475,30,1.00 [0.48-2.08],0.990375775646734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,1478,29,1.08 [0.74-1.58],0.6983133976926019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIT,Citron Rho-interacting kinase,1456,28,1.10 [0.51-2.37],0.8078895640646279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,1732,37,6.55 [3.87-11.08],2.544609259135544e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,1499,29,3.02 [2.00-4.57],1.7640665621280845e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1711,37,1.46 [0.92-2.30],0.1065012268615477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLASP1,CLIP-associating protein 1,1438,27,0.85 [0.46-1.57],0.6081029968127603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,1721,39,1.92 [1.36-2.72],0.0002407448286789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,1708,37,3.59 [1.60-8.02],0.0018734421135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,1724,37,0.93 [0.52-1.66],0.804216845311245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,1444,28,4.38 [1.33-14.43],0.0152575545298931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,1728,37,10.16 [4.90-21.10],4.913325580843677e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,1692,39,7.21 [4.42-11.76],2.305013943037928e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,1736,37,1.27 [0.95-1.70],0.1122791704519786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,1456,28,0.54 [0.19-1.58],0.2617096766436755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC3B,Tetranectin,1464,28,0.37 [0.10-1.39],0.1404899175052451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,1713,36,1.98 [0.87-4.47],0.1020396163086775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,1713,36,1.00 [0.54-1.85],0.9950204397928027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,1713,36,2.40 [1.61-3.59],1.779534322022042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,1713,36,1.85 [0.79-4.33],0.1564823645305047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,1497,29,1.40 [0.67-2.94],0.3723903212101753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,1720,39,10.88 [4.86-24.37],6.522720718901769e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,1675,38,2.62 [1.58-4.34],0.000186056464482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,1738,37,3.91 [2.26-6.79],1.1809424071734838e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,1456,28,1.24 [0.57-2.71],0.5831908245001494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,1456,28,0.97 [0.37-2.57],0.9546658478495186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLINT1,Clathrin interactor 1,1438,27,1.10 [0.46-2.60],0.8313434587218655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,1713,36,1.02 [0.78-1.33],0.8891289759030274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,1740,39,30.68 [12.76-73.78],2.063349693905975e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLNS1A,Methylosome subunit pICln,1456,28,1.20 [0.44-3.24],0.7223383550292419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1704,37,1.33 [0.99-1.78],0.0586380546050611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPS,Colipase,1726,37,0.83 [0.58-1.19],0.3213544503675084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSPN,Claspin,1657,36,0.86 [0.34-2.14],0.7377200526825298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN1,Calsyntenin-1,1661,36,0.82 [0.45-1.48],0.5027593396577718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,1738,37,1.07 [0.55-2.09],0.8343059535197426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN3,Calsyntenin-3,1486,27,1.14 [0.36-3.62],0.8235884112232857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLTA,Clathrin light chain A,1692,39,1.48 [0.85-2.59],0.1651026443494936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLU,Clusterin,1505,30,1.15 [0.34-3.91],0.8236441669007107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLUL1,Clusterin-like protein 1,1721,39,1.72 [1.00-2.95],0.0482854846178014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,1493,29,1.18 [0.80-1.74],0.3939505511164477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMIP,C-Maf-inducing protein,1490,30,0.92 [0.61-1.38],0.6799901359654149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,1733,39,0.83 [0.48-1.43],0.4975058535577898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,1432,28,0.94 [0.46-1.93],0.8603529572122836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1456,30,0.82 [0.52-1.29],0.3897552621467726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY2,Protein canopy homolog 2,1692,39,1.21 [0.83-1.77],0.3262958325273231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY4,Protein canopy homolog 4,1722,38,1.45 [0.98-2.13],0.0627145300378132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNST,Consortin,1724,39,1.12 [0.86-1.46],0.3913634042179444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTF,Ciliary neurotrophic factor,1432,28,1.83 [0.60-5.55],0.2863588135241112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,1742,39,5.00 [1.96-12.76],0.0007659094292066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,1740,39,2.11 [1.18-3.75],0.0112334129435873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN3,Contactin-3,1728,37,0.61 [0.28-1.34],0.2183179227051867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN4,Contactin-4,1728,37,3.47 [1.10-11.03],0.0344870727154785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN5,Contactin-5,1720,37,0.61 [0.28-1.30],0.1985046279284051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,1713,36,1.77 [0.93-3.36],0.0798156089367068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,1456,28,0.94 [0.62-1.41],0.757293154514102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,1493,29,1.84 [1.02-3.31],0.0423497079870816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,1499,29,3.41 [1.26-9.22],0.0156394691336807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,1725,39,15.02 [6.12-36.88],3.329955026484237e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,1742,39,2.90 [0.99-8.50],0.0526478312408734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,1478,29,1.18 [0.64-2.19],0.5971434248658096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,1456,28,1.22 [0.80-1.86],0.3547920649166511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,1461,30,1.39 [0.94-2.05],0.1008090257268536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,1499,29,3.71 [1.20-11.50],0.0232610616498202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,1724,39,2.30 [1.39-3.82],0.0012622331014037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,1471,30,0.84 [0.44-1.62],0.6089895775299892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,1471,29,2.03 [1.15-3.55],0.0138813197375738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,1742,39,6.77 [4.25-10.78],7.260008110397886e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,1713,36,1.97 [1.25-3.10],0.0036008083688155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,1475,30,0.93 [0.41-2.11],0.8561570281977338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,1714,37,9.25 [4.58-18.70],5.595556571535182e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD1,COMM domain-containing protein 1,1461,30,1.14 [0.64-2.03],0.650790788528439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD9,COMM domain-containing protein 9,1490,30,1.35 [0.61-3.00],0.456603513580947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,1706,39,1.07 [0.48-2.40],0.8640832497091273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMT,Catechol O-methyltransferase,1676,39,0.96 [0.68-1.36],0.8240779091200894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPB2,Coatomer subunit beta',1439,28,0.96 [0.41-2.26],0.9328299769466638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPE,Coatomer subunit epsilon,1661,36,1.35 [0.89-2.04],0.1568201340336123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1461,30,0.80 [0.34-1.90],0.6143668292309681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO1A,Coronin-1A,1686,37,1.08 [0.79-1.49],0.6234399066143306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,1432,28,1.93 [1.14-3.25],0.0139796427458679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1722,38,1.39 [0.96-2.03],0.0838214390602326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,1493,29,2.14 [0.86-5.30],0.1015913554168853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA1,Carboxypeptidase A1,1742,39,0.70 [0.48-1.01],0.0580178779329444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,1731,37,1.22 [0.85-1.76],0.2858495589742343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,1431,28,2.51 [1.11-5.66],0.0264613880804613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB1,Carboxypeptidase B,1742,39,0.75 [0.48-1.18],0.21056626305397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB2,Carboxypeptidase B2,1501,30,0.52 [0.13-2.12],0.3594571802275715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPE,Carboxypeptidase E,1724,39,0.77 [0.40-1.47],0.4236117390853094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPLX2,Complexin-2,1438,27,1.24 [0.47-3.28],0.666011467024673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPM,Carboxypeptidase M,1727,37,0.66 [0.32-1.37],0.2649504097758903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1444,28,0.74 [0.19-2.83],0.6564218898372621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,1736,37,1.35 [0.89-2.05],0.1546355572798295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPQ,Carboxypeptidase Q,1498,29,1.20 [0.50-2.90],0.6794725149696595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,1439,28,1.58 [0.83-3.01],0.1669381638847271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,1738,39,1.11 [0.54-2.31],0.7728948394542177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,1729,38,1.43 [0.96-2.13],0.0756078720135211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,1493,29,5.54 [1.77-17.35],0.0032696885970917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR1,Complement receptor type 1,1500,29,1.95 [0.79-4.83],0.1504985569868838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,1733,39,1.53 [0.86-2.71],0.1469817865125068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1675,38,1.19 [0.88-1.62],0.2649696886944262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRADD,Death domain-containing protein CRADD,1704,37,1.07 [0.73-1.58],0.7134933683376234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,1438,27,1.28 [0.68-2.40],0.4491722922537476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,1438,27,0.65 [0.14-2.90],0.5681464894762227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREG1,Protein CREG1,1705,38,0.50 [0.23-1.06],0.0695467589670637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,1471,29,3.90 [1.89-8.05],0.0002297721881072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,1721,37,1.98 [1.27-3.07],0.002360658094456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRH,Corticoliberin,1671,38,1.00 [0.72-1.39],0.9931432420620292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,1714,37,3.11 [1.15-8.41],0.0258588267373213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,1692,39,0.79 [0.47-1.33],0.3697065422958397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,1726,37,3.16 [0.94-10.61],0.0627912281439702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,1708,37,2.35 [1.34-4.10],0.0026857626751064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,1740,39,0.88 [0.58-1.33],0.5384063190045036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,1486,29,1.07 [0.29-3.99],0.9160478730346524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRKL,Crk-like protein,1720,37,1.05 [0.79-1.38],0.7449716871237835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,1726,37,1.07 [0.36-3.22],0.903681953564232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,1684,39,1.33 [0.93-1.88],0.1150973878912523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,1742,39,0.83 [0.33-2.08],0.6927270009060471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,1708,37,2.46 [1.49-4.06],0.0004393122074694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAP,Cartilage-associated protein,1456,28,1.04 [0.48-2.25],0.92936078961572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRX,Cone-rod homeobox protein,1692,39,1.25 [1.04-1.52],0.0199846472569993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB1,Beta-crystallin B1,1493,29,1.22 [0.71-2.10],0.4614304140595088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB2,Beta-crystallin B2,1486,27,1.29 [0.97-1.70],0.0765352739367412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYGD,Gamma-crystallin D,1486,27,0.95 [0.67-1.35],0.7839128531403927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,1432,28,0.60 [0.33-1.09],0.0949724465182646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,1461,30,0.95 [0.65-1.39],0.7811164530577516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,1439,28,0.91 [0.64-1.30],0.6026269168364518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,1726,37,4.88 [2.25-10.60],6.214726067261194e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,1502,29,2.24 [1.01-4.99],0.0483406755307979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,1439,28,1.03 [0.39-2.74],0.9462410939632584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1708,37,0.96 [0.58-1.60],0.884909483559429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,1444,28,1.25 [0.55-2.84],0.5976502947263673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,1676,36,0.84 [0.45-1.58],0.5966165925599911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,1444,28,1.83 [0.97-3.48],0.0629937897237387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,1502,29,2.07 [0.59-7.24],0.2569953304158506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,1444,28,1.19 [0.70-2.03],0.5126755211317355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,1498,30,0.92 [0.42-2.01],0.8351542532310974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,1499,29,4.40 [1.69-11.50],0.0024829613040628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,1432,28,1.07 [0.53-2.13],0.8547365458851786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,1439,28,1.11 [0.78-1.56],0.5695162093467541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1319,26,1.38 [0.97-1.96],0.0740067785034408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,1726,39,9.66 [5.51-16.95],2.460089135397097e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,1692,36,1.73 [1.07-2.81],0.0265076640934134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,1674,39,2.25 [1.34-3.79],0.002282956268794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST7,Cystatin-F,1721,37,1.07 [0.80-1.43],0.6406876912720001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,1697,39,3.48 [2.04-5.94],4.943569429700432e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,1470,30,1.08 [0.57-2.04],0.8231610632002342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTBS,Di-N-acetylchitobiase,1474,29,0.90 [0.30-2.67],0.8430744258552824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTF1,Cardiotrophin-1,1692,39,1.25 [0.92-1.70],0.1567333127316217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,1499,29,3.99 [1.74-9.12],0.0010606015516613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,1499,29,0.64 [0.19-2.13],0.4648451608466987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTNNA1,Catenin alpha-1,1432,28,1.37 [0.56-3.37],0.4894150131053597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRB1,Chymotrypsinogen B,1728,37,0.75 [0.49-1.13],0.1704597098612963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,1714,37,0.64 [0.45-0.91],0.0122678820741602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,1486,27,0.67 [0.42-1.06],0.0873931388724015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,1722,39,1.69 [1.03-2.78],0.0367512263439689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,1722,37,1.06 [0.55-2.03],0.8689756804336612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,1619,38,1.03 [0.55-1.91],0.9355735635338724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,1471,29,2.09 [1.17-3.73],0.0123610398697518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSF,Cathepsin F,1729,38,3.38 [1.93-5.90],1.9950885368598453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,1690,39,1.87 [1.26-2.79],0.002071898144021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,1724,39,3.81 [1.34-10.82],0.0119040288579796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,1738,37,1.54 [0.64-3.72],0.3332246162376643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,1342,30,2.87 [0.67-12.35],0.1571198393275401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,1736,39,0.75 [0.41-1.38],0.3519781116560402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,1728,39,4.33 [2.05-9.13],0.0001174938082899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,1456,28,0.55 [0.18-1.70],0.2979688756870513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,1471,29,1.08 [0.62-1.88],0.7886581620516099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,1708,37,5.21 [2.81-9.63],1.450768131361412e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,1713,36,2.67 [1.73-4.13],8.761961194990878e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL1,Growth-regulated alpha protein,1719,37,1.18 [0.91-1.53],0.2004902749029024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,1726,37,1.15 [0.77-1.72],0.498236712433916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,1736,37,1.32 [0.96-1.82],0.0928962286841951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,1676,36,0.96 [0.47-1.96],0.91110116397136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,1736,37,1.48 [1.13-1.93],0.0042401239044589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,1676,36,1.31 [0.91-1.90],0.1516197647234217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,1739,39,10.14 [4.66-22.08],5.325504205479139e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,1738,37,1.65 [0.84-3.26],0.1470935192733246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,1716,37,1.20 [0.87-1.66],0.257550351361226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,1720,39,1.07 [0.84-1.35],0.5964066564117381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,1738,37,1.49 [1.06-2.11],0.0223502903516052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL8,Interleukin-8,1709,38,1.35 [1.00-1.83],0.051542377924527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,1726,37,1.50 [1.07-2.09],0.0187171806870698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5A,Cytochrome b5,1438,27,0.53 [0.27-1.03],0.0605163596847251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,1462,29,1.46 [0.86-2.50],0.1623447934176629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1439,28,0.65 [0.34-1.22],0.1802813570295109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTH3,Cytohesin-3,1438,27,0.68 [0.37-1.25],0.2112586646137049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,1499,29,3.00 [0.82-10.97],0.0972748617314551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,1471,29,1.05 [0.68-1.60],0.8290090232207921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAB2,Disabled homolog 2,1740,39,1.14 [0.88-1.48],0.3279695223158547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAG1,Dystroglycan,1726,37,1.51 [0.81-2.81],0.1966807081523754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,1444,28,1.01 [0.56-1.82],0.9765790086164626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPK2,Death-associated protein kinase 2,1444,28,1.20 [0.68-2.12],0.5295640661857075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1713,36,0.99 [0.77-1.26],0.9131291336571636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",1704,37,1.09 [0.73-1.63],0.6813254746643931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBH,Dopamine beta-hydroxylase,1501,29,0.86 [0.65-1.16],0.3266174483427732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBI,Acyl-CoA-binding protein,1717,37,1.37 [0.95-1.99],0.0944576998411584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBN1,Drebrin,1444,28,1.46 [0.77-2.74],0.2451251503592358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBNL,Drebrin-like protein,1726,37,1.06 [0.77-1.45],0.7277309521619284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1729,38,5.59 [2.85-10.95],5.31048854951886e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,1456,28,1.07 [0.19-6.08],0.938488006966103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,1438,27,1.24 [0.74-2.08],0.421924322715004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCLRE1C,Protein artemis,1438,27,1.78 [0.56-5.72],0.3312063213611253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,1692,39,16.79 [6.95-40.58],3.7036114946814976e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTD,Deoxycytidylate deaminase,1471,29,0.95 [0.65-1.38],0.7895157192689547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN1,Dynactin subunit 1,1740,39,1.27 [0.82-1.96],0.289090125415368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN2,Dynactin subunit 2,1722,38,1.02 [0.76-1.39],0.8799061698994556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN6,Dynactin subunit 6,1661,36,1.12 [0.79-1.60],0.5149583265437918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,1724,39,2.45 [1.02-5.89],0.0446781422939475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D1,DCN1-like protein 1,1432,28,0.99 [0.61-1.61],0.9615295409739582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D2,DCN1-like protein 2,1438,27,1.09 [0.73-1.62],0.6900669974746302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCXR,L-xylulose reductase,1729,38,0.46 [0.26-0.79],0.0050304081142361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,1439,28,0.71 [0.26-1.95],0.5014943378390336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1722,38,2.72 [1.54-4.80],0.0005379714610255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,1724,39,1.28 [0.77-2.13],0.3402046136613724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDHD2,Phospholipase DDHD2,1498,30,0.88 [0.51-1.50],0.6379913959564232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,1471,29,0.68 [0.43-1.08],0.1028233729210737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,1736,37,4.03 [1.36-11.97],0.0121012498266446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDT,D-dopachrome decarboxylase,1499,29,0.47 [0.20-1.14],0.0947937428860149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,1478,29,1.02 [0.55-1.89],0.9623189506745072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,1456,28,0.63 [0.20-2.00],0.4340964605425935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,1444,28,0.48 [0.08-2.86],0.422431576144886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,1444,28,0.44 [0.17-1.17],0.1001602783734369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,1456,28,0.36 [0.15-0.84],0.0182847874764939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,1675,38,0.99 [0.62-1.58],0.9511484780026402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1713,36,1.07 [0.78-1.46],0.6869328605833718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,1676,38,1.99 [1.37-2.89],0.0002757377773541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,1439,28,1.02 [0.47-2.20],0.9674403346599968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,1432,28,0.60 [0.26-1.39],0.2335116749371668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB116,Beta-defensin 116,1432,28,0.73 [0.40-1.36],0.3233358413950729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB118,Beta-defensin 118,1432,28,1.02 [0.58-1.80],0.9364383786797869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,1710,38,1.18 [0.99-1.41],0.0660246375424282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,1439,28,0.98 [0.43-2.22],0.9570096098221784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENR,Density-regulated protein,1444,28,0.81 [0.40-1.68],0.5778332193440572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,1738,37,1.06 [0.69-1.63],0.7759656163370234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGCR6,Protein DGCR6,1432,28,1.20 [0.60-2.42],0.6052082414022508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,1444,28,1.00 [0.51-1.96],0.9973253202482156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,1676,36,0.71 [0.30-1.72],0.4509617591340753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,1439,28,1.02 [0.50-2.08],0.9499598015027028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,1490,30,0.68 [0.27-1.73],0.4154327857158797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1486,27,1.78 [1.14-2.78],0.0115679637359025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",1720,39,1.08 [0.83-1.40],0.5613375785626686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,1456,28,1.03 [0.47-2.26],0.9466209744579528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,1471,29,2.28 [0.91-5.73],0.0798330712560682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK1,Dickkopf-related protein 1,1736,37,1.51 [0.93-2.46],0.0963991568855655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,1742,39,4.50 [1.93-10.46],0.0004848081856082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,1707,37,3.80 [2.54-5.69],8.076046644169268e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKKL1,Dickkopf-like protein 1,1722,38,1.46 [0.99-2.17],0.0570306730157214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLG4,Disks large homolog 4,1486,27,0.91 [0.54-1.55],0.7384893572445547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLGAP5,Disks large-associated protein 5,1498,30,1.12 [0.65-1.93],0.6787499293932291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,1742,39,2.21 [1.39-3.52],0.0008397661883986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,1729,38,7.81 [4.36-13.98],4.487016789882685e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL4,Delta-like protein 4,1461,30,1.03 [0.67-1.57],0.8999994354701535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,1461,30,1.44 [0.89-2.35],0.1418262644145696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,1461,30,0.64 [0.41-0.99],0.0450796241538166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,1438,27,0.58 [0.21-1.61],0.2939621629822268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,1734,37,1.22 [0.85-1.75],0.292142299734851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,1486,27,0.81 [0.49-1.33],0.403825519502305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,1722,38,1.27 [0.92-1.76],0.1469272614822865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,1478,29,1.22 [0.75-2.00],0.4165018515904651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,1471,29,0.71 [0.37-1.36],0.299272149677927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,1459,29,1.01 [0.66-1.54],0.973166261823903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,1692,39,1.45 [1.02-2.06],0.0391677968592714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,1486,27,0.68 [0.24-1.95],0.4734797824861525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,1461,30,1.10 [0.73-1.63],0.6526952054019066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,1478,29,0.91 [0.57-1.44],0.683308346345862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,1711,37,2.65 [0.96-7.34],0.0610171473533671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNLZ,DNL-type zinc finger protein,1432,28,1.33 [0.94-1.89],0.1123619211079206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM1,Dynamin-1,1478,29,1.01 [0.74-1.39],0.9263181822309592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,1498,30,1.58 [0.90-2.77],0.10929507708318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNMBP,Dynamin-binding protein,1708,37,1.58 [1.05-2.37],0.0265035581782581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,1486,27,1.03 [0.55-1.92],0.9284373310569772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1725,37,0.80 [0.47-1.36],0.4091949534504799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,1456,28,0.80 [0.27-2.41],0.6975500267243132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,1432,28,1.15 [0.87-1.52],0.3349712862716961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK1,Docking protein 1,1486,27,1.01 [0.77-1.32],0.9554720578306288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK2,Docking protein 2,1724,39,1.06 [0.84-1.34],0.6457900406819186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP1,Dipeptidase 1,1704,37,0.63 [0.38-1.02],0.059753904767898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP2,Dipeptidase 2,1722,38,2.07 [0.83-5.19],0.1206053886168959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,1713,36,0.86 [0.40-1.83],0.6932487260607785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,1707,39,1.03 [0.43-2.43],0.9492197010254538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,1722,38,2.51 [1.19-5.30],0.0159375238998032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,1712,38,1.54 [0.95-2.49],0.081013220782695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,1742,39,30.72 [9.49-99.39],1.0883315818615544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,1733,39,1.99 [1.39-2.85],0.0001611147020119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,1708,37,3.58 [1.93-6.63],5.1077708315202456e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,1722,38,1.23 [0.75-2.01],0.4152157063835998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,1709,36,2.83 [2.06-3.88],1.0278511175087735e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,1498,30,1.16 [0.47-2.88],0.7475129767996983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,1728,37,6.89 [3.08-15.43],2.659824556867132e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,1735,39,3.34 [1.53-7.26],0.0023682209035426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,1714,38,1.34 [0.76-2.35],0.3077202792094121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,1471,29,0.93 [0.62-1.40],0.7368189872126845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,1488,30,2.08 [1.06-4.07],0.0328138194712616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,1456,28,0.83 [0.44-1.54],0.5466045100955718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,1722,38,10.79 [3.90-29.83],4.597033898071544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTYMK,Thymidylate kinase,1493,29,0.90 [0.55-1.49],0.6865832965819172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUOX2,Dual oxidase 2,1692,39,1.02 [0.69-1.50],0.925496819645898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,1490,30,1.26 [0.59-2.67],0.5525507649525965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,1456,28,1.10 [0.65-1.84],0.7251929838373365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,1661,36,1.29 [1.01-1.65],0.044793797963463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1478,29,1.10 [0.79-1.54],0.5778590965347351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DXO,Decapping and exoribonuclease protein,1486,27,0.85 [0.38-1.90],0.6958707109996123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1490,30,1.64 [0.89-2.99],0.1113830424555897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,1456,28,0.96 [0.62-1.50],0.8642336358642945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,1490,30,0.78 [0.35-1.73],0.5463320543706265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1708,37,1.12 [0.83-1.51],0.4651558543151642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,1735,39,5.58 [2.74-11.35],2.055393708089108e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,1661,36,0.99 [0.45-2.19],0.986495721499838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1493,29,0.58 [0.36-0.93],0.0233360160191642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",1461,30,0.90 [0.63-1.29],0.5683869734507134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,1439,28,1.60 [1.03-2.47],0.034837292471616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECM1,Extracellular matrix protein 1,1461,30,0.43 [0.20-0.94],0.0351837352904971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,1432,28,1.32 [0.66-2.63],0.4360979249981189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,1740,39,4.41 [2.98-6.53],1.0929618177563001e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,1713,36,1.17 [0.85-1.62],0.3405343604702662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,1490,30,0.78 [0.32-1.92],0.5912850681154561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1439,28,1.23 [0.47-3.25],0.6775356563188162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,1498,30,1.13 [0.69-1.85],0.6182892796208899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1692,39,3.03 [1.50-6.11],0.001944137780589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,1461,30,5.61 [1.97-15.98],0.0012222311939729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDNRB,Endothelin receptor type B,1444,28,1.75 [1.06-2.89],0.0286256135193211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EEF1D,Elongation factor 1-delta,1493,29,1.16 [0.80-1.68],0.441808886971848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,1478,29,6.00 [2.76-13.04],6.0172467024419004e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,1475,30,1.09 [0.44-2.72],0.8506692884518006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1730,39,6.36 [3.19-12.69],1.5514648066353154e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,1498,30,2.27 [1.29-3.98],0.0045202311739397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,1727,37,8.51 [4.72-15.32],1.0336127055275432e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,1705,37,11.02 [6.39-19.01],6.477336462740701e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,1456,28,1.53 [1.06-2.20],0.021746862983013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGF,Pro-epidermal growth factor,1711,37,1.16 [0.87-1.55],0.301826132660421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,1675,38,2.42 [1.24-4.74],0.0097316770591963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,1478,29,1.68 [0.62-4.56],0.3128544515138712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFR,Epidermal growth factor receptor,1742,39,0.60 [0.14-2.68],0.5071753274672879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGLN1,Egl nine homolog 1,1713,36,1.19 [0.78-1.82],0.4212217989385356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHBP1,EH domain-binding protein 1,1493,29,1.14 [0.71-1.85],0.5816731961593264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHD3,EH domain-containing protein 3,1461,30,0.96 [0.71-1.30],0.7860492013471863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1486,27,0.53 [0.21-1.35],0.181509604438613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1471,29,1.05 [0.77-1.44],0.7452725647217857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1439,28,1.11 [0.66-1.87],0.6927443312865367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1461,30,0.77 [0.30-1.98],0.5890611878874646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,1708,37,0.98 [0.60-1.59],0.9325195872306314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,1444,28,1.02 [0.68-1.54],0.9199678236163176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1724,39,1.18 [0.79-1.76],0.4285308647149937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1738,37,1.22 [0.90-1.66],0.2044904868673664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1498,30,1.15 [0.70-1.88],0.5736364706096486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,1439,28,2.00 [1.34-2.98],0.0006577854311191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,1676,36,0.49 [0.16-1.47],0.2039407188753172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,1498,30,1.06 [0.70-1.62],0.7684843735059778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,1432,28,0.65 [0.39-1.11],0.1139599312391136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,1493,29,4.74 [2.23-10.08],5.1319838032125175e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOA,Elongin-A,1722,38,0.99 [0.57-1.72],0.9842998817151044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOB,Elongin-B,1439,28,1.77 [1.19-2.63],0.0044912715685643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,1676,36,2.61 [1.62-4.20],7.928017659425074e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1373,26,1.93 [1.18-3.14],0.0088118205427516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,1742,39,3.43 [0.81-14.50],0.0942584161711338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO1,Alpha-enolase,1720,37,1.04 [0.71-1.53],0.843576336223247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO2,Gamma-enolase,1736,37,1.34 [0.87-2.06],0.1877456303387068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO3,Beta-enolase,1461,30,0.46 [0.24-0.87],0.0175518628242345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,1490,30,0.64 [0.35-1.18],0.1562354809890335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1439,28,0.95 [0.28-3.24],0.9310324215011596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,1439,28,1.10 [0.51-2.37],0.808253569109289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1742,39,0.58 [0.24-1.37],0.212552917056087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1726,37,0.85 [0.43-1.69],0.6415064632817264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1461,30,1.63 [0.65-4.09],0.2971519104359525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1653,34,0.87 [0.62-1.22],0.4294960679970705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENSA,Alpha-endosulfine,1490,30,0.80 [0.40-1.60],0.5289640115827647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1675,38,1.04 [0.59-1.82],0.9008705499213152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1692,39,1.29 [0.34-4.90],0.7078791201001023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1692,39,1.59 [0.49-5.15],0.4407345487414675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,1461,30,0.79 [0.45-1.40],0.4259497339485566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EP300,Histone acetyltransferase p300,1444,28,2.26 [0.95-5.34],0.0640105158198995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,1456,28,1.08 [0.61-1.90],0.7914198816662681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,1716,37,1.28 [0.96-1.71],0.0972034088384647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPGN,Epigen,1490,30,0.74 [0.28-1.99],0.5544202427451717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,1725,37,4.04 [1.84-8.89],0.0005146129745027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,1661,36,1.17 [0.77-1.77],0.4611216213100221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,1666,37,5.37 [3.61-7.97],9.636216548576866e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,1471,29,7.13 [2.25-22.64],0.00085680315797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,1742,39,8.62 [5.20-14.28],6.502297535841834e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,1704,37,6.34 [3.08-13.08],5.685049810363809e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,1692,39,0.76 [0.44-1.31],0.3206729853654431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPN1,Epsin-1,1475,30,0.48 [0.16-1.45],0.1916601613232321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,1713,36,1.08 [0.77-1.53],0.6441538974769931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPPK1,Epiplakin,1461,30,1.16 [0.77-1.77],0.478144453104808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1738,39,4.70 [2.41-9.15],5.400374624926451e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,1729,38,0.37 [0.13-1.02],0.0553148252102731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,1712,37,1.01 [0.22-4.56],0.9885360267470586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,1729,38,1.68 [0.69-4.05],0.2513697123106803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBIN,Erbin,1722,38,1.21 [0.91-1.61],0.1945220496846872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERC2,ERC protein 2,1456,28,0.80 [0.44-1.46],0.4661706906617973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,1438,27,0.85 [0.25-2.93],0.7940732800786076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EREG,Proepiregulin,1704,37,1.34 [0.97-1.85],0.079444509477675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,1475,30,0.52 [0.16-1.63],0.259968038273352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,1444,28,1.23 [0.54-2.79],0.621872069104462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1490,30,0.65 [0.26-1.63],0.3622271319621133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,1471,29,1.02 [0.75-1.38],0.919365066477176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,1720,38,0.74 [0.25-2.20],0.5852343135086815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1439,28,1.18 [0.58-2.40],0.6564550705419946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,1742,39,9.90 [5.22-18.78],2.2049128736595467e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,1714,37,2.02 [0.94-4.32],0.0709984520379576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESPL1,Separin,1438,27,1.48 [0.92-2.36],0.1030769959797941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESR1,Estrogen receptor,1444,28,0.52 [0.19-1.43],0.2044208191621202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESYT2,Extended synaptotagmin-2,1486,27,1.28 [0.84-1.97],0.252166605920304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI2B,Protein EVI2B,1438,27,1.80 [1.12-2.90],0.0158607451966688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,1444,28,0.94 [0.62-1.41],0.7550415246768105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVPL,Envoplakin,1475,30,1.86 [0.84-4.12],0.1272169800256236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXOSC10,Exosome component 10,1439,28,0.83 [0.42-1.66],0.6028812328380149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXTL1,Exostosin-like 1,1439,28,0.96 [0.44-2.12],0.9282766713750836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EZR,Ezrin,1736,37,0.96 [0.29-3.18],0.941433838338858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F10,Coagulation factor X,1502,29,1.08 [0.32-3.61],0.8999510048988911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11,Coagulation factor XI,1484,30,0.70 [0.20-2.40],0.56582367590639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11R,Junctional adhesion molecule A,1728,37,1.81 [1.11-2.95],0.0169679232988741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F12,Coagulation factor XII,1505,30,0.48 [0.23-1.01],0.0519958124286719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F13B,Coagulation factor XIII B chain,1498,30,0.81 [0.24-2.80],0.7416153106276254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2,Prothrombin,1505,30,0.31 [0.05-2.11],0.2309293138516019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,1721,37,1.81 [1.10-2.98],0.0187135206210948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,1729,39,6.74 [3.31-13.73],1.5096170826218798e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F7,Coagulation factor VII,1731,39,1.50 [0.64-3.53],0.3532747964916336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F9,Coagulation factor IX,1732,39,0.52 [0.12-2.28],0.3868480525328687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",1714,37,1.64 [1.26-2.13],0.0002317144901762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",1724,39,1.91 [1.42-2.55],1.3644470720970136e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",1493,29,2.59 [1.61-4.17],8.877804166300529e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",1742,39,2.58 [1.83-3.64],7.3887238301137e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP5,Fatty acid-binding protein 5,1734,37,1.76 [1.22-2.53],0.0023645739079911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,1689,39,2.63 [1.85-3.74],7.80969035712353e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,1713,36,1.47 [0.90-2.41],0.1248525202028768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FADD,FAS-associated death domain protein,1724,39,1.08 [0.74-1.58],0.6757258387296305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM13A,Protein FAM13A,1478,29,0.92 [0.53-1.58],0.7577189343096827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171A2,Protein FAM171A2,1498,30,0.89 [0.70-1.13],0.3435534914952143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,1490,30,1.27 [0.42-3.85],0.673224572114236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,1461,30,1.05 [0.60-1.84],0.8761198630991053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM20A,Pseudokinase FAM20A,1493,29,0.67 [0.19-2.32],0.5233766827812566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,1722,38,3.44 [1.84-6.40],0.000100552740467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,1724,39,12.67 [6.93-23.18],1.6427244520482348e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,1478,29,1.47 [0.97-2.22],0.0683391310434062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAP,Prolyl endopeptidase FAP,1742,39,1.21 [0.49-3.02],0.6761822588256614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,1456,28,0.63 [0.34-1.19],0.1586698522248002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,1737,39,2.06 [1.38-3.05],0.0003610619200885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,1738,37,1.86 [0.86-4.05],0.1170615301632923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,1499,29,4.69 [2.24-9.82],4.0889487653694695e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBN2,Fibrillin-2,1456,28,0.76 [0.40-1.47],0.4153550441916261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",1724,39,0.89 [0.63-1.27],0.5377635973351886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1493,29,0.95 [0.60-1.48],0.8059492695318747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,1713,36,1.09 [0.60-1.99],0.7827900169838875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1498,30,2.20 [0.46-10.64],0.3254297432386488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,1728,37,1.76 [1.01-3.08],0.047338563241083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1726,39,1.79 [1.01-3.18],0.0465508648843292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1675,38,0.98 [0.59-1.63],0.9400184445229612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1730,39,1.60 [0.89-2.86],0.1146030153927254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN1,Ficolin-1,1501,29,0.70 [0.45-1.11],0.1296400987174181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN2,Ficolin-2,1721,39,0.49 [0.28-0.88],0.0161891077833533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,1724,39,1.15 [0.64-2.09],0.6394403607369513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,1728,37,1.52 [0.92-2.50],0.0996613680196606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL3,Fc receptor-like protein 3,1676,36,1.26 [0.75-2.11],0.3754808534364354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL5,Fc receptor-like protein 5,1728,37,1.42 [0.87-2.30],0.1613604347663454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,1713,36,1.74 [1.14-2.67],0.0105838875756975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,1675,38,1.18 [0.79-1.76],0.4169165349853615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",1439,28,1.13 [0.66-1.95],0.6546624276421489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",1439,28,1.33 [0.73-2.44],0.3531108051226378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FEN1,Flap endonuclease 1,1675,38,1.10 [0.75-1.60],0.64003886655452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,1675,38,1.18 [0.67-2.08],0.5755495020726021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FETUB,Fetuin-B,1732,39,1.42 [0.59-3.44],0.4322517068225544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,1456,28,1.61 [0.51-5.04],0.4160605157479322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1498,30,1.10 [0.72-1.67],0.6717213316785826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF12,Fibroblast growth factor 12,1444,28,0.90 [0.37-2.19],0.8226179914020981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF16,Fibroblast growth factor 16,1444,28,0.55 [0.23-1.30],0.1747521484006983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,1726,37,1.15 [0.81-1.65],0.4290406272253768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF2,Fibroblast growth factor 2,1713,36,1.17 [0.78-1.75],0.454981490209747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF20,Fibroblast growth factor 20,1444,28,0.62 [0.20-1.94],0.4120782004064635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,1735,39,1.05 [0.84-1.30],0.6726710007866883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,1737,39,1.82 [1.38-2.41],2.098091882623436e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF3,Fibroblast growth factor 3,1444,28,3.63 [1.63-8.07],0.0015572452140542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,1676,36,4.43 [2.31-8.47],7.019276802206946e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF6,Fibroblast growth factor 6,1444,28,1.08 [0.44-2.61],0.8728941181502278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF7,Fibroblast growth factor 7,1438,27,1.48 [1.10-1.99],0.0100743593719132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF9,Fibroblast growth factor 9,1435,27,1.28 [0.55-2.98],0.5642456634191761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,1729,38,0.55 [0.24-1.29],0.1702955933545641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,1499,29,0.74 [0.38-1.47],0.3941015943188121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,1486,27,0.46 [0.17-1.24],0.1251979028077656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,1729,38,3.22 [1.19-8.71],0.0214080497397905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,1471,29,2.06 [1.10-3.86],0.0231401886029351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,1502,29,3.10 [1.95-4.94],1.7865826321163724e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,1661,36,1.00 [0.63-1.59],0.9836536456722266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",1432,28,0.83 [0.49-1.42],0.4975990618203953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,1439,28,0.97 [0.49-1.89],0.9192160283622072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,1661,36,1.05 [0.70-1.57],0.8058370430009412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,1720,37,1.24 [0.87-1.76],0.2296945325997436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1498,30,1.05 [0.74-1.50],0.7755549206211556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1725,37,1.08 [0.84-1.39],0.5452485189858326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1708,37,1.81 [0.90-3.63],0.0938802589301826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1708,37,1.24 [0.90-1.70],0.1960834517501683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1657,36,1.68 [1.17-2.39],0.0046219772233289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBPL,FK506-binding protein-like,1478,29,0.90 [0.49-1.65],0.7353685886042475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,1675,38,1.18 [0.92-1.51],0.2043020314493392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1708,37,2.79 [1.41-5.54],0.0032428171472477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,1719,38,3.74 [1.76-7.95],0.0006040365490136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,1675,38,1.33 [0.49-3.61],0.5779882008539916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,1738,37,1.64 [0.70-3.84],0.256363364192163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,1729,38,0.94 [0.40-2.21],0.89038961317539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMNL1,Formin-like protein 1,1661,36,0.98 [0.64-1.50],0.9272757381977584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,1675,38,0.80 [0.35-1.82],0.5987987941058737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FN1,Fibronectin,1505,30,0.29 [0.10-0.81],0.0180057673871478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,1486,27,1.63 [0.80-3.33],0.1795787478137041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1490,30,0.86 [0.30-2.44],0.7761658082984848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,1444,28,0.83 [0.51-1.36],0.4622083162639588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,1720,38,11.89 [6.16-22.93],1.5069716030717452e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,1736,37,3.17 [1.38-7.30],0.0066697042776241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR3,Folate receptor gamma,1721,38,1.00 [0.87-1.16],0.9546739304995916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOS,Proto-oncogene c-Fos,1435,27,1.09 [0.37-3.18],0.8739208251515908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOSB,Protein fosB,1661,36,1.00 [0.44-2.28],0.9981392924318712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXJ3,Forkhead box protein J3,1444,28,1.14 [0.52-2.49],0.7393905230974094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO1,Forkhead box protein O1,1713,36,0.99 [0.69-1.41],0.9597498514491248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO3,Forkhead box protein O3,1675,38,0.86 [0.62-1.20],0.3861304874383183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,1439,28,1.23 [0.75-2.02],0.4043737237382112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD7,FERM domain-containing protein 7,1456,28,0.84 [0.32-2.21],0.7216911350061946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,1702,37,0.34 [0.14-0.78],0.0110244550255264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSHB,Follitropin subunit beta,1461,30,1.63 [0.97-2.74],0.0632939058069523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FST,Follistatin,1721,37,0.96 [0.53-1.76],0.8961487708848775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,1461,30,10.00 [3.03-33.00],0.000157470818858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,1714,36,4.11 [2.23-7.60],6.3319798014665445e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,1484,27,0.71 [0.48-1.04],0.0796947493733332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,1736,39,1.08 [0.76-1.55],0.6554218634687305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUOM,Fucose mutarotase,1471,29,0.81 [0.49-1.33],0.3997000067198576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FURIN,Furin,1729,38,0.51 [0.23-1.11],0.0910507995808942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUS,RNA-binding protein FUS,1672,38,2.86 [1.49-5.50],0.0015990783112619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1471,30,1.18 [0.74-1.90],0.4872125303999397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1736,37,1.38 [0.77-2.46],0.2730432015717305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",1708,37,1.47 [0.92-2.34],0.1093586375323703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXN,"Frataxin, mitochondrial",1740,39,1.21 [0.83-1.76],0.3125790506574444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,1676,36,1.16 [0.76-1.75],0.4888555915679622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FYB1,FYN-binding protein 1,1726,37,1.08 [0.79-1.49],0.6244314182021822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD10,Frizzled-10,1456,28,1.11 [0.66-1.85],0.6944802439700757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,1432,28,1.42 [0.75-2.69],0.2791326807463046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,1490,30,0.70 [0.32-1.52],0.3650110223990395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1475,30,0.71 [0.35-1.46],0.3569013888710954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1432,28,1.10 [0.69-1.75],0.6803196052370144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD1,Glutamate decarboxylase 1,1438,27,0.67 [0.15-3.00],0.5998628296149233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD2,Glutamate decarboxylase 2,1444,28,0.57 [0.19-1.70],0.3145670901908262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1475,30,0.79 [0.32-1.95],0.6037394933496149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1461,30,1.23 [0.66-2.28],0.5165867429368973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAGE2A,G antigen 2A,1438,27,0.55 [0.24-1.24],0.1483694965382317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAL,Galanin peptides,1726,37,0.85 [0.53-1.35],0.4894320460429295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1722,38,1.89 [0.72-4.96],0.19917026812436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1740,39,0.66 [0.23-1.88],0.4420079320029592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1676,36,1.60 [0.85-3.00],0.142370001299956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1493,29,2.26 [0.92-5.57],0.0758771605824681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,1722,38,0.82 [0.23-2.94],0.7567611127504805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,1439,28,1.17 [0.52-2.61],0.7050628547681074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1431,28,2.12 [0.54-8.26],0.2790101619925134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,1498,30,0.77 [0.20-2.97],0.7054366421902996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS2,Growth arrest-specific protein 2,1475,30,1.25 [0.72-2.17],0.4273463106065873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,1732,39,3.91 [1.45-10.52],0.0070074510598777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,1439,28,0.53 [0.24-1.18],0.1189035478330155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,1486,27,1.02 [0.82-1.28],0.8255445474045864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1438,27,1.79 [0.45-7.19],0.411973609972036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1461,30,1.10 [0.71-1.70],0.6652008268101782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,1456,28,1.18 [0.64-2.18],0.5928913085219184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP1,Guanylate-binding protein 1,1484,27,0.71 [0.45-1.13],0.1490638154610832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP2,Guanylate-binding protein 2,1676,36,1.38 [0.84-2.25],0.198174281166392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP4,Guanylate-binding protein 4,1661,36,0.94 [0.52-1.71],0.8390731292051112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP6,Guanylate-binding protein 6,1439,28,0.89 [0.39-2.05],0.7880100966492463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GC,Vitamin D-binding protein,1505,30,2.39 [0.66-8.65],0.1829248325824448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,1486,27,1.09 [0.77-1.54],0.6418250891968441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,1675,38,1.51 [1.22-1.87],0.0001891955861222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1434,28,1.56 [0.93-2.62],0.0886112866998414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,1439,28,0.90 [0.41-2.00],0.803341043267612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1722,38,1.84 [0.87-3.93],0.1122238688034739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,1742,39,3.17 [2.22-4.53],2.426773274925873e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF2,Growth/differentiation factor 2,1724,39,1.69 [0.80-3.55],0.1682838696598296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,1661,36,1.92 [1.13-3.27],0.0165875831300156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GET3,ATPase GET3,1493,29,0.75 [0.38-1.49],0.406295665716446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFAP,Glial fibrillary acidic protein,1672,38,1.20 [0.66-2.20],0.5482533299329289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,1675,38,1.33 [0.87-2.05],0.1922187377682193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1675,38,0.87 [0.65-1.16],0.3356763122936851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,1735,39,15.48 [7.58-31.61],5.314854069383018e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,1722,38,6.29 [1.59-24.93],0.0088122032775306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,1702,37,7.52 [3.53-16.01],1.7257974791520405e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,1441,27,0.71 [0.40-1.26],0.2397032515909899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,1661,36,0.67 [0.38-1.20],0.1775650291124156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,1493,29,0.94 [0.56-1.57],0.8184266396838581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,1492,29,1.21 [0.58-2.51],0.6164738209707854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,1695,38,0.36 [0.16-0.81],0.0128410921995069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,1727,37,0.57 [0.31-1.03],0.06054913281156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,1708,37,4.37 [1.56-12.27],0.0050248626689857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH1,Somatotropin,1724,39,1.19 [1.01-1.40],0.0367041118490392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH2,Growth hormone variant,1675,38,0.98 [0.82-1.17],0.801361801342007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHR,Growth hormone receptor,1471,29,0.30 [0.12-0.73],0.0080626411504586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,1661,36,1.37 [0.92-2.04],0.1244432132087114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,1724,39,1.74 [1.24-2.44],0.0014200730575639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,1498,30,1.37 [0.61-3.06],0.4410494597301079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,1498,30,1.32 [0.84-2.08],0.2237769011869638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,1471,29,2.56 [0.93-7.09],0.0692937385971879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,1438,27,1.14 [0.58-2.25],0.7074655774348965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIP,Gastric inhibitory polypeptide,1461,30,2.52 [1.53-4.17],0.000302315074084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,1486,27,3.21 [1.21-8.53],0.0191570116751828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,1478,29,1.15 [0.79-1.68],0.4667301359439731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,1444,28,1.21 [0.66-2.22],0.5395127609902413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,1444,28,1.09 [0.75-1.58],0.6483124013338735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GJA8,Gap junction alpha-8 protein,1438,27,0.85 [0.42-1.70],0.6443021005550269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GKN1,Gastrokine-1,1625,34,1.91 [0.93-3.90],0.0766903497248606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLA,Alpha-galactosidase A,1467,29,1.26 [0.53-3.03],0.6025881990989466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLB1,Beta-galactosidase,1708,37,0.49 [0.24-1.01],0.0524190000075145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLI2,Zinc finger protein GLI2,1444,28,0.45 [0.11-1.85],0.269846722011438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLO1,Lactoylglutathione lyase,1692,39,1.09 [0.68-1.74],0.7348905657383684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,1715,37,1.23 [0.55-2.74],0.6190812783714756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,1432,28,1.57 [0.79-3.13],0.201096482333966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX,Glutaredoxin-1,1712,37,1.24 [0.76-2.01],0.3815196529963469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1471,29,1.06 [0.71-1.59],0.7607354602757347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1661,36,0.72 [0.35-1.52],0.3928834028165134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,1490,30,0.51 [0.22-1.15],0.1040479093655957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,1464,28,3.23 [2.02-5.16],9.685836530534662e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMFG,Glia maturation factor gamma,1493,29,1.02 [0.62-1.67],0.9496342898088715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,1738,37,0.92 [0.52-1.61],0.7623461360287697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR2,GMP reductase 2,1471,29,0.96 [0.57-1.63],0.881363438943951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,1498,30,0.89 [0.59-1.34],0.5635054483152011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1675,38,0.95 [0.61-1.50],0.8362653321288485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1456,28,0.89 [0.40-1.95],0.7633357824530512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNLY,Granulysin,1728,37,1.44 [0.84-2.47],0.1816920337391102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,1461,30,0.77 [0.25-2.38],0.643737292885475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,1471,29,0.74 [0.29-1.89],0.5262994965878917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,1498,30,1.16 [0.74-1.82],0.5150799166109261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,1736,37,2.42 [0.87-6.72],0.0912045314287549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1713,36,1.05 [0.78-1.41],0.7573418585214728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,1478,29,1.18 [0.57-2.47],0.6523684591581991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",1499,29,0.39 [0.17-0.91],0.0291153371366589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,1724,39,1.95 [0.89-4.27],0.0933163707429357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,1439,28,1.22 [0.72-2.07],0.4559625068449822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1668,39,1.43 [1.14-1.81],0.0022589977380702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP5,Platelet glycoprotein V,1471,29,1.34 [0.47-3.81],0.5828114347152085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP6,Platelet glycoprotein VI,1726,37,1.34 [0.95-1.88],0.0947403557079854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPA33,Cell surface A33 antigen,1722,38,0.99 [0.81-1.23],0.9630071204328472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,1740,39,7.21 [3.03-17.17],8.20934432241769e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC5,Glypican-5,1708,37,1.22 [0.73-2.03],0.4459390129615584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,1490,30,1.29 [0.77-2.15],0.3366225340556196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,1478,29,0.95 [0.46-1.96],0.8877679011916051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,1502,29,1.10 [0.54-2.25],0.7904120221497188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1478,29,1.90 [1.19-3.05],0.0073646251546306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,1661,36,1.82 [0.93-3.56],0.082743423483773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,1679,36,6.83 [2.77-16.85],3.036916030231156e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,1432,28,1.05 [0.57-1.95],0.8683528889764709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,1498,30,1.69 [0.88-3.23],0.1146253498672962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR15L,Protein GPR15L,1478,29,1.74 [1.06-2.84],0.0285487999287321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,1692,39,3.30 [2.27-4.79],3.4462476719130766e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,1490,30,0.96 [0.56-1.64],0.8814657820729697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,1724,39,1.06 [0.85-1.33],0.6015280938227133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1493,29,0.95 [0.55-1.63],0.8433086354175733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",1498,30,0.88 [0.37-2.10],0.7726367097342188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1432,28,1.14 [0.63-2.06],0.6589291931057257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,1692,39,1.20 [0.74-1.95],0.4495813936636079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,1721,37,4.04 [1.30-12.55],0.0158789994532544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,1461,30,1.58 [1.04-2.41],0.0317648601728601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",1722,38,0.97 [0.61-1.53],0.8874625871598915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRSF1,G-rich sequence factor 1,1430,27,0.98 [0.62-1.57],0.946116465590044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSAP,Gamma-secretase-activating protein,1675,38,0.88 [0.59-1.31],0.5390120517154278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSN,Gelsolin,1496,29,4.17 [0.62-28.19],0.143564974672662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",1497,29,0.33 [0.08-1.47],0.147580395587451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA1,Glutathione S-transferase A1,1721,39,0.61 [0.44-0.86],0.0042617655506622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA3,Glutathione S-transferase A3,1675,38,0.64 [0.45-0.93],0.0179411639674601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,1439,28,1.14 [0.75-1.73],0.5401117967027592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTP1,Glutathione S-transferase P,1654,36,0.85 [0.53-1.34],0.4774536237291492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,1486,27,0.91 [0.78-1.06],0.2265907894440514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1475,30,1.27 [0.85-1.89],0.2489125357960975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTPBP2,GTP-binding protein 2,1456,28,0.85 [0.54-1.35],0.4929686887772553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,1720,37,5.34 [3.43-8.34],1.504451023911226e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,1475,30,1.08 [0.74-1.58],0.6933296334599615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUK1,Guanylate kinase,1439,28,1.41 [0.61-3.26],0.4208963360763746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUSB,Beta-glucuronidase,1732,39,0.68 [0.46-1.01],0.0582292156546219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",1692,39,1.10 [0.81-1.51],0.5339662384260322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,1738,37,1.89 [0.90-4.00],0.0947113692446792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMB,Granzyme B,1713,36,1.10 [0.69-1.77],0.6793052545801997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMH,Granzyme H,1692,39,1.34 [0.96-1.87],0.0867039093354055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",H2AP,Huntingtin-interacting protein M,1438,27,0.42 [0.13-1.35],0.1451641610406867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1439,28,1.04 [0.62-1.76],0.8854630215777187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1733,39,0.91 [0.63-1.32],0.6308673726209084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,1740,39,0.78 [0.63-0.97],0.0263188121647098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",1728,37,1.13 [0.78-1.65],0.5133765717494441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,1738,39,2.82 [2.23-3.56],4.414358608862013e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,1728,37,4.56 [2.36-8.81],6.4302805321750124e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,1733,39,1.22 [0.83-1.80],0.3130194090877944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,1740,39,0.81 [0.50-1.30],0.3775618668255531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,1493,29,0.66 [0.44-0.97],0.0328761580988312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCG22,Protein PBMUCL2,1439,28,0.88 [0.38-2.02],0.7620437988288431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,1738,37,1.71 [0.98-2.98],0.0595726486892096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC8,Histone deacetylase 8,1444,28,0.88 [0.43-1.81],0.7222594363081958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC9,Histone deacetylase 9,1432,28,1.03 [0.57-1.85],0.9293326515116812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,1478,29,0.64 [0.28-1.45],0.2812702413514758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGF,Hepatoma-derived growth factor,1738,39,1.05 [0.78-1.42],0.7386622913003076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,1486,27,0.76 [0.41-1.39],0.3685586647772088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEBP1,Heme-binding protein 1,1692,39,0.58 [0.30-1.10],0.0934102219290453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEG1,Protein HEG homolog 1,1471,29,3.49 [1.13-10.75],0.0292910473831149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPACAM2,HEPACAM family member 2,1486,27,0.80 [0.33-1.90],0.6082274211342613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,1493,29,8.95 [2.76-28.99],0.0002595378565417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEXIM1,Protein HEXIM1,1713,36,1.12 [0.78-1.62],0.5330789556644835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGF,Hepatocyte growth factor,1738,37,1.74 [0.83-3.66],0.1411685510548127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,1491,29,0.96 [0.29-3.22],0.948745034644244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1675,38,1.06 [0.73-1.53],0.7714566264739904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,1486,27,1.37 [0.83-2.25],0.2166488444201889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,1444,28,0.90 [0.48-1.71],0.7579864492588394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,1439,28,0.81 [0.24-2.67],0.7263595908789988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,1484,27,1.42 [0.88-2.30],0.1542582678882575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,1498,30,1.37 [0.83-2.27],0.2194284289049052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HK2,Hexokinase-2,1692,39,0.79 [0.28-2.25],0.6641948717386186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1498,30,1.32 [0.45-3.89],0.6098321405919674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1710,36,1.73 [0.84-3.56],0.137682161169368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1713,36,9.33 [4.95-17.59],5.2260102194940855e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,1740,39,0.63 [0.35-1.12],0.1121293131370693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,1467,29,3.90 [2.21-6.86],2.5306062456423805e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1461,30,1.29 [0.73-2.26],0.3808436975002699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1439,28,1.35 [0.82-2.22],0.2353163328786788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,1436,27,1.10 [0.55-2.20],0.7937427187488044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX1,Heme oxygenase 1,1712,38,0.58 [0.32-1.03],0.0649618059228481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,1661,36,1.60 [0.95-2.72],0.0797598268539078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,1456,28,1.30 [0.96-1.75],0.0862671174714075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,1700,37,1.17 [0.68-2.00],0.5737185320570108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1688,39,1.07 [0.75-1.53],0.6899676972952594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1498,30,1.41 [0.77-2.58],0.2591303083563661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,1738,37,1.18 [0.79-1.78],0.4245214947496054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,1675,38,0.61 [0.28-1.32],0.2058181996114508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPSE,Heparanase,1483,29,1.16 [0.79-1.71],0.4518569715945119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRAS,GTPase Hras,1471,30,1.15 [0.90-1.48],0.2676682173427665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1461,30,1.57 [0.91-2.70],0.1048263951661126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRG,Histidine-rich glycoprotein,1498,30,0.34 [0.15-0.81],0.0141771054766633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,1461,30,1.13 [0.75-1.68],0.562820198134315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1722,38,1.75 [0.85-3.61],0.1300022026352787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1740,39,1.25 [0.61-2.56],0.5480319143582988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1444,28,3.49 [1.67-7.29],0.0008804510593532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,1461,30,1.12 [0.77-1.62],0.5651192998964274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1713,36,1.30 [0.66-2.55],0.4469220150121501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1486,27,1.07 [0.62-1.83],0.8095679635977406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,1439,28,1.55 [1.03-2.33],0.0349347842987839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1461,30,1.30 [0.65-2.58],0.4601730209105436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSP90B1,Endoplasmin,1658,36,1.02 [0.66-1.57],0.9372312287494992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,1725,37,1.19 [0.81-1.75],0.3654382018225381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,1490,30,2.13 [1.34-3.40],0.0014008279266864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB1,Heat shock protein beta-1,1697,38,1.02 [0.65-1.60],0.9271933286549048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,1740,39,3.80 [2.26-6.40],4.654615646945178e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1718,39,8.13 [4.78-13.82],9.667414763535752e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,1432,28,1.30 [0.91-1.85],0.1510885873312037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,1432,28,0.95 [0.37-2.45],0.920517669411386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",1729,38,1.28 [0.81-2.02],0.2827809433018448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,1711,39,3.60 [1.28-10.10],0.0151745328013874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,1742,39,21.02 [8.16-54.18],2.9001369904367825e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICA1,Islet cell autoantigen 1,1676,36,1.16 [0.82-1.66],0.4014924150769564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,1722,39,1.07 [0.44-2.59],0.8802462303220813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,1742,39,4.85 [2.04-11.50],0.0003455214034605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,1742,39,3.11 [1.33-7.27],0.0086585609306484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,1713,36,0.99 [0.57-1.74],0.9859525104339812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,1724,39,2.18 [1.26-3.77],0.0050786079269632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,1722,38,2.53 [0.68-9.40],0.1648004083133216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,1475,30,0.95 [0.43-2.08],0.898140504501501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,1661,36,1.26 [0.70-2.25],0.4436969790223261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",1461,30,1.36 [0.86-2.15],0.1927996656304051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDS,Iduronate 2-sulfatase,1738,37,14.19 [0.55-366.37],0.1097986158620092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDUA,Alpha-L-iduronidase,1740,39,1.82 [0.96-3.44],0.0667179835281196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1443,28,2.04 [0.87-4.77],0.1006305413805267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1475,30,0.51 [0.24-1.09],0.0831247461941076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1475,30,0.75 [0.30-1.88],0.5340862142726761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,1478,29,0.65 [0.15-2.78],0.5637832895852384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,1676,36,1.04 [0.80-1.36],0.742695037505195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,1726,37,9.93 [3.58-27.57],1.0549672827304366e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,1708,37,1.00 [0.60-1.69],0.9854222999589196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,1661,36,1.60 [1.03-2.50],0.0374275885195204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL2,Interferon lambda-2,1432,28,0.83 [0.41-1.64],0.5848204861010009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,1713,36,1.68 [0.77-3.70],0.19537212290976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNW1,Interferon omega-1,1439,28,0.77 [0.24-2.46],0.6628547949305597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,1456,28,1.27 [0.59-2.74],0.5462271099508653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,1498,30,1.01 [0.58-1.75],0.975523859850387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1432,28,1.14 [0.56-2.35],0.7133467310496093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1499,29,6.63 [1.98-22.17],0.0021340074680689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,1722,38,18.04 [5.78-56.35],6.38584074958974e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1439,28,1.28 [0.64-2.58],0.4841538866667392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,1728,37,4.15 [1.31-13.20],0.0158904534243594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,1740,39,1.56 [1.24-1.97],0.000178682743107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,1740,39,3.03 [2.11-4.36],2.029039799575104e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,1733,39,0.74 [0.37-1.51],0.4123878198408769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,1704,36,3.67 [2.63-5.14],2.7495446912510872e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,1725,39,6.41 [4.03-10.20],3.882236027875181e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,1742,39,3.79 [2.12-6.79],7.473582071912564e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,1724,39,2.38 [1.33-4.23],0.0033099950265832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,1444,28,0.63 [0.30-1.33],0.2283370522272148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,1439,28,1.20 [0.65-2.21],0.5643879726665655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,1500,30,2.88 [1.10-7.56],0.031383483018519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLON5,IgLON family member 5,1438,27,0.50 [0.23-1.12],0.091509653096216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,1461,30,1.11 [0.49-2.47],0.8064005776066643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,1722,38,0.98 [0.52-1.86],0.9525256827087728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,1724,39,6.24 [2.94-13.25],1.892255803325867e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF9,Protein turtle homolog A,1493,29,0.64 [0.45-0.92],0.0159139747408181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,1713,36,1.04 [0.75-1.44],0.8215960305136063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKZF2,Zinc finger protein Helios,1675,38,0.97 [0.69-1.35],0.8384130463950212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,1676,36,1.36 [1.07-1.73],0.0106225298599268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,1676,36,1.12 [0.70-1.77],0.6379921921716003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,1726,37,4.99 [2.62-9.52],1.0495395612078008e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL11,Interleukin-11,1676,36,0.97 [0.60-1.57],0.8977204420092684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,1722,38,1.95 [1.44-2.65],1.5882320038674244e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,1738,37,2.69 [1.64-4.42],9.36727470096485e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,1676,36,3.01 [1.59-5.70],0.0007322497139244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,1444,28,1.36 [0.57-3.26],0.4897960855791535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13,Interleukin-13,1676,36,0.94 [0.52-1.69],0.8287638867762852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,1705,38,0.56 [0.15-2.16],0.4013421172831646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,1432,28,3.53 [0.93-13.45],0.064011599289937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,1713,36,2.50 [1.53-4.08],0.0002565404116621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,1676,36,5.35 [2.51-11.40],1.3768812243053762e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,1738,37,1.54 [0.92-2.57],0.1021460958919429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,1673,36,1.37 [0.80-2.35],0.256575381733633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,1676,36,1.64 [1.23-2.19],0.0008274367414383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,1676,36,1.49 [0.99-2.26],0.0578090634015307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17F,Interleukin-17F,1676,36,1.07 [0.75-1.53],0.7175371314155446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RA,Interleukin-17 receptor A,1728,37,1.40 [0.75-2.59],0.2880750248004671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,1692,36,2.92 [1.77-4.82],2.834902364724812e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,1712,37,1.52 [0.86-2.67],0.150043568879267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,1733,39,6.30 [3.36-11.83],9.888007261496535e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,1738,37,1.83 [0.89-3.75],0.0979697995460278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,1691,37,0.98 [0.83-1.17],0.8614304345900644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,1686,38,2.11 [1.58-2.80],3.392164111215343e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1A,Interleukin-1 alpha,1676,36,1.21 [0.79-1.84],0.3784500239324941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1B,Interleukin-1 beta,1670,36,1.30 [0.82-2.05],0.2602760302031642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,1727,37,7.09 [2.75-18.23],4.86177967168128e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,1712,37,0.63 [0.18-2.16],0.4611721082867472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,1728,37,1.33 [0.70-2.54],0.3799211667610931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,1737,39,2.04 [1.19-3.49],0.0097340304822906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,1676,36,1.20 [0.57-2.53],0.6319508098894346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,1717,37,1.17 [0.78-1.76],0.4571035457888943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2,Interleukin-2,1676,36,0.59 [0.23-1.53],0.2815397696854831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20,Interleukin-20,1676,36,0.90 [0.49-1.65],0.7304865132502592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,1676,36,1.32 [0.78-2.23],0.3037482269602066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,1444,28,1.18 [0.51-2.73],0.6950790813245482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL21R,Interleukin-21 receptor,1444,28,0.66 [0.26-1.69],0.3879305803828284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,1490,30,1.06 [0.64-1.78],0.8100988275009555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,1676,36,2.19 [1.42-3.39],0.0004025878115973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL24,Interleukin-24,1676,36,1.30 [0.82-2.06],0.2576650777956426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL25,Interleukin-25,1434,27,0.73 [0.26-2.06],0.5507343715978303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,1714,38,3.67 [2.11-6.39],4.396561944714453e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,1676,36,1.09 [0.60-1.99],0.7826295674321974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,1490,30,1.34 [0.84-2.14],0.2181508050007107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3,Interleukin-3,1438,27,1.76 [0.90-3.43],0.0958686487529627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31,Interleukin-31,1444,28,0.84 [0.43-1.67],0.6229812665855106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,1438,28,2.37 [1.06-5.30],0.035264641488777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,1713,36,1.22 [0.72-2.07],0.4630149805850173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,1676,36,0.79 [0.37-1.68],0.5390074443128536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL34,Interleukin-34,1660,36,1.04 [0.46-2.35],0.9279763086242718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36A,Interleukin-36 alpha,1444,28,0.90 [0.48-1.67],0.7299034292580426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36G,Interleukin-36 gamma,1443,28,1.30 [0.88-1.91],0.1824810167131981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,1676,36,1.11 [0.45-2.76],0.8155491049917166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4,Interleukin-4,1676,36,1.02 [0.75-1.39],0.8840229491513414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,1713,36,2.47 [1.42-4.32],0.0014505584415122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5,Interleukin-5,1676,36,1.04 [0.86-1.27],0.6604559893027125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,1713,36,1.11 [0.67-1.82],0.6839055662109661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,1722,38,0.95 [0.64-1.41],0.8047093122841851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,1720,39,3.63 [1.61-8.19],0.0019399893903187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,1724,39,8.80 [1.99-38.82],0.0040860374817157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7,Interleukin-7,1713,36,0.90 [0.56-1.44],0.6542931462809698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,1728,37,1.57 [0.89-2.79],0.1200939435733156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL9,Interleukin-9,1475,30,0.60 [0.24-1.47],0.2632104230653449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1657,36,1.20 [0.76-1.90],0.4233997368677826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,1490,30,1.46 [0.84-2.56],0.1835421165771854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPA1,Inositol monophosphatase 1,1708,37,0.96 [0.59-1.55],0.8548360673312827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPACT,Protein IMPACT,1486,27,0.71 [0.37-1.37],0.3119505818762633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,1432,28,1.47 [0.60-3.59],0.3968429469462823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ING1,Inhibitor of growth protein 1,1657,36,0.98 [0.50-1.94],0.958917391466334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,1471,29,1.94 [1.12-3.35],0.0176807067792431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,1728,37,0.73 [0.37-1.45],0.3736635600891413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,1722,38,1.62 [1.00-2.63],0.0496630043918524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1461,30,1.06 [0.57-1.96],0.8584533255735904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1498,30,1.26 [0.56-2.83],0.5720428673137423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1722,38,1.20 [0.90-1.60],0.2216707175841728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL3,Insulin-like 3,1486,27,0.61 [0.37-1.02],0.0574598592363656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,1490,30,1.55 [1.02-2.37],0.0403022354091764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,1478,29,1.04 [0.74-1.45],0.8298243845117872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,1444,28,1.75 [0.22-13.72],0.5928856642023785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,1705,37,1.12 [0.80-1.57],0.510257541364568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,1722,38,1.32 [0.81-2.17],0.2689165959765509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1692,39,1.13 [0.84-1.52],0.4261857588770558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,1676,36,1.31 [0.87-1.95],0.1923211694460827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,1713,36,1.03 [0.77-1.37],0.8462015928483458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1634,34,2.06 [0.98-4.34],0.0562371563788315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,1713,36,1.39 [0.67-2.89],0.3796707695099928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM2,Isthmin-2,1499,29,1.16 [0.53-2.55],0.708456263310706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IST1,IST1 homolog,1466,29,1.07 [0.74-1.54],0.7124157113345898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA11,Integrin alpha-11,1713,36,1.44 [0.68-3.03],0.3412022564545816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA2,Integrin alpha-2,1471,29,0.77 [0.28-2.12],0.6200274986323828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA5,Integrin alpha-5,1728,37,0.66 [0.23-1.87],0.4344514788361562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA6,Integrin alpha-6,1713,36,1.53 [0.98-2.40],0.0620859556017607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,1444,28,2.24 [1.05-4.80],0.0372708705691177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAM,Integrin alpha-M,1728,37,2.70 [1.19-6.12],0.0176967719694167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAV,Integrin alpha-V,1740,39,0.73 [0.15-3.47],0.6898949242865513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAX,Integrin alpha-X,1475,30,0.94 [0.48-1.86],0.868741455520803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1,Integrin beta-1,1724,39,2.45 [0.81-7.42],0.1121633263795702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,1675,38,1.52 [0.75-3.12],0.2481335749541463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,1692,39,1.09 [0.84-1.41],0.5275635544570063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,1708,39,3.33 [1.45-7.66],0.0045369585336811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB5,Integrin beta-5,1729,38,1.61 [0.89-2.93],0.1178904666255059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,1676,36,5.19 [2.05-13.14],0.0005122501091746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,1740,39,1.78 [1.03-3.06],0.0372264752359318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,1499,29,1.61 [0.92-2.82],0.0941499267798015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1505,30,2.15 [0.49-9.45],0.3098524552980409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1733,39,3.44 [1.64-7.21],0.001095866039767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1505,30,0.79 [0.23-2.71],0.7123631967438386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1490,30,1.57 [0.85-2.90],0.1530348390502575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,1713,36,1.08 [0.66-1.78],0.7559182718438086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,1439,28,0.59 [0.35-1.01],0.0547714016712594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1461,30,1.19 [0.74-1.93],0.4704448257044143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1432,28,1.39 [0.78-2.48],0.2668427173703324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1661,36,1.22 [0.70-2.12],0.4793870121787623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,1438,27,0.78 [0.33-1.86],0.5763404878860808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,1736,37,9.49 [5.21-17.31],2.1022004757888985e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,1471,29,2.18 [1.30-3.64],0.002967220992672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,1676,36,1.02 [0.63-1.66],0.9379299812420016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1438,27,1.13 [0.59-2.16],0.7077561293748076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,1478,29,1.15 [0.76-1.74],0.5109378751525978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,1676,36,1.37 [0.93-2.01],0.1148671095098611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1722,38,3.21 [1.67-6.19],0.0004868908360454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZN,Kazrin,1478,29,1.00 [0.71-1.40],0.9779303791128596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,1432,28,1.32 [0.80-2.20],0.2759957861938541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,1456,28,0.84 [0.46-1.52],0.5648640201150046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,1661,36,1.46 [0.99-2.17],0.0568579129330825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,1460,26,0.61 [0.25-1.51],0.2847681284860909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,1444,28,0.62 [0.31-1.23],0.1723252515375034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,1729,38,1.52 [0.46-5.02],0.4963534317255632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KEL,Kell blood group glycoprotein,1661,36,0.97 [0.44-2.14],0.9373855673660448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHDC3L,KH domain-containing protein 3,1438,27,1.20 [0.77-1.88],0.4154028944658794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHK,Ketohexokinase,1461,30,0.77 [0.46-1.29],0.3202014806834476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,1486,27,2.59 [1.28-5.22],0.0078990494178208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,1475,30,0.75 [0.50-1.14],0.1820065876067842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,1475,30,0.77 [0.21-2.79],0.6895177020534436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,1490,30,1.08 [0.59-1.98],0.8085746431570392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,1439,28,1.88 [0.89-3.96],0.0958215566053675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,1432,28,1.08 [0.71-1.64],0.7142600077085868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF22,Kinesin-like protein KIF22,1439,28,0.88 [0.65-1.20],0.4231016218118445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIFBP,KIF-binding protein,1722,38,1.11 [0.77-1.58],0.581798375220669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1490,30,0.92 [0.63-1.34],0.6585012462262606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1675,38,1.04 [0.74-1.47],0.8264715606854984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1478,29,1.06 [0.87-1.29],0.5726973123648837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1675,38,1.21 [0.98-1.49],0.0732147948024189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1438,27,1.11 [0.77-1.60],0.5762545267276532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,1432,28,1.05 [0.50-2.21],0.8901781254564106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,1661,36,1.76 [1.00-3.09],0.0508708181484405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,1732,39,1.65 [0.68-4.00],0.2675214350947456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,1724,39,3.67 [1.83-7.36],0.0002425401571349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,1661,36,1.65 [1.14-2.37],0.0076877673244511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLF4,Krueppel-like factor 4,1432,28,3.04 [1.24-7.45],0.0149627945211973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,1498,30,0.97 [0.46-2.06],0.932379945774386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK1,Kallikrein-1,1705,37,1.27 [1.03-1.56],0.0256837328467498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,1722,38,2.44 [1.51-3.96],0.000288307052614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,1708,38,3.42 [2.31-5.06],7.301976662084018e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK12,Kallikrein-12,1675,38,1.13 [0.92-1.40],0.2383764650959956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK13,Kallikrein-13,1682,37,1.49 [0.89-2.49],0.1313648691929983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,1740,39,2.05 [1.18-3.55],0.0105512402341534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,1489,30,1.28 [0.66-2.51],0.467307856054894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK3,Prostate-specific antigen,1499,29,0.65 [0.35-1.19],0.1625777948606446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,1740,39,2.15 [1.57-2.94],1.6621514539037216e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,1727,38,4.01 [1.82-8.85],0.000574212961432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK7,Kallikrein-7,1427,29,0.64 [0.25-1.69],0.3701486343993991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,1665,38,3.59 [1.94-6.66],4.908318258779458e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLKB1,Plasma kallikrein,1470,30,0.31 [0.08-1.13],0.0762458116304575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,1738,37,4.95 [2.98-8.24],7.505573943462462e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1432,28,1.40 [0.89-2.19],0.1489995888806283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,1738,37,2.32 [1.32-4.05],0.0032220991193882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,1444,28,1.39 [0.84-2.30],0.2010776235866427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,1486,27,1.05 [0.48-2.34],0.8967863149336324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",1606,33,0.92 [0.31-2.79],0.8861553502084697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",1439,28,1.08 [0.42-2.79],0.8687098098559901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",1722,38,0.99 [0.74-1.32],0.9464672982906128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",1707,35,2.22 [1.64-3.02],2.9772011457575173e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",1661,36,1.58 [0.92-2.70],0.0981702233657122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",1439,28,1.14 [0.52-2.49],0.736120191565385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",1432,28,0.86 [0.61-1.21],0.3800024035323494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,1721,39,0.98 [0.60-1.61],0.950291990280012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYNU,Kynureninase,1738,37,0.36 [0.19-0.68],0.0015355280719683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,1729,38,1.91 [0.77-4.75],0.1644883914354984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1493,29,1.08 [0.72-1.61],0.721937068650202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,1486,30,0.84 [0.39-1.82],0.657478978237419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,1724,39,1.07 [0.70-1.64],0.7674222709774314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,1722,38,2.91 [1.83-4.64],6.472561797561794e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1714,37,1.97 [1.34-2.89],0.0005734350594055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1708,37,1.22 [0.91-1.62],0.18513948434886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA1,Laminin subunit alpha-1,1439,28,0.50 [0.18-1.40],0.1854431896450022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,1726,37,2.78 [1.28-6.01],0.0094164885573818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,1461,30,4.26 [1.41-12.86],0.0100775129208192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,1457,29,1.54 [0.53-4.44],0.4288289095937146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,1676,35,0.70 [0.14-3.41],0.6578435224996619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,1736,37,1.79 [1.06-3.03],0.030499570273191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,1490,30,0.92 [0.37-2.25],0.8467994629623035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAP3,Cytosol aminopeptidase,1676,36,0.86 [0.44-1.67],0.6551853122414544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LARP1,La-related protein 1,1490,30,0.67 [0.35-1.28],0.220870546510921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,1738,37,1.36 [0.90-2.06],0.1479704135971557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,1722,38,1.07 [0.86-1.34],0.5412814695163577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,1444,28,1.10 [0.71-1.71],0.6630232782479104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,1704,37,6.93 [4.32-11.12],9.752051676272149e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,1733,39,1.04 [0.65-1.68],0.8645291395780481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,1736,37,1.29 [0.92-1.80],0.138627509041418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,1502,29,0.65 [0.13-3.14],0.5904125219573385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,1498,30,1.83 [1.34-2.51],0.000139518151952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,1676,38,4.70 [2.98-7.43],3.3132603684524414e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCP1,Plastin-2,1499,29,0.68 [0.30-1.52],0.3468382301528045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLR,Low-density lipoprotein receptor,1723,37,0.91 [0.53-1.56],0.7280716214601517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,1498,30,1.08 [0.76-1.54],0.669429538037708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,1493,29,1.66 [1.10-2.51],0.0155219133076006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,1735,39,1.30 [0.77-2.19],0.3311330645109153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEG1,Protein LEG1 homolog,1423,29,1.55 [0.99-2.45],0.0569565545770349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,1432,28,0.81 [0.46-1.42],0.4568784598792734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,1498,30,1.44 [0.81-2.53],0.2111678607116101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEP,Leptin,1724,39,1.33 [0.79-2.25],0.2842442695378827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,1724,39,6.94 [3.40-14.16],1.0055983284103509e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,1498,30,1.99 [1.20-3.28],0.0072189986262216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,1724,39,7.20 [3.74-13.89],3.766050900318443e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,1721,39,4.28 [1.73-10.57],0.0016415407312076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,1505,30,0.44 [0.14-1.40],0.1636554472770068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,1714,37,3.20 [2.13-4.79],1.756470489698746e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,1725,39,2.52 [1.70-3.72],3.5454697210188303e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS8,Galectin-8,1736,37,1.44 [0.92-2.27],0.1133689338731972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,1716,37,3.63 [1.70-7.72],0.0008261031842918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,1726,37,1.98 [0.91-4.27],0.0831464061243964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHB,Lutropin subunit beta,1675,38,1.29 [0.94-1.76],0.1127715621862356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1722,37,0.89 [0.55-1.42],0.616406494613884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIF,Leukemia inhibitory factor,1661,36,1.19 [0.69-2.07],0.5301451362326114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,1713,36,4.44 [2.08-9.47],0.0001182610571515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1728,37,1.28 [0.60-2.76],0.5240933007802528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1499,29,1.02 [0.78-1.32],0.9010596888594996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1439,28,1.13 [0.62-2.05],0.6903277728717043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1724,39,4.61 [1.97-10.80],0.0004279729718518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1493,29,1.47 [0.92-2.35],0.1077169653572845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1742,39,1.06 [0.41-2.77],0.9064500986772028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1735,39,1.45 [0.66-3.19],0.354476750250156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1676,36,2.98 [1.75-5.07],5.7168800371564034e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1742,39,0.65 [0.45-0.94],0.021831688542273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,1461,30,0.66 [0.39-1.13],0.1280765850885449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB1,Lamin-B1,1474,29,0.76 [0.43-1.35],0.3553976790401061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,1486,27,7.70 [3.04-19.49],1.6627061634538807e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,1498,30,3.38 [1.79-6.38],0.0001727366157611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD2,Leiomodin-2,1432,28,0.90 [0.48-1.68],0.7368525168640552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",1461,30,1.18 [0.79-1.76],0.4169233900975642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPA,Apolipoprotein(a),1456,29,1.21 [0.98-1.49],0.0726974308356081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,1722,38,1.03 [0.58-1.83],0.909833922392824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPL,Lipoprotein lipase,1724,39,1.52 [0.84-2.74],0.1669607269768471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPO,Lactoperoxidase,1666,36,1.99 [1.40-2.84],0.0001357414610462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPP,Lipoma-preferred partner,1439,28,0.88 [0.51-1.53],0.6566408751669257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1439,28,1.41 [0.84-2.38],0.1929705730035089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1456,28,0.90 [0.39-2.07],0.7970169547845585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,1505,30,3.21 [0.93-11.08],0.0647267708136721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1733,39,1.86 [0.86-4.02],0.1156447675746221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1440,28,1.54 [0.64-3.71],0.3319397525807973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,1722,38,1.16 [0.40-3.36],0.7851848673332181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,1724,39,5.93 [3.58-9.84],5.207591649968411e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,1456,28,0.86 [0.30-2.41],0.7666908688750159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2BP,LRP2-binding protein,1456,28,1.13 [0.78-1.62],0.5208763872915652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1736,37,1.01 [0.61-1.65],0.9798125230529184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,1722,38,1.77 [0.89-3.49],0.10108337407749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,1478,29,0.80 [0.35-1.80],0.5841277829322361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,1456,28,1.01 [0.48-2.15],0.9744004048037758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,1493,29,1.60 [0.86-2.99],0.1402430881944156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1490,30,1.13 [0.57-2.23],0.7272298476891457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,1676,36,0.43 [0.21-0.87],0.0200698972938255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1456,28,0.60 [0.21-1.69],0.3349839218382523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1498,30,2.26 [0.91-5.60],0.0774367355146785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,1675,38,1.18 [0.76-1.83],0.4568670409372373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,1475,30,1.01 [0.69-1.48],0.9503321787652866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,1713,36,1.39 [0.68-2.82],0.3630693904608498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA,Lymphotoxin-alpha,1713,36,0.99 [0.47-2.05],0.9703553017614752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,1740,39,1.60 [1.04-2.49],0.0340968950771385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTB,Lymphotoxin-beta,1490,30,0.82 [0.28-2.35],0.7069052864978869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,1742,39,4.13 [2.21-7.71],9.006479240038897e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,1675,38,1.43 [0.99-2.07],0.0567867622075886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,1708,37,5.67 [3.38-9.50],4.447842911281776e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTO1,Protein LTO1 homolog,1676,36,0.60 [0.26-1.38],0.2290592124993991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,1490,30,1.29 [0.79-2.10],0.309059143357586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,1695,37,0.81 [0.51-1.28],0.3635267565637862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,1708,37,3.58 [2.27-5.65],3.8720296438895337e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,1713,36,1.30 [0.60-2.79],0.5077444220076723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,1705,37,2.72 [1.19-6.21],0.0174758800946787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY96,Lymphocyte antigen 96,1708,37,1.10 [0.49-2.47],0.8084092503067701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,1675,38,1.34 [0.81-2.20],0.2556279845008881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,1722,38,1.11 [0.78-1.56],0.5655330408249049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,1661,36,1.23 [0.83-1.82],0.2956886011262962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,1706,38,1.85 [0.86-3.98],0.1148461361445388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,1675,38,1.21 [0.74-1.99],0.4550250870055898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,1432,28,0.72 [0.46-1.12],0.1442567275267998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1456,28,1.19 [0.89-1.58],0.2384504370676203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1505,30,3.67 [0.72-18.76],0.1186462783901523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,1438,27,0.55 [0.17-1.81],0.3242212789952918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,1471,29,1.08 [0.65-1.79],0.7641898776225478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,1461,30,0.84 [0.34-2.09],0.7095991057888529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1701,37,1.52 [1.06-2.18],0.0211561809238193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,1675,38,0.80 [0.37-1.74],0.5804171121363265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAG,Myelin-associated glycoprotein,1456,28,0.70 [0.32-1.53],0.3721937443172373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,1475,30,0.82 [0.60-1.12],0.2204090013415447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,1675,38,1.23 [0.72-2.11],0.4456577134478051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,1493,29,3.65 [1.86-7.13],0.0001570002812339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,1490,30,1.17 [0.66-2.08],0.5899786158975673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1461,30,6.15 [1.66-22.82],0.0066665675192168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,1493,29,0.89 [0.50-1.57],0.6838965202504941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1438,27,0.64 [0.31-1.33],0.2322391698241818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,1726,37,1.10 [0.84-1.42],0.48933811064723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,1729,38,6.23 [2.97-13.08],1.3469559063348958e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,1439,28,1.30 [0.78-2.16],0.3118933480326151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1432,28,2.56 [0.95-6.88],0.0617549686735586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1439,28,0.98 [0.56-1.72],0.9510276648941306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2,Microtubule-associated protein 2,1486,27,1.36 [0.69-2.69],0.371199949263982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1478,29,1.34 [0.80-2.27],0.2676259900858238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1713,36,1.07 [0.79-1.44],0.6582951726441154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1675,38,1.07 [0.80-1.43],0.6420243569796268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1704,37,1.10 [0.85-1.43],0.4638249850028398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,1438,27,1.53 [0.96-2.45],0.0751255359980334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,1713,36,1.77 [0.91-3.43],0.0909509625777773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,1475,30,0.84 [0.51-1.36],0.4660690859301342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,1438,27,0.84 [0.59-1.20],0.3487333437861265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPT,Microtubule-associated protein tau,1661,36,1.28 [0.73-2.27],0.3891679773503316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARCO,Macrophage receptor MARCO,1724,39,2.62 [0.96-7.20],0.0613660870011298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",1467,29,0.91 [0.60-1.40],0.6728073530864005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,1704,37,0.65 [0.20-2.11],0.4742043281177488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,1718,37,2.85 [1.21-6.70],0.0164664790151214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN3,Matrilin-3,1705,37,1.79 [0.88-3.64],0.107310301076774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,1675,38,1.32 [0.98-1.79],0.0712270969035489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAX,Protein max,1661,36,1.09 [0.82-1.44],0.5650712875173598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,1742,39,1.55 [0.96-2.50],0.0722944270921739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MBL2,Mannose-binding protein C,1479,29,0.89 [0.65-1.23],0.4863327292241839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,1733,39,3.17 [1.65-6.07],0.0005050826000031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1498,30,1.22 [0.55-2.71],0.6184207460762676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,1444,28,0.97 [0.65-1.46],0.8987457844062976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,1715,38,2.17 [1.15-4.10],0.0167033748877241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,1478,29,1.48 [0.41-5.26],0.5486437209981148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1708,37,1.52 [1.03-2.24],0.0363538740958752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",1496,29,0.64 [0.26-1.61],0.3428737472241235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,1726,38,2.87 [1.76-4.67],2.379657880385043e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDM1,Nuclear protein MDM1,1456,28,1.44 [0.48-4.35],0.5142038838528624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1461,30,1.29 [0.88-1.87],0.1915443845903241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,1675,38,1.29 [0.88-1.88],0.1932693032424207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,1439,28,1.72 [1.05-2.81],0.0316492288498075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,1714,37,2.66 [1.28-5.55],0.0090267876519963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,1439,28,0.73 [0.20-2.67],0.6399941173720376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,1737,39,1.27 [0.35-4.60],0.7176258753503517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,1493,29,4.13 [2.01-8.46],0.0001092620030993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MENT,Protein MENT,1471,29,1.45 [0.33-6.34],0.6239854422866252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1A,Meprin A subunit alpha,1478,29,1.26 [0.81-1.97],0.3118459734250553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,1724,39,0.77 [0.62-0.96],0.0205864748214192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,1714,37,0.75 [0.29-1.92],0.5456862880154523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,1738,37,3.85 [1.59-9.31],0.0028097966147251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MESD,LRP chaperone MESD,1728,37,1.10 [0.87-1.40],0.4107962709646805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MET,Hepatocyte growth factor receptor,1723,37,5.98 [1.66-21.58],0.0062681220359206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1,Methionine aminopeptidase 1,1661,36,1.37 [0.53-3.55],0.5142179014492481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1713,36,1.09 [0.76-1.58],0.6295941138270134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP2,Methionine aminopeptidase 2,1735,39,1.28 [0.76-2.16],0.361874755511012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,1692,39,1.29 [0.83-2.02],0.2554300064074076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,1456,28,1.16 [0.75-1.79],0.5029190492692407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,1471,29,3.18 [1.24-8.19],0.0163063126470149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,1742,39,4.12 [2.34-7.24],8.5323089410744e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFGE8,Lactadherin,1728,37,1.94 [1.25-3.00],0.0028796476607258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGLL,Monoglyceride lipase,1721,37,1.17 [0.82-1.66],0.3808464045573032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,1713,36,1.08 [0.83-1.39],0.5745535128404002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,1729,38,2.51 [1.30-4.88],0.0064116958793514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICALL2,MICAL-like protein 2,1456,28,1.38 [0.85-2.22],0.191920453827093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1713,36,1.21 [0.95-1.55],0.1247758818429154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIF,Macrophage migration inhibitory factor,1725,37,1.02 [0.67-1.58],0.9108899872647888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,1676,36,1.99 [1.22-3.27],0.0062352237941861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1490,30,1.08 [0.77-1.50],0.6542589942227549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINK1,Misshapen-like kinase 1,1486,27,1.09 [0.73-1.63],0.6727545536438875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MITD1,MIT domain-containing protein 1,1708,37,1.07 [0.79-1.45],0.6665268814621903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,1444,28,0.69 [0.22-2.14],0.5220050524765096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLLT1,Protein ENL,1438,27,0.73 [0.38-1.41],0.349335356231139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,1713,36,1.82 [1.29-2.56],0.0005989973226613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MME,Neprilysin,1722,38,1.01 [0.73-1.39],0.954897959115577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,1659,34,1.13 [0.81-1.58],0.473636453213438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,1715,37,2.07 [1.45-2.97],7.299000525775135e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,1726,39,1.99 [1.26-3.13],0.0029976318533086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP13,Collagenase 3,1661,36,5.82 [2.88-11.78],9.61958320549552e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP15,Matrix metalloproteinase-15,1493,29,1.49 [0.82-2.69],0.1885017329177154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,1728,37,1.88 [1.23-2.86],0.0034100322601457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,1690,39,4.16 [2.47-6.99],7.515775638879616e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP8,Neutrophil collagenase,1733,37,1.79 [1.32-2.43],0.0001761488329617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP9,Matrix metalloproteinase-9,1727,37,1.79 [1.13-2.84],0.012884231708002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1439,28,1.18 [0.54-2.56],0.6753504269965509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MN1,Transcriptional activator MN1,1456,28,0.68 [0.31-1.48],0.3353516731862144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,1475,30,0.79 [0.34-1.86],0.5944395640892752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,1721,39,0.96 [0.72-1.26],0.7488414263778176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,1471,29,0.91 [0.53-1.57],0.7409411957316643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,1740,39,4.91 [2.69-8.99],2.392355512326581e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,1486,27,0.58 [0.13-2.53],0.4677750113290162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,1475,30,0.41 [0.13-1.27],0.1210033907765743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,1438,27,1.12 [0.45-2.76],0.8069382973067029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORN4,MORN repeat-containing protein 4,1438,27,0.64 [0.33-1.23],0.1798990593043902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,1692,39,1.18 [0.82-1.69],0.3817829242156447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,1722,38,1.27 [0.92-1.77],0.1477353687493069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1721,37,1.18 [0.77-1.79],0.449194659307922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPO,Myeloperoxidase,1728,37,1.14 [0.63-2.07],0.6602955282336564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,1486,30,0.76 [0.34-1.66],0.4840318303620505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,1502,29,9.03 [3.44-23.71],7.87183974424192e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,1456,28,0.51 [0.32-0.83],0.0065874559768367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",1439,28,1.17 [0.54-2.50],0.6941831662618926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",1498,30,0.37 [0.11-1.25],0.1090274889068227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",1661,36,1.16 [0.45-2.97],0.7596226964346452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",1436,27,1.95 [0.55-6.89],0.2995524581488043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1498,30,0.89 [0.53-1.48],0.6460549690275683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",1444,28,0.35 [0.06-2.15],0.2547021813254471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,1715,37,1.77 [1.17-2.68],0.0066262031445474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLNL,Mesothelin-like protein,1456,28,0.74 [0.25-2.17],0.5858154795228924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,1721,38,2.41 [1.76-3.32],5.30142504940364e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,1736,37,2.02 [1.11-3.67],0.0216963441260281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,1729,38,1.16 [0.78-1.73],0.4704044453073973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,1475,29,1.54 [0.67-3.55],0.3114918556885043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,1692,39,1.03 [0.59-1.77],0.9289328804975046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTDH,Protein LYRIC,1444,28,1.04 [0.71-1.53],0.8274479335915494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1486,27,1.63 [0.48-5.52],0.4302782315884467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1475,30,0.94 [0.69-1.28],0.6748728839918656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",1478,29,1.18 [0.79-1.74],0.4188421591685123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTPN,Myotrophin,1692,39,0.40 [0.13-1.17],0.0952575647336049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTR,Methionine synthase,1439,28,0.86 [0.47-1.56],0.6242266067217563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS1,Protein MTSS 1,1478,29,1.06 [0.77-1.45],0.7326262478447085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS2,Protein MTSS 2,1490,30,0.97 [0.68-1.38],0.868704555618218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,1475,30,0.69 [0.36-1.31],0.2552942633276495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,1661,36,2.29 [1.62-3.25],3.249998338771933e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC16,Mucin-16,1722,38,0.92 [0.80-1.06],0.2665610393358473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC2,Mucin-2,1499,29,1.61 [1.16-2.23],0.0043105623743317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUCL3,Mucin-like protein 3,1438,27,1.33 [0.67-2.64],0.4143846332361969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MVK,Mevalonate kinase,1676,36,0.91 [0.65-1.28],0.5964656618936359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,1471,29,3.74 [1.31-10.66],0.0137191856322809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",1493,29,1.45 [0.95-2.21],0.0884933722788808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",1461,30,1.09 [0.74-1.60],0.6611568746990948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1498,30,1.22 [0.76-1.96],0.4153892754994915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYDGF,Myeloid-derived growth factor,1493,29,1.17 [0.81-1.68],0.3974276445162098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH4,Myosin-4,1439,28,0.93 [0.39-2.21],0.868913349948295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,1438,27,0.39 [0.13-1.17],0.0928108492377272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH9,Myosin-9,1499,29,1.24 [0.91-1.70],0.1733958381306721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1439,28,1.40 [0.80-2.45],0.2409774653464427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,1461,30,1.28 [0.81-2.02],0.2970344831572331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL4,Myosin light chain 4,1461,30,0.87 [0.44-1.69],0.6749277752411672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL6B,Myosin light chain 6B,1456,28,0.78 [0.46-1.30],0.3380432553442297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1456,28,1.96 [1.16-3.30],0.0116371596861054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,1498,30,1.31 [0.62-2.80],0.4815983678758493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO9B,Unconventional myosin-IXb,1676,36,1.25 [0.84-1.86],0.273422595193973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,1728,37,1.92 [1.03-3.59],0.0410273664861532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM1,Myomesin-1,1432,28,1.02 [0.47-2.19],0.9660256685721672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,1439,28,1.21 [0.60-2.46],0.5956493841234178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM3,Myomesin-3,1471,29,1.14 [0.79-1.66],0.485936947095446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,1723,37,1.96 [1.16-3.29],0.0114617602175468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,1675,38,0.98 [0.55-1.74],0.9423383979552296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,1439,28,1.89 [0.97-3.70],0.0628219109979388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,1456,28,1.07 [0.79-1.45],0.6576732335918731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,1701,37,0.89 [0.54-1.47],0.6457478050830768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,1490,30,1.23 [0.71-2.16],0.4586891348825402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NADK,NAD kinase,1724,39,1.19 [0.76-1.86],0.4474596162768577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,1440,28,0.93 [0.45-1.92],0.8383985876071725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,1456,30,0.73 [0.39-1.34],0.3069298615894861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1471,29,6.62 [1.50-29.34],0.012782428405765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,1675,38,1.15 [0.76-1.73],0.5151331324927078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,1476,29,0.66 [0.30-1.48],0.3153392225456485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,1486,27,1.30 [0.49-3.42],0.6000338099046812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",1498,30,1.22 [0.58-2.57],0.6018469788458731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,1729,38,12.85 [6.33-26.07],1.5059687417837452e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBN,Nibrin,1676,36,1.19 [0.73-1.93],0.4872619143049661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,1733,39,1.57 [0.64-3.85],0.3224651621692914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,1728,37,2.22 [0.81-6.11],0.1227393082195377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAN,Neurocan core protein,1736,37,0.70 [0.35-1.39],0.3038431598831304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,1710,36,1.09 [0.80-1.50],0.5731776894907923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,1726,37,1.09 [0.83-1.43],0.5364128694744492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCLN,Nicalin,1676,36,0.86 [0.42-1.74],0.6671705104059802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,1713,36,5.51 [3.11-9.76],4.932427057641922e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1478,29,6.49 [2.80-15.02],1.2730386482457813e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,1740,39,11.77 [5.32-26.03],1.1395001896030595e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDRG1,Protein NDRG1,1661,36,1.28 [0.94-1.75],0.120113559291282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1490,30,1.08 [0.66-1.75],0.7694117024725025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1441,28,1.16 [0.43-3.12],0.7718801353723074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1478,29,1.01 [0.68-1.51],0.9454984993132688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1675,38,1.12 [0.80-1.58],0.5104600824707712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEB,Nebulin,1439,28,1.94 [0.93-4.05],0.0772635395878081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,1439,28,1.22 [0.74-2.02],0.4412358689624654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN1,Nectin-1,1444,28,1.17 [0.36-3.79],0.7900945989823586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,1724,39,8.18 [4.88-13.69],1.3148856551679352e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,1729,38,3.48 [2.51-4.83],9.406519291964649e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1444,28,0.66 [0.33-1.35],0.2568656326919141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD9,Enhancer of filamentation 1,1444,28,2.69 [1.30-5.58],0.0075907434446036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,1655,35,5.03 [3.34-7.59],1.2110901364647151e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,1475,30,0.84 [0.49-1.42],0.5110425660064875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,1729,38,0.58 [0.33-1.03],0.0639439469240744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,1726,37,1.65 [0.67-4.09],0.2768998299292613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NENF,Neudesin,1490,30,0.95 [0.68-1.33],0.7565144659741064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,1498,30,3.58 [1.16-11.04],0.0262683986761328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEXN,Nexilin,1502,29,1.28 [0.79-2.07],0.3168089774809809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,1738,37,5.54 [2.53-12.11],1.8049702089574872e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,1444,28,1.05 [0.69-1.60],0.803952397386749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1713,36,1.01 [0.74-1.38],0.9353928255921352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1676,36,1.14 [0.72-1.81],0.5838151197086898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,1461,30,1.11 [0.69-1.79],0.6551508840729383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFIC,Nuclear factor 1 C-type,1498,30,1.33 [0.85-2.06],0.2111331900860684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,1439,28,0.98 [0.59-1.63],0.948359121094992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,1475,30,0.89 [0.42-1.86],0.7506905824154907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,1675,38,1.22 [0.69-2.15],0.503340234209287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1478,29,1.22 [0.86-1.72],0.2640293789522171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,1439,28,1.02 [0.62-1.67],0.9484756587305184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,1439,28,1.02 [0.39-2.67],0.970217072575246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,1708,37,0.06 [0.01-0.37],0.0028289686863666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,1493,29,3.09 [1.47-6.48],0.0028563391420708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,1486,27,3.47 [1.04-11.65],0.0437397851244988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,1427,28,3.95 [1.25-12.53],0.0194609576741425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID1,Nidogen-1,1732,39,1.72 [0.87-3.41],0.1174337986431733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID2,Nidogen-2,1728,37,1.40 [0.97-2.03],0.0733716196512281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NINJ1,Ninjurin-1,1675,38,1.16 [0.73-1.86],0.5268570769356291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,1461,30,0.69 [0.33-1.45],0.3298752504545697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT2,Omega-amidase NIT2,1482,29,0.74 [0.45-1.21],0.2289804347283811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN1,Neuroligin-1,1456,28,0.68 [0.33-1.40],0.2997589710859725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN2,Neuroligin-2,1432,28,0.89 [0.39-2.04],0.7793487651180566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,1444,28,1.00 [0.18-5.53],0.9971463572797608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,1718,37,1.61 [0.60-4.31],0.3452809994475204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMI,N-myc-interactor,1482,30,1.01 [0.61-1.66],0.969194631837474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1708,37,0.81 [0.52-1.25],0.3360652729657756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,1438,27,0.55 [0.16-1.90],0.3465451002120661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1498,30,1.18 [0.75-1.84],0.4804802964944853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOMO1,Nodal modulator 1,1728,37,1.12 [0.35-3.54],0.8529805228296536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOP56,Nucleolar protein 56,1439,28,1.14 [0.86-1.52],0.3566233408672522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",1661,36,1.97 [1.19-3.28],0.008596039893534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",1439,28,2.07 [1.07-4.00],0.0310524704930746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",1661,36,1.44 [0.97-2.14],0.068179581780869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,1742,39,30.40 [6.79-136.22],8.109905076454117e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,1499,29,6.17 [2.14-17.81],0.0007713448151323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,1742,39,2.65 [1.40-5.01],0.0028082104296985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,1482,28,8.41 [3.76-18.78],2.098856276702616e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,1724,39,4.44 [2.96-6.66],5.63576736733894e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,1444,28,0.31 [0.10-0.96],0.0417419894728361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS2,Podocin,1444,28,0.79 [0.51-1.23],0.2985321743177774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPL,N-acetylneuraminate lyase,1493,29,0.37 [0.17-0.77],0.0083767005388305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,1692,39,1.39 [1.13-1.70],0.0015262473049865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,1713,36,1.94 [1.24-3.01],0.0034581673078402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,1439,28,0.54 [0.14-2.12],0.3740764433676262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTN,Neuroplastin,1675,38,1.07 [0.76-1.51],0.6885820515125216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX1,Neuronal pentraxin-1,1728,37,1.04 [0.51-2.13],0.9169084929031446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX2,Neuronal pentraxin-2,1499,29,2.13 [0.80-5.66],0.1277507930171989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,1724,39,1.27 [0.67-2.42],0.4671679738064037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,1740,39,2.46 [1.57-3.84],7.821714842642373e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,1724,39,2.30 [1.06-5.01],0.0353816116206868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRGN,Neurogranin,1502,29,1.04 [0.71-1.54],0.8335291127216004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRN1,Neuritin,1498,30,1.03 [0.39-2.73],0.9595395625338328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,1734,39,3.27 [1.37-7.85],0.0078756843583567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP2,Neuropilin-2,1728,37,1.63 [0.64-4.19],0.3064575602771119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRTN,Neurturin,1676,36,0.89 [0.46-1.69],0.7146063346761653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRXN3,Neurexin-3,1456,28,0.32 [0.07-1.47],0.1424934799819535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,1736,37,1.08 [0.70-1.65],0.739658057420557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1493,29,1.16 [0.71-1.90],0.5468565779258968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,1486,27,1.82 [0.86-3.86],0.1171321769314047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,1712,36,0.88 [0.63-1.22],0.4365265303738179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5E,5'-nucleotidase,1729,38,0.63 [0.36-1.09],0.0956070846081356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,1713,36,0.99 [0.46-2.14],0.9802033709143896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF4,Neurotrophin-4,1675,38,1.16 [0.62-2.16],0.6417377988446491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,1724,39,2.08 [0.76-5.70],0.15347142420919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK3,NT-3 growth factor receptor,1736,37,3.96 [1.17-13.41],0.027144410416796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,1724,39,1.67 [1.36-2.05],1.3147611023550225e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,1713,36,0.92 [0.64-1.32],0.6486513060562555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1490,30,0.60 [0.37-0.96],0.0314624591401755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,1739,39,5.87 [3.03-11.36],1.5004328812399898e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDC,Nuclear migration protein nudC,1738,37,1.22 [0.75-1.98],0.4241622908996674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1461,30,0.84 [0.23-3.08],0.7915976139071875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1439,28,0.89 [0.44-1.79],0.7467915005036612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,1476,29,1.10 [0.73-1.64],0.6595310662329361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1722,38,0.81 [0.48-1.39],0.4512963757486937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,1728,37,1.58 [1.01-2.48],0.0456607135262562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUMB,Protein numb homolog,1444,28,1.07 [0.69-1.68],0.7525602429873675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,1439,28,1.35 [0.76-2.40],0.3067897341161424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPE4,NXPE family member 4,1439,28,1.23 [0.60-2.52],0.5702377240736738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,1661,36,1.85 [1.02-3.34],0.0411762372562039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,1444,28,7.88 [2.40-25.91],0.0006713370169055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OBP2B,Odorant-binding protein 2b,1703,37,1.11 [0.73-1.68],0.6295757190881779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,1498,30,3.08 [1.71-5.57],0.0001917546209017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,1660,36,1.45 [0.99-2.12],0.0576514915560443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,1475,30,1.16 [0.75-1.80],0.5082120067650375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGA,Protein O-GlcNAcase,1478,29,1.02 [0.61-1.70],0.944311391406328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,1722,38,2.67 [1.18-6.05],0.018756846612572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,1728,37,5.41 [3.34-8.76],6.465677213563081e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1475,30,0.69 [0.32-1.47],0.3333572857078691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLFM4,Olfactomedin-4,1414,28,1.29 [0.96-1.72],0.0894379656519228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,1716,39,1.83 [1.25-2.69],0.0020686008613381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMD,Osteomodulin,1726,37,0.98 [0.55-1.77],0.957170490514662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,1722,38,0.74 [0.49-1.12],0.155662768977093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMP,Olfactory marker protein,1432,28,1.06 [0.53-2.13],0.8712261678177281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPHN1,Oligophrenin-1,1486,27,1.07 [0.76-1.50],0.7113799433431867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPLAH,5-oxoprolinase,1461,30,0.76 [0.45-1.30],0.3174673395787749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,1722,38,1.83 [1.07-3.16],0.0285887850810134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,1502,30,0.67 [0.12-3.67],0.6485845305297542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,1486,27,0.76 [0.25-2.31],0.6297119375264213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,1718,37,4.26 [1.85-9.79],0.0006395899834414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSM,Oncostatin-M,1707,36,1.48 [1.00-2.20],0.0483492808570062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,1734,39,1.43 [0.39-5.21],0.5874772115814427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSTN,Osteocrin,1456,28,0.71 [0.24-2.10],0.5310755095950295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTOA,Otoancorin,1432,28,1.46 [0.99-2.16],0.0547513033987729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,1478,29,0.95 [0.52-1.72],0.8552724132716223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,1498,30,1.71 [0.99-2.94],0.0525557653526703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1461,30,0.84 [0.51-1.39],0.5009899794158956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXT,Oxytocin-neurophysin 1,1736,37,0.87 [0.70-1.08],0.1994076726172531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,1710,38,2.51 [1.21-5.20],0.0130410462642363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,1439,28,1.00 [0.56-1.79],0.995788321534261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,1676,36,1.47 [1.01-2.13],0.0447618268719048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,1660,36,0.96 [0.66-1.39],0.8224446612873386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAEP,Glycodelin,1708,37,0.96 [0.74-1.26],0.7820664372010216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1498,30,0.99 [0.72-1.36],0.940524746664102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1475,30,0.81 [0.39-1.69],0.5729324449684157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1692,39,1.42 [0.88-2.28],0.1528807924664492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,1461,30,0.86 [0.40-1.88],0.7138322687201819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1435,27,0.89 [0.41-1.91],0.7593788482326458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,1661,36,1.55 [1.02-2.35],0.0382130769695661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALLD,Palladin,1444,28,0.86 [0.31-2.37],0.7737402910118616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,1471,29,3.76 [1.81-7.84],0.0004051489035538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,1486,27,1.92 [0.88-4.21],0.1026763365456975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM3,Paralemmin-3,1439,28,0.76 [0.36-1.60],0.4629547374667497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,1736,39,5.34 [2.41-11.84],3.782238213704446e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,1728,37,0.61 [0.23-1.66],0.334411901577517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAPPA,Pappalysin-1,1676,36,1.03 [0.56-1.90],0.9324366472503928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARD3,Partitioning defective 3 homolog,1475,30,1.26 [0.83-1.91],0.2799426135059869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARK7,Parkinson disease protein 7,1728,37,1.17 [0.69-1.98],0.5652339573520879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,1713,36,1.09 [0.65-1.82],0.7423270148162485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAXX,Protein PAXX,1471,29,1.17 [0.56-2.43],0.6836156145998316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,1438,27,0.83 [0.24-2.84],0.7630404451165077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,1661,36,0.68 [0.39-1.20],0.1818402768782557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1478,29,1.87 [0.64-5.44],0.2491364749432751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,1432,28,0.80 [0.47-1.37],0.4214157599818176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1470,29,0.58 [0.30-1.14],0.1126640267219931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,1498,30,0.93 [0.58-1.49],0.7494184378326241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,1732,37,2.36 [0.94-5.92],0.0660167166677141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH12,Protocadherin-12,1498,30,1.73 [0.46-6.48],0.4182299117052779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,1724,39,1.64 [0.86-3.15],0.1346479031547426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,1478,29,1.89 [1.05-3.40],0.0335674604949673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH9,Protocadherin-9,1478,29,0.61 [0.25-1.51],0.2867063100442427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,1490,30,1.30 [0.64-2.65],0.4730744568991257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,1438,27,1.35 [0.93-1.97],0.1166194473423479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,1490,30,0.56 [0.24-1.31],0.1799324118996605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,1742,39,1.90 [0.96-3.75],0.0653819757410558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,1478,29,1.27 [0.78-2.07],0.3442225525948625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,1493,29,1.21 [0.84-1.76],0.3102230849238414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,1739,39,2.17 [1.45-3.27],0.0001896054552106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,1722,38,6.44 [3.00-13.82],1.7430712718233096e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD5,Programmed cell death protein 5,1736,37,1.72 [1.09-2.74],0.0211148269482422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD6,Programmed cell death protein 6,1724,39,1.22 [0.74-2.02],0.4298638355270051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCL2,Phosducin-like protein 2,1438,27,0.99 [0.48-2.04],0.9868843847495592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1438,27,1.57 [1.12-2.19],0.0086257192290279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1439,28,1.19 [0.73-1.96],0.4840316631828506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1471,29,0.96 [0.68-1.36],0.8293901957950331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,1742,39,1.12 [0.76-1.67],0.5590167277907536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,1726,37,1.25 [0.88-1.77],0.2198149939332399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFC,Platelet-derived growth factor C,1675,38,1.57 [0.79-3.12],0.1948966099731056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,1724,39,5.67 [2.69-11.98],5.362564987588301e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,1742,39,0.87 [0.40-1.88],0.7290644219667358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,1438,27,0.59 [0.20-1.80],0.3557346619994892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,1471,29,5.38 [1.98-14.61],0.0009533996256516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,1499,29,1.05 [0.59-1.87],0.8658432154927442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,1438,27,0.89 [0.47-1.69],0.7211164189479378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,1498,30,0.96 [0.72-1.28],0.7646709786528771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,1726,37,1.19 [0.95-1.49],0.1326894549625976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1675,38,0.83 [0.42-1.63],0.5807823139849014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,1456,28,0.96 [0.49-1.87],0.908719858825306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1438,27,0.65 [0.26-1.62],0.3596719208389545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,1439,28,1.29 [0.81-2.07],0.2784076920850608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1444,28,1.14 [0.61-2.15],0.6741916413580387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,1742,39,10.98 [3.77-32.04],1.147439714897032e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,1728,37,1.10 [0.68-1.79],0.6888853573594406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,1728,37,1.58 [0.66-3.81],0.305494822126108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,1461,30,1.41 [0.38-5.26],0.6135734647731232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,1471,29,5.53 [2.80-10.91],8.242845379217684e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,1502,29,1.19 [0.32-4.41],0.7949350906278934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PER3,Period circadian protein homolog 3,1444,28,0.93 [0.69-1.26],0.6538242336171403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PF4,Platelet factor 4,1494,30,0.82 [0.57-1.17],0.2771568403618978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN2,Prefoldin subunit 2,1661,36,1.18 [0.70-1.97],0.5402614062380808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN4,Prefoldin subunit 4,1438,27,0.44 [0.18-1.05],0.0647437505814125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN6,Prefoldin subunit 6,1456,28,0.79 [0.40-1.57],0.5000065111659537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1720,38,1.09 [0.76-1.57],0.6265040526540021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,1502,29,1.30 [0.87-1.94],0.2067204709781999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1493,29,1.89 [1.21-2.97],0.0054432692887307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,1738,37,7.44 [4.23-13.07],3.102598306090829e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,1735,39,2.78 [1.72-4.48],2.819213112019177e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1490,30,0.67 [0.22-2.00],0.4698627741991991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,1439,28,1.06 [0.59-1.92],0.8356188592034806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGM2,Phosphoglucomutase-2,1456,28,0.81 [0.37-1.75],0.5934829574369449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGR,Progesterone receptor,1444,28,0.82 [0.50-1.36],0.4455927758671362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,1498,30,1.03 [0.76-1.39],0.8586413466574548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,1478,29,2.91 [1.59-5.31],0.0005258679671198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,1438,27,1.25 [0.93-1.67],0.141778505086412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1708,37,4.09 [1.64-10.19],0.0024720099627707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1471,29,0.42 [0.19-0.93],0.0331600998911218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,1502,29,9.69 [2.56-36.66],0.0008172755963575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,1703,39,2.65 [1.98-3.56],7.730172166691825e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1498,30,1.35 [0.88-2.07],0.1669225810904041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,1706,36,3.13 [1.73-5.69],0.0001757466684099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1713,36,0.85 [0.54-1.35],0.4958580427187466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1728,37,8.95 [5.22-15.35],1.6489225176148113e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1444,28,1.01 [0.51-1.99],0.972862890723994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,1728,37,3.83 [1.88-7.79],0.0002196057848365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,1724,39,2.53 [1.45-4.42],0.0011255868971709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1471,29,0.77 [0.47-1.28],0.3219102549544108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PITHD1,PITH domain-containing protein 1,1435,27,0.87 [0.52-1.43],0.5742167364969226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,1493,29,15.36 [4.27-55.25],2.864865261346893e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,1439,28,1.35 [0.75-2.41],0.3149399247916807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKLR,Pyruvate kinase PKLR,1720,37,0.63 [0.40-1.00],0.0522041000467027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,1475,30,0.97 [0.62-1.52],0.9027545938506688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,1708,37,2.32 [1.50-3.58],0.0001439807643039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,1729,38,1.24 [0.47-3.25],0.6659445818475855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,1739,39,0.78 [0.46-1.31],0.3493734572959772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",1713,39,1.29 [0.89-1.89],0.1817656893033311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,1726,37,1.06 [0.77-1.47],0.7101725960322391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,1728,37,0.32 [0.16-0.61],0.0006561369196898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAT,Tissue-type plasminogen activator,1737,39,0.68 [0.42-1.10],0.1149060692654694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,1728,37,0.82 [0.32-2.13],0.684770435161129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,1707,37,8.77 [4.16-18.48],1.1581671817013324e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",1486,27,0.74 [0.39-1.42],0.365830127569299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1444,28,0.46 [0.15-1.43],0.1776088204610794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1486,27,0.98 [0.67-1.42],0.8986298859425195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,1486,27,0.99 [0.60-1.66],0.9790963972723238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLG,Plasminogen,1460,28,0.34 [0.08-1.54],0.1608627075605865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN1,Perilipin-1,1661,36,1.23 [0.58-2.59],0.5846917993519314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,1724,39,2.41 [1.41-4.14],0.0013533520644471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,1724,39,1.08 [0.72-1.63],0.7089394751199154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,1483,27,1.30 [0.70-2.41],0.4073707814563209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLTP,Phospholipid transfer protein,1736,39,1.90 [0.89-4.07],0.0964724989157301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,1675,38,1.11 [0.45-2.70],0.8210442251404793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,1486,27,2.12 [0.86-5.26],0.103216042347086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNA4,Plexin-A4,1713,36,1.09 [0.75-1.57],0.6539611403772887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,1730,39,7.86 [3.43-18.00],1.0832148689106455e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB3,Plexin-B3,1718,39,1.25 [0.70-2.26],0.4503330642761443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1721,39,0.96 [0.82-1.11],0.5704843297708571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMCH,Pro-MCH,1439,28,1.13 [0.76-1.69],0.5318280194105746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMM2,Phosphomannomutase 2,1439,28,0.97 [0.52-1.81],0.9250908502182832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMS1,PMS1 protein homolog 1,1456,28,0.93 [0.47-1.85],0.83453850679641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMVK,Phosphomevalonate kinase,1658,36,1.07 [0.81-1.42],0.639489875811889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,1502,29,0.76 [0.46-1.27],0.2966030559707098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,1486,27,1.02 [0.67-1.56],0.916025850905282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,1714,37,1.04 [0.93-1.15],0.5177119289451302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,1461,30,1.16 [0.66-2.05],0.6118002542140679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,1432,28,0.69 [0.28-1.68],0.4127736564601418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1676,36,1.00 [0.77-1.30],0.9907116288959678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL,Podocalyxin,1722,38,0.32 [0.07-1.55],0.1567422294145373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,1729,38,2.67 [1.21-5.87],0.0148255384240115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,1444,28,2.11 [1.36-3.27],0.000887529011342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,1444,28,0.63 [0.16-2.53],0.5163291162340224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1722,38,2.42 [1.52-3.88],0.000218597383165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POMC,Pro-opiomelanocortin,1461,30,0.89 [0.55-1.45],0.6404848530571632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,1502,29,0.45 [0.21-0.99],0.048544960086854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,1692,39,0.88 [0.41-1.89],0.742333063518685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,1726,37,0.49 [0.23-1.06],0.0690729638971777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POSTN,Periostin,1499,29,2.13 [0.92-4.96],0.0786049013277127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPBP,Platelet basic protein,1491,30,1.05 [0.69-1.61],0.8131971813347205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,1736,37,0.96 [0.53-1.74],0.8983130682996859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,1722,39,1.26 [0.92-1.72],0.1533874000775111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,1475,30,1.07 [0.64-1.78],0.8024805423165453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1499,29,1.15 [0.70-1.90],0.5736770589177909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,1444,28,1.82 [0.87-3.81],0.1101593706063942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1A,Protein phosphatase 1A,1675,38,1.57 [0.81-3.04],0.180853209823078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1B,Protein phosphatase 1B,1444,28,0.65 [0.27-1.57],0.3405564312091905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1F,Protein phosphatase 1F,1493,29,0.94 [0.47-1.84],0.8471249167997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,1722,38,1.07 [0.68-1.69],0.7667659266894189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1490,30,1.02 [0.67-1.56],0.922291702892618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1729,38,1.26 [0.94-1.68],0.1175713510645743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1475,30,1.16 [0.75-1.80],0.5082579075266671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1498,30,0.99 [0.63-1.56],0.9666189256040668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1498,30,2.40 [1.59-3.63],3.2490892473270005e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,1724,39,1.30 [0.91-1.84],0.1483760033599339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R9B,Neurabin-2,1738,37,1.21 [0.89-1.65],0.2213152791004794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1478,29,1.04 [0.77-1.39],0.80615537404342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,1708,37,1.55 [0.78-3.09],0.2130330451456245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,1456,28,0.85 [0.50-1.46],0.5636764982772621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,1719,35,1.32 [1.02-1.72],0.0370127592187509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,1675,38,1.12 [0.70-1.80],0.625884432101351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,1438,27,0.65 [0.15-2.80],0.5614624194026672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,1499,29,1.59 [0.68-3.76],0.2865579452979547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,1490,30,0.94 [0.43-2.06],0.8793604691784949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,1734,39,1.72 [0.81-3.66],0.1549260702751679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX1,Peroxiredoxin-1,1665,36,0.91 [0.64-1.29],0.5978477276231052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,1471,29,0.62 [0.34-1.13],0.121555717439895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1676,36,1.11 [0.74-1.68],0.6120004882489665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",1738,37,1.08 [0.69-1.70],0.7383743085817194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,1740,39,0.93 [0.58-1.47],0.7411195201711742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,1676,36,2.34 [1.18-4.63],0.0144427393589797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,1714,37,8.73 [3.59-21.22],1.7264890859780107e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,1499,29,2.26 [1.34-3.83],0.002290712234471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,1499,29,0.99 [0.52-1.89],0.9812871869281328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1676,36,1.53 [0.91-2.55],0.1064643149345862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1456,28,0.87 [0.26-2.90],0.8266155909214344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1724,39,1.04 [0.74-1.47],0.8229901771479288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1483,26,0.89 [0.56-1.42],0.6226903109513812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKCQ,Protein kinase C theta type,1676,36,0.97 [0.50-1.86],0.9273970209450532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,1439,28,0.55 [0.17-1.77],0.3184645486630714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,1471,29,1.10 [0.83-1.46],0.5186187587192213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1675,38,1.12 [0.73-1.71],0.5970116147124949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRL,Prolactin,1736,37,1.18 [0.86-1.63],0.3110145107813317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,1486,27,1.04 [0.57-1.90],0.9026786490146378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROC,Vitamin K-dependent protein C,1732,39,0.70 [0.25-2.01],0.5116705344265485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROCR,Endothelial protein C receptor,1439,28,1.70 [0.93-3.12],0.0832603595197638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROK1,Prokineticin-1,1713,36,1.31 [0.87-1.96],0.1920024636911375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROS1,Vitamin K-dependent protein S,1505,30,0.56 [0.15-2.14],0.3954642996944533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,1456,28,1.95 [1.32-2.88],0.000767050551508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR5,Proline-rich protein 5,1444,28,0.39 [0.15-1.04],0.0591346884450749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,1461,30,2.95 [1.66-5.22],0.0002140080503521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,1733,39,1.09 [0.70-1.70],0.7168608220431045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,1444,28,3.47 [1.83-6.61],0.0001477356906484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,1720,39,5.56 [3.06-10.09],1.6922964087791756e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS53,Serine protease 53,1486,27,0.75 [0.29-1.89],0.5361447334028255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,1716,37,2.94 [1.62-5.32],0.0003804852944807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1661,36,1.08 [0.82-1.43],0.572018030221257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,1740,39,3.89 [1.55-9.79],0.003860121716265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,1680,39,1.74 [1.09-2.77],0.0210552062248335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRUNE2,Protein prune homolog 2,1475,30,0.39 [0.12-1.24],0.1097091438569058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,1490,29,10.67 [3.61-31.49],1.827185730688396e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,1478,29,1.73 [0.93-3.24],0.085271633395643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,1478,29,1.08 [0.94-1.25],0.2865607370311805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,1708,37,1.70 [1.33-2.18],2.0993995026285447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,1713,36,1.16 [0.77-1.74],0.4885578638479505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,1675,38,0.39 [0.20-0.76],0.0059419678669493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,1438,27,1.06 [0.35-3.19],0.9193770400899862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,1498,30,1.55 [0.98-2.45],0.0608413434949938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,1456,28,0.92 [0.44-1.89],0.8132296167878574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,1722,38,0.92 [0.56-1.49],0.7243288285421576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,1707,37,0.90 [0.41-1.97],0.7989094837109676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,1698,37,0.81 [0.35-1.86],0.6212319243200295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,1713,36,0.70 [0.39-1.25],0.2239687322644546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,1444,28,0.74 [0.38-1.46],0.3873219360988917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSPN,Persephin,1713,36,1.19 [0.91-1.54],0.1973788330618569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,1675,38,1.46 [0.97-2.19],0.0674667020391906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1428,29,1.06 [0.76-1.50],0.7194492403830068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1661,36,2.95 [1.20-7.27],0.0184438732804143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,1715,39,6.96 [4.34-11.15],7.30414436628011e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,1433,28,1.65 [0.86-3.15],0.1293903925659529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGR1,Prostaglandin reductase 1,1493,29,0.97 [0.66-1.43],0.875882105065657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,1456,28,1.21 [0.83-1.77],0.3241370425967441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1713,36,1.90 [1.30-2.78],0.0009535560995786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,1661,36,3.40 [1.72-6.72],0.0004490631762015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTN,Pleiotrophin,1692,39,1.42 [0.82-2.48],0.215478061112941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,1444,28,0.69 [0.31-1.56],0.3726301400139843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1708,37,1.24 [0.87-1.79],0.2363190277987595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1721,37,1.06 [0.75-1.49],0.7482046539437122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1444,28,0.69 [0.22-2.13],0.5153683800938483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,1493,29,1.37 [0.43-4.34],0.594350380111891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,1499,29,6.14 [1.49-25.38],0.012125157496149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,1742,39,3.25 [1.33-7.93],0.0096655321566443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,1478,29,1.09 [0.54-2.23],0.8097767882161242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1478,29,1.07 [0.27-4.25],0.9274493147753844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,1710,36,1.66 [0.55-5.02],0.3668623865411039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1703,37,3.40 [2.19-5.29],5.2198057899383074e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,1486,27,2.43 [1.03-5.72],0.0427207242711891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,1742,39,13.55 [4.79-38.29],8.823243574108382e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1493,29,3.53 [1.21-10.28],0.0207212141237224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1471,29,0.92 [0.51-1.66],0.7775420443828119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,1651,35,0.54 [0.33-0.90],0.0176231274193653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTTG1,Securin,1475,30,1.13 [0.52-2.47],0.7571812591879306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,1713,36,1.97 [0.99-3.91],0.0535963521126746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVALB,Parvalbumin alpha,1731,39,0.97 [0.76-1.24],0.818954312535055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,1736,37,0.81 [0.39-1.70],0.5789724468444815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXDNL,Peroxidasin-like protein,1490,30,1.45 [0.99-2.12],0.0533431126657638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,1661,36,1.78 [1.16-2.74],0.0085786882694315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,1461,30,1.07 [0.50-2.28],0.8567568479142837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,1439,28,1.61 [1.23-2.12],0.0005544798930526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PZP,Pregnancy zone protein,1505,30,0.88 [0.51-1.51],0.6336126148116198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QDPR,Dihydropteridine reductase,1718,38,0.95 [0.49-1.85],0.8909630200204679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,1727,39,10.11 [4.19-24.37],2.555701366032543e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,1474,30,0.76 [0.24-2.37],0.637047958145343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB10,Ras-related protein Rab-10,1493,29,1.31 [0.71-2.41],0.3899503789356877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,1493,29,1.06 [0.77-1.47],0.7199068800073236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,1493,29,1.17 [0.73-1.87],0.5064785544147583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,1490,30,0.90 [0.51-1.58],0.7105509645182884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,1439,28,1.03 [0.59-1.78],0.927242845667329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB37,Ras-related protein Rab-37,1676,36,1.09 [0.78-1.51],0.6250560545806462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,1439,28,0.91 [0.57-1.46],0.7010750973344151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1432,28,1.05 [0.58-1.91],0.8689228314079953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB44,Ras-related protein Rab-44,1490,30,1.23 [0.75-2.03],0.4135613222554666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,1713,36,0.56 [0.30-1.05],0.0690930741233964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,1661,36,1.21 [0.73-2.01],0.4547029701801622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,1471,29,0.93 [0.59-1.47],0.763906075595643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,1675,38,0.96 [0.58-1.59],0.8663007155581633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,1676,36,1.18 [0.75-1.86],0.4765036237743039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,1456,28,0.93 [0.53-1.66],0.8140385844134584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,1675,38,1.02 [0.54-1.90],0.9579365929254132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,1475,30,1.13 [0.57-2.23],0.7303966460548286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALB,Ras-related protein Ral-B,1444,28,0.39 [0.11-1.36],0.1379272422270327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,1490,30,0.95 [0.47-1.92],0.8945112157849198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,1461,30,0.58 [0.30-1.12],0.1066840883031071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,1432,28,2.23 [0.89-5.60],0.0889208027598385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,1675,38,1.01 [0.55-1.86],0.9647631550784966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,1444,28,1.19 [0.84-1.69],0.3255955236918664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,1475,30,1.14 [0.59-2.18],0.697359094845504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,1675,38,2.01 [1.25-3.22],0.0039335030470328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,1734,39,2.40 [1.39-4.14],0.0017028186918553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,1661,36,1.35 [0.60-3.04],0.4614181107193477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1438,27,1.12 [0.52-2.43],0.7735143448449533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,1675,38,1.24 [0.87-1.78],0.2362785481128745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,1498,30,2.17 [1.50-3.14],3.849343581299618e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,1683,37,0.57 [0.41-0.79],0.0007770376863713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM17,Splicing factor 45,1498,30,1.26 [0.81-1.96],0.3020926260092725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM19,Probable RNA-binding protein 19,1439,28,1.34 [0.63-2.85],0.4444249885784854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM25,RNA-binding protein 25,1438,27,0.97 [0.44-2.13],0.939912329684998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP1,Retinol-binding protein 1,1456,28,1.08 [0.66-1.78],0.7510534863730913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,1722,38,2.68 [1.91-3.75],1.1541814657291944e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,1722,38,1.58 [1.06-2.36],0.0254810420858952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,1478,29,1.57 [1.04-2.37],0.0327491856227267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,1444,28,0.71 [0.32-1.55],0.3866624689689332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,1461,30,1.12 [0.80-1.58],0.5102309903568666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCC1,Regulator of chromosome condensation,1490,30,1.06 [0.59-1.93],0.8418711969227581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCOR1,REST corepressor 1,1692,39,1.27 [0.76-2.13],0.3616933403648612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1461,30,1.53 [0.25-9.25],0.6434422865825811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,1498,30,1.47 [0.88-2.46],0.1390261630066497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,1721,39,3.27 [2.38-4.51],3.91407231629824e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,1742,39,2.23 [1.63-3.04],5.379083454514143e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,1742,39,2.82 [2.09-3.80],1.4689284025098275e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,1490,30,0.94 [0.41-2.16],0.8915304042906512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,1718,37,3.51 [2.31-5.32],3.5960199999678646e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELB,Transcription factor RelB,1444,28,1.07 [0.55-2.09],0.8369658186070211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,1728,37,7.63 [4.05-14.40],3.3869709307649485e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,1724,39,1.97 [1.59-2.44],6.704848291724703e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,1444,28,0.82 [0.31-2.21],0.6968873946409563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REST,RE1-silencing transcription factor,1438,27,1.97 [0.94-4.14],0.0731756182131224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1722,38,0.57 [0.30-1.07],0.0816325658410304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,1721,39,2.82 [1.86-4.27],9.334250077695153e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",1439,28,1.13 [0.57-2.25],0.7184450563309142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RFC4,Replication factor C subunit 4,1490,30,0.95 [0.20-4.52],0.952583101879716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,1498,30,1.04 [0.66-1.64],0.8759927529013635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1475,30,1.01 [0.61-1.67],0.9709026997118152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,1736,37,5.88 [2.56-13.50],2.9748449694200328e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,1736,37,7.96 [3.83-16.53],2.6296704437555534e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,1498,30,1.10 [0.61-1.97],0.7606527512147092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,1676,36,0.78 [0.44-1.40],0.4098357461696804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,1700,37,1.18 [0.90-1.54],0.2341533203574628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,1444,28,0.94 [0.48-1.85],0.862928544162096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1471,29,0.95 [0.52-1.74],0.8610247299015434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILP,Rab-interacting lysosomal protein,1733,39,0.94 [0.60-1.49],0.8052153520876176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILPL2,RILP-like protein 2,1493,29,1.07 [0.74-1.55],0.7273259499510407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1439,28,1.05 [0.62-1.77],0.8550913580741388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,1498,30,0.84 [0.43-1.67],0.6273762592406769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,1466,29,1.12 [0.85-1.48],0.4130630680501826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,1502,29,13.48 [5.63-32.30],5.33342889383729e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,1461,30,1.82 [0.98-3.36],0.0579955611503309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE3,Eosinophil cationic protein,1717,39,1.11 [0.89-1.39],0.3656022784580451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,1446,29,5.97 [1.94-18.36],0.0018175695015447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,1489,29,4.21 [2.29-7.75],3.7399083200631934e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,1498,30,0.95 [0.46-1.99],0.9011179700175764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,1736,39,4.01 [2.76-5.83],3.510491463676884e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,1461,30,4.97 [2.46-10.04],7.68175548057131e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,1444,28,1.22 [0.54-2.76],0.6296128519969495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,1444,28,0.76 [0.25-2.31],0.6226389716341619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,1475,30,1.26 [0.83-1.91],0.2705154041347183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,1675,38,1.02 [0.67-1.57],0.9153041087978252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,1475,30,1.01 [0.56-1.85],0.9652426469052732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,1461,30,0.76 [0.47-1.23],0.2638277543905244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO1,Roundabout homolog 1,1718,37,1.15 [0.46-2.86],0.7596965352123972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO2,Roundabout homolog 2,1736,37,1.84 [0.56-6.00],0.3140804487669866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,1461,30,15.39 [2.29-103.50],0.0049450333532895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1724,39,10.81 [5.41-21.61],1.567745418060009e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RP2,Protein XRP2,1722,38,0.93 [0.48-1.81],0.8342125357747183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,1444,28,1.16 [0.38-3.54],0.7905365631938812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,1475,30,0.74 [0.42-1.30],0.2957153270535364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,1456,28,0.77 [0.32-1.83],0.5468001027329132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPL14,60S ribosomal protein L14,1461,30,1.49 [0.82-2.70],0.1927007261548478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPS10,40S ribosomal protein S10,1439,28,1.08 [0.49-2.38],0.8525349224627148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRAS,Ras-related protein R-Ras,1456,28,1.01 [0.76-1.33],0.9426233375231152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,1675,38,1.22 [0.79-1.88],0.378475876678588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1675,38,1.10 [0.72-1.69],0.6568959690520705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRP15,RRP15-like protein,1432,28,0.96 [0.65-1.42],0.8371976764101143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,1708,37,3.10 [1.55-6.20],0.0014130965657488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,1740,39,5.79 [3.31-10.11],6.816726273495142e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,1722,38,2.52 [1.79-3.55],1.0422788319705616e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTKN2,Rhotekin-2,1439,28,1.53 [1.05-2.23],0.0262864895898499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1498,30,1.19 [0.82-1.74],0.3662083357179377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,1740,39,2.80 [1.26-6.19],0.0111292689199483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RUVBL1,RuvB-like 1,1675,38,0.91 [0.67-1.24],0.5493322720026472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RWDD1,RWD domain-containing protein 1,1736,37,1.20 [0.77-1.88],0.4259577988775723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RYR1,Ryanodine receptor 1,1439,28,0.68 [0.19-2.45],0.5516494127613352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A11,Protein S100-A11,1711,39,1.52 [1.00-2.30],0.0490214357111757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A12,Protein S100-A12,1708,37,1.09 [0.74-1.60],0.6627712469267641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A13,Protein S100-A13,1444,28,1.50 [0.58-3.88],0.4023296120494192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A14,Protein S100-A14,1498,30,0.99 [0.54-1.82],0.9777956480228452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A16,Protein S100-A16,1660,36,1.28 [0.82-1.98],0.2739126277978783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A3,Protein S100-A3,1490,30,0.35 [0.09-1.37],0.1304298957036301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,1729,38,1.00 [0.61-1.66],0.9894294129841572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,1498,30,0.86 [0.41-1.80],0.6808768661685508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,1692,39,1.70 [1.19-2.42],0.0033753476323573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAA4,Serum amyloid A-4 protein,1505,30,1.39 [0.54-3.54],0.4919479218499449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAFB2,Scaffold attachment factor B2,1498,30,1.35 [0.35-5.26],0.6620136256215732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAG,S-arrestin,1432,28,1.18 [0.68-2.05],0.543918970773448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,1713,36,1.23 [0.83-1.83],0.2983378682806674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,1475,30,1.04 [0.67-1.61],0.8741961209375304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,1490,29,1.12 [0.81-1.54],0.4957953830930079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,1439,28,1.04 [0.40-2.68],0.9339943483452172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT1,Diamine acetyltransferase 1,1439,28,0.96 [0.48-1.94],0.9162190660666252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,1475,30,1.03 [0.63-1.68],0.91758789411114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SATB1,DNA-binding protein SATB1,1498,30,0.83 [0.24-2.85],0.7695829358240579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,1494,29,1.88 [0.76-4.64],0.1687274978589825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,1722,38,1.36 [0.98-1.89],0.0626090092235833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,1736,37,8.62 [4.77-15.58],9.69245670603552e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,1661,36,0.86 [0.49-1.52],0.6055161623401732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,1671,37,5.76 [3.71-8.94],6.9168207840737204e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,1742,39,3.33 [1.84-6.03],7.200389148849448e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,1736,37,8.62 [3.96-18.75],5.6718947439635735e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,1732,39,7.55 [4.04-14.09],2.1773010696503784e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,1718,37,2.26 [1.00-5.11],0.0510162823295474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,1723,37,2.40 [1.39-4.16],0.0017138999503919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB2A2,Mammaglobin-A,1439,28,1.17 [0.37-3.77],0.7864168710311068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,1471,29,8.37 [2.20-31.81],0.0018124896310865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,1721,37,1.37 [1.14-1.66],0.0008549862176483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,1676,36,4.20 [2.65-6.66],9.62455410852908e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCIN,Adseverin,1432,28,0.92 [0.54-1.56],0.7452010493026336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCLY,Selenocysteine lyase,1733,39,0.63 [0.37-1.07],0.0853398736885537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,1432,28,0.74 [0.31-1.79],0.5060102206781134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,1456,28,1.44 [0.50-4.19],0.4999052631853615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,1456,28,0.42 [0.15-1.18],0.1005632180975965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,1432,28,0.58 [0.22-1.53],0.2700045085003382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,1461,30,3.30 [1.87-5.81],3.586052817239819e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,1675,38,0.97 [0.65-1.44],0.8783750369178376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,1456,30,2.15 [1.12-4.13],0.0214013068593052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,1493,29,6.74 [2.82-16.07],1.714596582299276e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRIB,Protein scribble homolog,1461,30,1.32 [0.99-1.76],0.0618650527818563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRN1,Secernin-1,1713,36,1.63 [1.03-2.60],0.0375780395434615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCT,Secretin,1456,28,2.65 [1.31-5.33],0.0064124538757099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,1724,39,2.60 [1.67-4.04],2.2742755368983803e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,1724,39,0.84 [0.45-1.54],0.5640943237012884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,1490,30,0.97 [0.71-1.32],0.8385913771825265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDHB,Succinate dehydrogenase,1478,29,0.89 [0.51-1.54],0.6655638804357737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,1471,29,0.40 [0.19-0.85],0.0173454731672079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEC31A,Protein transport protein Sec31A,1461,30,1.01 [0.63-1.61],0.9798608249210732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,1461,30,2.09 [1.23-3.54],0.0062303060428349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,1742,39,1.36 [0.83-2.24],0.223892259345754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELENOP,Selenoprotein P,1505,30,0.77 [0.18-3.21],0.7195845815137136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELL,L-selectin,1505,30,0.31 [0.10-0.96],0.0425604050284307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELP,P-selectin,1733,39,1.37 [0.85-2.23],0.1976542684081441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,1713,36,1.03 [0.45-2.34],0.9532353360378968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,1724,39,6.34 [2.60-15.46],4.911273420050625e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3G,Semaphorin-3G,1471,29,1.27 [0.60-2.66],0.5295097414849788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,1722,38,1.38 [0.71-2.69],0.3378912852193801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4D,Semaphorin-4D,1736,37,2.50 [0.90-6.91],0.0773837420440655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,1444,28,1.72 [0.50-5.90],0.3851427916805664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,1737,39,3.35 [1.66-6.74],0.0007329450006087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,1498,30,1.20 [0.76-1.90],0.4418267927145557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN7,Septin-7,1475,30,0.62 [0.27-1.45],0.2734482788609982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,1485,27,2.34 [1.31-4.19],0.0042227217734865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN9,Septin-9,1722,38,0.55 [0.19-1.62],0.2766472041134477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,1476,30,2.32 [0.04-153.25],0.6944607412725701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA11,Serpin A11,1742,39,1.30 [0.66-2.56],0.444132647804687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA12,Serpin A12,1681,36,0.87 [0.67-1.12],0.2877179525781362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,1499,30,0.45 [0.05-4.12],0.4761557553191468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA4,Kallistatin,1468,29,0.30 [0.11-0.83],0.0203818752023254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,1483,30,0.43 [0.14-1.32],0.1412618988784549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,1505,30,0.59 [0.08-4.36],0.6049748529929257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,1505,30,0.13 [0.03-0.57],0.0065449293404874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA9,Serpin A9,1710,38,1.18 [0.83-1.70],0.3580705922690442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,1724,37,1.17 [0.86-1.59],0.3182817862522316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB5,Serpin B5,1692,39,1.09 [0.60-1.95],0.7815551157241246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB6,Serpin B6,1731,37,1.61 [1.00-2.60],0.0520499094389894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,1738,37,1.40 [1.01-1.95],0.0434144145977007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB9,Serpin B9,1708,37,1.00 [0.39-2.55],0.9944671486360542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINC1,Antithrombin-III,1501,30,0.33 [0.06-1.79],0.1989401406416686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPIND1,Heparin cofactor 2,1501,30,0.60 [0.19-1.86],0.3757823925624437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,1742,39,1.01 [0.65-1.56],0.9688951642668684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE2,Glia-derived nexin,1493,29,1.13 [0.67-1.91],0.6494930592436405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,1475,30,2.16 [0.66-7.05],0.2008950855660026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,1471,30,0.19 [0.04-1.00],0.0504555564887222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,1501,30,3.00 [0.50-18.06],0.2314465427120844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINH1,Serpin H1,1475,30,1.17 [0.90-1.53],0.2349405535470775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI1,Neuroserpin,1467,29,0.72 [0.25-2.12],0.5551819479725437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI2,Serpin I2,1478,29,0.78 [0.41-1.48],0.4396250396747588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1661,36,0.89 [0.56-1.43],0.6404762079995552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,1701,37,0.56 [0.20-1.59],0.2784894446034653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,1456,28,1.41 [0.52-3.82],0.4980169738075589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,1729,38,5.54 [3.02-10.17],3.2215424981131184e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,1722,38,2.29 [0.76-6.92],0.1434398884852645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,1722,38,1.27 [0.87-1.84],0.2123665367418247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,1704,37,2.31 [1.39-3.85],0.0012651295066089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,1471,29,1.81 [0.83-3.96],0.1363771380190759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,1675,38,1.14 [0.74-1.75],0.5601907675381717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,1675,38,0.88 [0.50-1.57],0.6694796682822318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,1724,39,1.48 [0.97-2.27],0.0706000337046492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,1469,28,1.21 [0.67-2.16],0.5281315677574601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2B3,SH2B adapter protein 3,1675,38,1.06 [0.79-1.42],0.7091538715918542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,1713,36,1.21 [0.73-2.01],0.4505725600492777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1432,28,0.55 [0.23-1.31],0.1776729829115725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,1478,29,0.76 [0.33-1.74],0.5206774240615717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GL3,Endophilin-A3,1463,30,0.82 [0.54-1.25],0.3635729239001964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GLB2,Endophilin-B2,1486,27,1.10 [0.65-1.86],0.7263817301970925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHBG,Sex hormone-binding globulin,1502,29,1.48 [0.83-2.65],0.1825056031005079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHC1,SHC-transforming protein 1,1438,27,0.89 [0.64-1.24],0.4963406172328884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,1435,28,1.27 [1.01-1.60],0.0417174526899901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHH,Sonic hedgehog protein,1444,28,0.73 [0.29-1.84],0.502033395142061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,1499,29,7.11 [3.70-13.69],4.1353166011474545e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",1721,37,0.86 [0.61-1.20],0.3658788439083954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHPK,Sedoheptulokinase,1475,30,1.44 [0.75-2.76],0.2755143492899296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIAE,Sialate O-acetylesterase,1728,38,1.93 [1.08-3.44],0.0261454211365078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,1726,37,1.90 [1.07-3.37],0.0292427476978362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,1713,36,4.29 [2.06-8.97],0.0001051521616384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,1661,36,1.22 [0.91-1.64],0.1798213406831204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,1728,37,1.64 [1.16-2.32],0.0046723062913796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,1740,39,3.84 [1.82-8.07],0.0003958500706627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,1724,39,2.77 [1.11-6.89],0.028315434627183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,1461,30,1.49 [0.73-3.05],0.2759188629792786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,1738,39,1.29 [0.52-3.20],0.5845350557752862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,1461,30,1.75 [0.89-3.45],0.1049946743497714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1720,39,1.38 [0.81-2.34],0.2364785905111966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,1713,37,4.04 [2.44-6.69],5.951428955702447e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,1444,28,0.83 [0.46-1.51],0.5498254223189549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,1722,38,1.09 [0.78-1.50],0.6244222114285647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1661,36,1.03 [0.64-1.65],0.9094313909100078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,1676,36,1.07 [0.64-1.79],0.7992375292017115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,1704,37,0.86 [0.57-1.28],0.4473360414084339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,1726,37,1.13 [0.86-1.50],0.3777191842186904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKIV2L,Helicase SKI2W,1439,28,0.80 [0.29-2.17],0.6598247198752756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLA2,Src-like-adapter 2,1498,30,1.20 [0.85-1.68],0.3022121009643348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,1676,36,1.45 [0.92-2.29],0.1126096602751838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,1675,38,2.04 [1.29-3.24],0.0024940912239258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,1713,36,2.00 [1.30-3.07],0.0016393398871519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,1675,38,1.91 [1.13-3.21],0.0150982134751848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,1439,28,0.86 [0.23-3.19],0.8191170438297477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,1490,30,1.57 [1.15-2.16],0.0049108937114403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,1661,36,1.09 [0.71-1.67],0.7001624454804763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,1456,28,1.34 [0.78-2.30],0.2905278237650469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,1661,36,1.41 [0.98-2.01],0.0614575078943667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,1438,27,0.76 [0.36-1.62],0.4800952411195477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,1438,27,1.16 [0.58-2.32],0.6721987954479243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,1661,36,2.22 [1.65-2.99],1.244513668906373e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,1713,36,2.35 [1.39-3.96],0.0013533531164072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,1456,28,0.86 [0.48-1.52],0.5958910868636775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,1499,29,1.66 [0.83-3.33],0.1531013202673201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,1439,28,1.37 [0.93-2.00],0.1118035005246188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1471,29,1.12 [0.74-1.71],0.5856359483089366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1478,29,1.26 [0.76-2.08],0.3716142492395763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1438,27,1.31 [0.81-2.14],0.2735188050989827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIT2,Slit homolog 2 protein,1661,36,0.61 [0.32-1.15],0.1254859411893639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,1444,28,1.31 [0.42-4.08],0.6354672426091107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,1740,39,3.28 [1.63-6.61],0.0008812079311294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,1692,39,9.09 [4.72-17.50],3.993412792505277e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,1475,30,0.83 [0.48-1.43],0.4969580950418285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,1478,29,1.41 [0.96-2.07],0.08074816899064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,1482,29,1.71 [0.91-3.23],0.0978510227853137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,1675,38,1.32 [0.95-1.84],0.0981917292608294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,1490,30,0.88 [0.54-1.45],0.6202127428988151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,1490,30,1.52 [0.81-2.86],0.1901518306438256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,1722,38,0.27 [0.09-0.82],0.0215464776631758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,1661,36,0.93 [0.62-1.40],0.7312219758348076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,1438,27,1.11 [0.60-2.05],0.7416033383627731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,1478,29,1.13 [0.68-1.87],0.6489414772940586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,1740,39,2.89 [1.33-6.27],0.0072963568627951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,1726,37,3.13 [1.96-5.00],1.7189873676805277e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,1724,37,1.29 [0.74-2.24],0.3629255248472586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,1444,28,1.10 [0.60-2.01],0.7568883577166878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1725,37,0.91 [0.59-1.39],0.6481157068908441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1490,30,0.52 [0.24-1.10],0.0851724221592391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMS,Spermine synthase,1432,28,1.06 [0.62-1.80],0.8436645553402929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,1483,27,1.13 [0.79-1.62],0.5009460713819163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,1724,39,1.02 [0.73-1.42],0.9247295921211564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,1432,28,1.00 [0.49-2.04],0.9986630261541956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,1729,38,1.28 [0.93-1.76],0.1225502889509243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,1498,30,0.73 [0.39-1.35],0.311134703928225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCA,Alpha-synuclein,1471,29,1.08 [0.80-1.46],0.6157434760652992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,1708,37,2.66 [1.84-3.83],1.62660951572039e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1461,30,1.73 [0.78-3.80],0.1761667110337779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',1486,27,1.17 [0.67-2.06],0.5743299133762416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNU13,NHP2-like protein 1,1439,28,0.66 [0.29-1.49],0.3139739202337486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX15,Sorting nexin-15,1471,29,1.00 [0.53-1.88],0.989597005544701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX18,Sorting nexin-18,1478,29,0.97 [0.46-2.04],0.9354767786415424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX2,Sorting nexin-2,1490,30,0.94 [0.59-1.51],0.8115742012024509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX5,Sorting nexin-5,1461,30,0.75 [0.23-2.48],0.636336096049259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX9,Sorting nexin-9,1724,39,1.34 [0.91-1.99],0.1416117682419149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],1694,39,1.20 [0.69-2.10],0.5132777485248109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",1728,37,0.48 [0.23-1.00],0.0484714042325669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD3,Extracellular superoxide dismutase,1502,29,1.41 [0.99-2.02],0.0577683697455895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,1498,30,1.24 [0.67-2.28],0.4892303294094711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,1675,38,8.00 [4.67-13.71],3.56605347316825e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,1730,39,0.52 [0.37-0.73],0.0001426138995743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORT1,Sortilin,1724,39,1.47 [0.72-3.02],0.2900818480867915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,1724,39,2.30 [1.15-4.62],0.0188918336656121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1456,28,1.01 [0.51-1.99],0.977458169601958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX2,Transcription factor SOX-2,1496,30,0.40 [0.09-1.85],0.2424979197289501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,1456,28,1.78 [0.45-7.03],0.4076908314085176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1498,30,1.60 [0.82-3.12],0.1645568721127301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPAG1,Sperm-associated antigen 1,1498,30,0.76 [0.40-1.43],0.3911362680435488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARC,SPARC,1729,38,1.14 [0.74-1.74],0.5606420257364598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,1722,39,3.80 [1.64-8.84],0.0018830111412212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPART,Spartin,1471,29,1.16 [0.73-1.84],0.5267393923670181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,1493,29,1.83 [0.59-5.71],0.2992882336706275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,1728,37,2.81 [2.00-3.95],2.753056072714668e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,1471,29,3.48 [1.77-6.81],0.0002835129402657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,1713,36,3.21 [2.28-4.53],2.568975076705365e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,1728,37,5.20 [2.57-10.52],4.539679978273385e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,1740,39,1.97 [1.19-3.24],0.0082294260170865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,1439,28,0.68 [0.22-2.12],0.5070349668449161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,1724,37,3.29 [1.52-7.14],0.002534607008653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,1726,37,3.89 [1.99-7.61],6.895570724918789e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,1478,29,0.84 [0.66-1.08],0.1805501831766391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,1708,37,0.33 [0.13-0.83],0.0191572294932185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,1718,37,3.51 [1.90-6.52],6.607583280770319e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,1719,39,4.61 [2.49-8.53],1.100482116654508e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,1740,39,2.56 [1.60-4.11],9.305189019835373e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1444,28,1.24 [0.59-2.58],0.5692770912617028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,1438,27,0.93 [0.44-1.99],0.8539397079608778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR1B,Cornifin-B,1475,30,1.12 [0.79-1.59],0.5323534869766604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,1486,27,1.96 [1.25-3.05],0.0031273331023379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRY2,Protein sprouty homolog 2,1676,36,1.12 [0.83-1.52],0.4699903769724863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1432,28,1.14 [0.44-2.92],0.7880254430713518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,1486,27,1.36 [0.64-2.89],0.418589831001139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,1725,38,1.10 [0.86-1.41],0.4345599820204691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,1722,38,1.44 [0.93-2.24],0.1058153071666896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPK2,SRSF protein kinase 2,1713,36,1.08 [0.78-1.51],0.6320601597448723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,1493,29,2.12 [0.88-5.15],0.0959595419606884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSB,Lupus La protein,1661,36,0.85 [0.49-1.50],0.5829361257871224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1444,28,0.93 [0.33-2.63],0.8911348083085008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1724,39,0.74 [0.58-0.94],0.0140082712731253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1733,39,0.75 [0.39-1.43],0.3801365108603709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,1438,27,0.55 [0.13-2.32],0.4172312710244268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,1478,29,1.21 [0.66-2.22],0.5397629203146311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST13,Hsc70-interacting protein,1471,29,0.76 [0.41-1.40],0.3771491780384463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1722,38,2.32 [1.40-3.84],0.0011398350181233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1742,39,4.46 [1.73-11.49],0.0019369023003993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1444,28,1.08 [0.48-2.44],0.8571613993309902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAB2,Stabilin-2,1499,29,1.41 [0.40-4.99],0.5984509060151515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAM,Signal transducing adapter molecule 1,1490,30,1.13 [0.46-2.79],0.7941142022801422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAMBP,STAM-binding protein,1704,37,1.04 [0.66-1.62],0.8747544456379577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,1444,28,1.14 [0.71-1.83],0.59263252434517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,1722,38,1.07 [0.87-1.31],0.5490704306812906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1438,27,0.72 [0.36-1.44],0.3561366756209623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,1736,37,1.78 [1.02-3.09],0.0406180152293387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,1726,37,1.54 [0.51-4.67],0.4482904846704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STEAP4,Metalloreductase STEAP4,1432,28,1.27 [0.86-1.88],0.2360720233464081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,1725,37,1.08 [0.71-1.64],0.7329888242848164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,1692,39,1.21 [0.83-1.76],0.3252674199143456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,1661,36,1.21 [0.75-1.96],0.4269675339579272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,1724,39,1.09 [0.78-1.53],0.6209818270002219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",1438,27,1.08 [0.72-1.61],0.7130246303114949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX16,Syntaxin-16,1675,38,1.05 [0.68-1.63],0.8154701556891796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX1B,Syntaxin-1B,1456,28,1.06 [0.47-2.40],0.892101257788513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX3,Syntaxin-3,1486,27,0.33 [0.08-1.43],0.1396973820180653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,1722,38,1.43 [1.00-2.05],0.0527714476410376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX5,Syntaxin-5,1444,28,0.87 [0.34-2.23],0.7646804639245792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX6,Syntaxin-6,1675,38,1.22 [0.82-1.80],0.3228419329140592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX7,Syntaxin-7,1444,28,1.04 [0.48-2.26],0.911823403544438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX8,Syntaxin-8,1713,36,1.68 [1.00-2.81],0.0486434938615204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,1498,30,0.95 [0.60-1.49],0.8185515789662492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,1675,38,1.21 [0.61-2.36],0.5869271449676593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,1478,29,1.17 [0.51-2.66],0.7153997559508869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGT1,Protein SGT1 homolog,1675,38,1.17 [0.82-1.68],0.3850947260704945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,1736,37,0.99 [0.79-1.24],0.9327304388642648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,1713,36,1.10 [0.74-1.64],0.6281241601906129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,1444,28,1.13 [0.73-1.74],0.5886489889532474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1736,37,1.90 [1.06-3.42],0.0313351724249911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",1498,30,0.74 [0.43-1.28],0.285224605651322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,1692,39,1.18 [0.64-2.17],0.5964315563802126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,1728,37,2.15 [0.84-5.47],0.1096703493315017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,1490,30,1.53 [0.86-2.71],0.1494059530293054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,1463,29,6.09 [2.50-14.87],7.252345258050565e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,1456,28,0.88 [0.48-1.60],0.6688349143314036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,1478,29,0.51 [0.17-1.55],0.2373348675507775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYAP1,Synapse-associated protein 1,1471,29,1.06 [0.58-1.93],0.855982783415599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1432,28,1.09 [0.60-1.97],0.7732550852750362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,1486,27,1.54 [0.74-3.18],0.246027016917478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,1493,29,1.19 [0.75-1.86],0.4602995131594888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1475,30,1.13 [0.80-1.58],0.4925876206552654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,1722,38,1.07 [0.83-1.36],0.606298438838178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,1539,35,6.29 [2.82-14.05],7.257668811502657e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TADA3,Transcriptional adapter 3,1490,30,0.87 [0.37-2.05],0.7465593918258411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,1722,38,4.62 [2.99-7.13],4.756344995161993e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAGLN3,Transgelin-3,1438,27,0.88 [0.47-1.64],0.68586333832929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TALDO1,Transaldolase,1497,29,0.90 [0.41-2.00],0.8004573571907254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,1676,36,1.08 [0.71-1.66],0.7122810345966207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAP1,Antigen peptide transporter 1,1475,30,0.68 [0.32-1.45],0.3149518773543003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,1661,36,1.25 [0.86-1.83],0.2423043294325852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1456,28,1.09 [0.69-1.72],0.7002976452097955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1490,30,0.53 [0.20-1.46],0.2226052082121805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,1486,27,1.10 [0.63-1.91],0.7376602422076809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D17,TBC1 domain family member 17,1661,36,0.94 [0.50-1.77],0.8409972338231495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D23,TBC1 domain family member 23,1722,38,1.17 [0.86-1.59],0.3199363088632621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D5,TBC1 domain family member 5,1713,36,1.15 [0.82-1.63],0.422191126225806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCA,Tubulin-specific chaperone A,1471,29,0.98 [0.65-1.47],0.9220565957202193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCB,Tubulin-folding cofactor B,1708,37,1.12 [0.83-1.50],0.4740331659217243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCC,Tubulin-specific chaperone C,1708,37,1.21 [0.84-1.73],0.3067755758026115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,1675,38,1.02 [0.73-1.44],0.898060791745773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBR1,T-box brain protein 1,1456,28,0.73 [0.29-1.86],0.5122874800814763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,1706,37,0.66 [0.51-0.86],0.0021088928057371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,1692,39,1.08 [0.78-1.50],0.6516741833264892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN1,Transcobalamin-1,1466,29,1.96 [0.94-4.06],0.0711713776120727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,1740,39,3.21 [1.94-5.34],6.220637065799839e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,1493,29,1.42 [0.48-4.23],0.5249517693903603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCP11,T-complex protein 11 homolog,1475,30,1.00 [0.57-1.76],0.9889521929621224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCTN3,Tectonic-3,1493,29,0.39 [0.13-1.19],0.0973725472221324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,1661,36,0.90 [0.73-1.12],0.358111257850687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",1456,28,1.13 [0.47-2.68],0.7850556201249175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,1490,30,0.59 [0.29-1.20],0.1439190491786928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,1661,36,1.34 [0.97-1.85],0.0778395305866912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEF,Thyrotroph embryonic factor,1439,28,0.52 [0.21-1.33],0.1739354987377506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEK,Angiopoietin-1 receptor,1729,38,0.93 [0.27-3.21],0.9118015134507408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,1444,28,0.86 [0.24-3.03],0.8148114332770895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,1471,30,0.96 [0.68-1.36],0.8173222342663785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,1456,28,0.76 [0.29-1.99],0.5746284119517748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX33,Testis-expressed protein 33,1475,30,0.97 [0.37-2.56],0.9493193837325824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TF,Serotransferrin,1505,30,0.23 [0.07-0.78],0.0175552870111356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,1432,28,1.16 [0.73-1.84],0.5372890893776602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,1720,37,2.00 [1.55-2.58],9.314123674448564e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,1721,37,2.40 [1.67-3.44],2.0707528467148246e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,1714,38,2.79 [2.06-3.79],3.6287943424886356e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,1727,39,1.42 [0.63-3.22],0.3962887354245772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,1724,38,1.69 [1.15-2.50],0.0079308527382499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,1733,39,1.75 [0.91-3.37],0.0919638245929257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,1490,30,1.01 [0.76-1.34],0.9475643054917794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,1713,36,2.68 [1.66-4.32],5.1049196139713085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,1736,37,2.54 [1.29-5.01],0.0071110434766887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,1490,30,0.39 [0.22-0.69],0.0010713556777024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,1720,39,0.45 [0.18-1.16],0.0986571753145667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,1444,28,3.00 [0.72-12.42],0.129861580019197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,1729,38,3.47 [2.42-5.00],1.89408992575384e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,1742,39,4.87 [2.53-9.37],2.101589129525824e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,1720,39,0.81 [0.56-1.16],0.2478891551423001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,1502,29,8.91 [4.11-19.35],3.1929024665836415e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,1435,27,0.92 [0.59-1.44],0.7193847666713425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,1724,39,6.54 [3.46-12.33],6.745339407289164e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,1728,37,1.18 [0.68-2.03],0.5643754468554427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,1732,39,0.61 [0.35-1.08],0.0888024111212997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,1718,39,0.35 [0.17-0.73],0.0052549364345042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THPO,Thrombopoietin,1692,39,2.60 [1.35-5.01],0.0040935997954354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,1439,28,1.00 [0.72-1.39],0.9992991757139982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,1433,28,1.21 [0.52-2.81],0.6512725827613435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THTPA,Thiamine-triphosphatase,1487,30,0.87 [0.59-1.30],0.5076402404558022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,1736,37,4.63 [2.17-9.91],7.660441331864282e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,1671,39,1.11 [0.88-1.40],0.3588513843868189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,1742,39,0.86 [0.47-1.58],0.6271750139219241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1657,36,0.97 [0.50-1.85],0.9160740112292132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1475,30,1.19 [0.53-2.71],0.6733394085665895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1733,39,0.82 [0.46-1.47],0.5051650698030098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1493,29,1.60 [0.71-3.61],0.255550294516685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1486,27,1.02 [0.66-1.56],0.931545992778107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,1703,38,3.79 [1.97-7.30],6.982275134636671e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,1493,29,2.60 [1.17-5.78],0.0185516885830558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,1726,37,1.15 [0.93-1.41],0.195961913496196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,1728,37,2.34 [1.38-3.96],0.001662030086521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,1722,39,11.25 [3.84-32.96],1.0275717177033896e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJAP1,Tight junction-associated protein 1,1729,38,1.15 [0.82-1.62],0.4119831821158208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJP3,Tight junction protein ZO-3,1432,28,1.52 [0.87-2.68],0.1436439863456498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",1475,30,0.67 [0.27-1.66],0.3856263386044188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR1,Toll-like receptor 1,1444,28,1.65 [0.46-5.93],0.445332354760335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR2,Toll-like receptor 2,1475,30,2.29 [0.52-10.15],0.2741075663848051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR3,Toll-like receptor 3,1738,37,1.37 [0.85-2.21],0.2018013945962647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR4,Toll-like receptor 4,1444,28,0.56 [0.14-2.23],0.4111824267698228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1456,28,0.85 [0.39-1.85],0.6899509640557664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,1475,30,1.04 [0.56-1.92],0.901494287459494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,1439,28,1.28 [0.67-2.47],0.4579537561079893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,1439,28,0.89 [0.46-1.73],0.7291594006370232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED8,Protein TMED8,1478,29,1.02 [0.72-1.43],0.9239528924955888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM106A,Transmembrane protein 106A,1490,30,1.23 [0.75-2.00],0.4068094024342401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM132A,Transmembrane protein 132A,1461,30,2.07 [1.41-3.04],0.0002246557855409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM25,Transmembrane protein 25,1498,30,1.41 [0.74-2.67],0.2935960222297021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,1438,27,0.80 [0.32-2.00],0.635580463318171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,1432,28,0.91 [0.55-1.51],0.7145612873254883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,1485,27,2.49 [1.44-4.28],0.0010337813347265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,1722,38,1.42 [1.04-1.95],0.0294509178098804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,1700,37,2.43 [1.11-5.33],0.027012308801439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,1728,37,1.93 [1.29-2.87],0.0012444707080389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,1733,39,2.44 [1.46-4.10],0.0007251018425561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,1691,39,1.96 [1.42-2.69],3.831490911820205e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1478,29,1.33 [0.74-2.37],0.3398735252949965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1676,36,0.99 [0.44-2.24],0.98025500381409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1471,29,1.01 [0.58-1.75],0.9728298389527248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1708,37,10.75 [5.39-21.45],1.5742380906135418e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1708,37,1.67 [1.39-2.01],5.9544281917349064e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1727,39,1.13 [0.62-2.04],0.6965813476272804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1738,37,4.96 [3.19-7.72],1.2688729421733498e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1714,37,1.64 [0.75-3.62],0.2168633651472181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1729,38,6.37 [4.01-10.11],4.369064535659369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1718,37,3.58 [2.08-6.15],3.8457328608031936e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1676,36,1.28 [0.65-2.53],0.4763879531621563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1718,37,6.30 [3.85-10.33],2.7939460440787096e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1471,29,3.45 [1.55-7.68],0.0023593444837771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1740,39,5.77 [3.86-8.63],1.1852523294685589e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1728,37,9.40 [5.18-17.04],1.6187282765095216e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1728,37,2.04 [1.57-2.65],1.1651750766973133e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1736,37,8.80 [3.68-21.04],9.964962336893473e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1736,37,4.51 [2.75-7.41],2.644196379821385e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1708,37,2.59 [1.68-4.00],1.5719055250534162e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1736,37,2.27 [1.45-3.56],0.0003349063571606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1708,37,4.60 [2.81-7.54],1.328372404864445e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,1738,37,1.51 [0.51-4.47],0.4585976905641146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,1713,36,0.76 [0.47-1.24],0.2700363586256946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,1738,37,2.55 [1.03-6.36],0.0440053914162398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,1726,37,7.40 [3.16-17.37],4.176008022368914e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1739,39,1.76 [0.76-4.08],0.187400608495674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,1708,37,1.67 [1.02-2.72],0.0414473978044488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,1499,29,2.21 [0.93-5.27],0.0741413210669418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,1486,27,0.94 [0.62-1.44],0.7864047761496711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNN,Tenascin-N,1499,29,0.76 [0.35-1.67],0.4966808430940664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",1692,39,1.02 [0.72-1.44],0.9147892268692284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNPO1,Transportin-1,1475,30,0.91 [0.32-2.60],0.8591078172578416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,1708,37,1.80 [0.97-3.35],0.0632198384882174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNXB,Tenascin-X,1728,37,0.86 [0.31-2.40],0.7731198892820051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1493,29,1.33 [0.87-2.04],0.1836008298535794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1,DNA topoisomerase 1,1478,29,0.76 [0.54-1.06],0.101315900333779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",1438,27,0.60 [0.22-1.61],0.3115852741549336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,1444,28,0.89 [0.55-1.44],0.6321960573188241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,1461,30,1.31 [0.81-2.13],0.2680349133756623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53,Cellular tumor antigen p53,1675,38,1.58 [0.83-3.02],0.1622058347126357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53BP1,TP53-binding protein 1,1444,28,1.29 [0.87-1.90],0.2087949827463409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,1431,28,0.70 [0.35-1.40],0.3178770507374796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,1692,39,0.72 [0.24-2.14],0.5551572892089439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP73,Tumor protein p73,1456,28,0.35 [0.13-0.91],0.0318344836281979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,1456,28,0.62 [0.22-1.76],0.3664122788084045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPD52L2,Tumor protein D54,1471,29,1.01 [0.72-1.42],0.935291005370518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,1493,29,1.44 [0.41-5.09],0.5725687213617144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,1439,28,1.45 [0.93-2.27],0.1006205127127926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,1675,38,0.72 [0.48-1.09],0.1240723802696237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,1706,37,1.06 [0.59-1.91],0.8357178338678242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,1475,30,1.14 [0.81-1.62],0.4465248751321449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,1661,36,0.92 [0.42-2.00],0.8250066212751845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPR,Nucleoprotein TPR,1439,28,1.06 [0.55-2.01],0.8684792747005092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,1438,27,0.93 [0.50-1.73],0.8231202984245046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,1734,37,1.38 [0.75-2.53],0.2944128842052986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,1498,30,0.75 [0.24-2.30],0.6092081563316709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSG1,Tryptase gamma,1444,28,0.48 [0.11-2.15],0.3409270928689714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPT1,Translationally-controlled tumor protein,1676,36,0.72 [0.39-1.33],0.2886641896119447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,1713,36,0.79 [0.52-1.22],0.2916317336303555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",1444,28,1.18 [0.52-2.71],0.6918482400005687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1439,28,0.88 [0.38-2.05],0.7611500906433487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1475,30,0.90 [0.59-1.39],0.6340222822616977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREH,Trehalase,1499,29,1.00 [0.63-1.59],0.9996514496098812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,1714,37,1.22 [0.77-1.96],0.3997217399092208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML1,Trem-like transcript 1 protein,1502,29,1.22 [0.64-2.32],0.5470032387221269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,1728,37,2.35 [1.02-5.42],0.0457085134704728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,1740,39,1.88 [1.22-2.91],0.0044352676748942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,1713,36,1.02 [0.72-1.44],0.8981439702737203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,1470,30,0.85 [0.48-1.49],0.5657721889482996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1478,29,0.92 [0.66-1.29],0.6409787501997848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,1438,27,0.58 [0.25-1.31],0.1880061127090737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,1456,28,0.90 [0.53-1.50],0.6788193696875191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,1713,36,0.91 [0.64-1.28],0.578161220247623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,1490,30,0.99 [0.67-1.47],0.9687480388985666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,1439,28,0.78 [0.34-1.77],0.5498658986297342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC1,Hamartin,1444,28,0.84 [0.46-1.54],0.5746849905647027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,1498,30,0.97 [0.58-1.64],0.917613470764076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSHB,Thyrotropin subunit beta,1724,39,0.77 [0.57-1.04],0.0888296731338809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,1692,39,0.96 [0.59-1.56],0.8608287440983273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSNAX,Translin-associated protein X,1439,28,0.71 [0.28-1.78],0.463489127870372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN1,Tetraspanin-1,1692,39,2.64 [1.64-4.23],5.836118029626695e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN15,Tetraspanin-15,1439,28,1.17 [0.65-2.10],0.6118750946886172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN7,Tetraspanin-7,1432,28,0.80 [0.45-1.42],0.4402299816786116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN8,Tetraspanin-8,1478,29,1.03 [0.75-1.41],0.854847065676846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,1444,28,1.58 [0.76-3.25],0.217617708246957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TST,Thiosulfate sulfurtransferase,1661,36,1.27 [0.86-1.87],0.2337809659993992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTF2,Transcription termination factor 2,1456,28,0.99 [0.48-2.05],0.9727970187004932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTN,Titin,1439,28,1.03 [0.60-1.77],0.9234179074750356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTR,Transthyretin,1493,30,0.37 [0.11-1.21],0.100667604559512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TUBB3,Tubulin beta-3 chain,1432,28,3.75 [1.20-11.66],0.0225430233772293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TWF2,Twinfilin-2,1499,29,1.09 [0.72-1.65],0.6775312851096553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,1475,30,0.74 [0.40-1.37],0.3449962553141441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXLNA,Alpha-taxilin,1708,37,1.10 [0.79-1.53],0.5749327673014706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXN,Thioredoxin,1475,29,0.69 [0.28-1.69],0.4141802933860683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,1729,38,1.08 [0.41-2.82],0.8761652134752854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,1736,37,1.90 [1.27-2.83],0.0017360014891019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,1486,27,1.18 [0.62-2.23],0.618671426273177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,1430,28,0.80 [0.49-1.31],0.3744441597667951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1728,37,0.80 [0.44-1.47],0.4787735906498622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYMP,Thymidine phosphorylase,1711,39,1.11 [0.72-1.71],0.6415256812396852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,1724,39,3.72 [1.39-9.95],0.0090079540727183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1444,28,2.36 [1.29-4.32],0.0052042567223879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,1722,38,0.55 [0.26-1.18],0.1261829679904044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,1490,30,0.57 [0.16-2.03],0.383684231068055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1493,29,1.48 [0.84-2.60],0.1750924416132896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1444,28,1.06 [0.57-1.97],0.854683914626174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,1439,28,0.94 [0.47-1.89],0.8635190541218963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBXN1,UBX domain-containing protein 1,1471,29,0.94 [0.57-1.56],0.8189777186158458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1478,29,1.06 [0.82-1.37],0.643203888201586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,1439,28,1.13 [0.83-1.52],0.4351601717927551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,1439,28,1.41 [0.60-3.32],0.4289984835483094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,1708,37,4.53 [2.54-8.07],2.951792428880039e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,1734,37,0.39 [0.26-0.57],2.214105227219072e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,1444,28,1.06 [0.25-4.45],0.9382303999398866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC79,Protein unc-79 homolog,1438,27,1.28 [0.70-2.33],0.4171070288390297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNG,Uracil-DNA glycosylase,1490,30,1.15 [0.44-3.02],0.7731261317996914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPB1,Beta-ureidopropionase,1493,29,0.62 [0.44-0.89],0.0093590930747064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3A,Uroplakin-3a,1432,28,0.63 [0.28-1.43],0.2677006842353916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,1473,30,1.30 [0.77-2.18],0.3266451314242943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,1471,29,0.87 [0.52-1.45],0.5890994104001697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,1456,28,1.06 [0.61-1.84],0.84724590329799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USO1,General vesicular transport factor p115,1722,38,1.17 [0.85-1.60],0.3392165866059937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,1490,30,1.11 [0.68-1.82],0.6643548238141481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,1486,27,1.53 [0.73-3.20],0.2638768544348936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,1439,28,1.15 [0.76-1.74],0.5101797070462663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,1692,39,1.12 [0.84-1.49],0.4458248716153566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,1675,38,0.90 [0.53-1.55],0.7102910217935502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,1692,39,1.13 [0.72-1.78],0.5982132000832148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,1444,28,1.01 [0.65-1.55],0.9762357351748204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,1713,36,0.97 [0.68-1.39],0.8861220112828337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,1701,39,5.83 [2.75-12.39],4.402805600981433e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,1502,29,1.00 [0.62-1.60],0.9936496151213434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1722,38,0.80 [0.18-3.50],0.7661374699443055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,1432,28,1.02 [0.71-1.48],0.8962030325326859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,1732,39,4.26 [2.01-9.02],0.0001558134601696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,1736,37,2.06 [0.85-5.02],0.1106808866543754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,1438,27,0.85 [0.51-1.41],0.5294596288455509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,1734,37,1.63 [1.05-2.51],0.0278367743329866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,1444,28,3.16 [1.06-9.44],0.0391387808296615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,1729,38,1.46 [0.88-2.42],0.1385348782126917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,1736,37,4.20 [2.05-8.61],8.934106358798282e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,1498,30,2.04 [1.06-3.95],0.0340919388094723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIM,Vimentin,1692,39,0.96 [0.76-1.21],0.7269273659236308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,1461,30,1.63 [0.64-4.14],0.3040380887721158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,1493,29,2.22 [1.12-4.40],0.0221890847615171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,1722,38,1.09 [0.70-1.68],0.7141483672112368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN1,Pantetheinase,1502,29,0.77 [0.50-1.19],0.2475746372398327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,1722,38,1.24 [0.65-2.37],0.5214403290080301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,1475,30,0.81 [0.46-1.40],0.4462346691626575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,1722,38,1.23 [0.87-1.74],0.2375831562223713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,1490,30,0.86 [0.60-1.25],0.4403074073443737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,1722,38,1.22 [0.86-1.73],0.2700821203860926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,1490,30,1.34 [0.64-2.79],0.4409795519669109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1439,28,0.87 [0.29-2.62],0.8033090762351908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,1490,30,1.73 [1.16-2.59],0.0075190097313349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,1726,37,4.46 [2.92-6.79],3.796060048544346e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1721,39,1.47 [0.99-2.17],0.0552403282198331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSNL1,Visinin-like protein 1,1486,27,0.51 [0.21-1.21],0.127415823204944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,1661,36,1.56 [0.90-2.71],0.1114331579805989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,1475,30,0.41 [0.16-1.08],0.0714185565068871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1692,39,1.16 [0.77-1.75],0.478208854049704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1736,37,1.24 [0.84-1.83],0.2859696389303947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,1675,38,2.65 [1.32-5.32],0.0062201241160386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1471,29,1.04 [0.56-1.91],0.9086501243769988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,1735,39,1.35 [0.69-2.65],0.3782123120598941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,1438,27,1.16 [0.80-1.68],0.4269171929635442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,1701,37,6.11 [3.28-11.38],1.1880943931509372e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,1498,30,0.80 [0.35-1.83],0.5923996895935233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWF,von Willebrand factor,1742,39,1.10 [0.75-1.62],0.6300297167895592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",1728,37,0.90 [0.42-1.93],0.792343738763989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,1676,36,1.05 [0.69-1.59],0.820401047304343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,1692,39,1.09 [0.80-1.48],0.5729975466222885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,1661,36,1.10 [0.77-1.59],0.5949374642497136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASHC3,WASH complex subunit 3,1486,27,1.25 [0.81-1.93],0.3208005122883144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,1444,28,0.80 [0.41-1.57],0.5159444500056489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WDR46,WD repeat-containing protein 46,1490,30,0.71 [0.24-2.06],0.5246767262057606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,1458,30,1.25 [0.82-1.91],0.3015571443584507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,1738,39,2.05 [1.44-2.93],7.632600740210698e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,1639,34,4.40 [3.14-6.17],7.942160302697547e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1701,37,0.38 [0.19-0.74],0.0046673524843374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1718,37,2.85 [1.37-5.92],0.0050554511172442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WIF1,Wnt inhibitory factor 1,1740,39,1.31 [0.61-2.82],0.4830189240536454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,1676,36,3.06 [2.07-4.52],1.9699631232664664e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1708,37,0.86 [0.50-1.47],0.5824568877514389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,1740,39,1.85 [1.41-2.41],6.506629096143173e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,1732,39,6.33 [4.08-9.81],1.5143481358615344e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,1444,28,1.24 [0.68-2.29],0.4808185668946295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,1729,38,0.78 [0.57-1.05],0.1025797464785055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XRCC4,DNA repair protein XRCC4,1661,36,0.94 [0.41-2.15],0.8856390669287136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,1486,27,6.02 [2.47-14.66],7.708051367939923e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1478,29,1.06 [0.82-1.35],0.6736279639136117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,1722,38,1.07 [0.84-1.37],0.5727236575443841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YJU2,Splicing factor YJU2,1490,30,1.25 [0.42-3.76],0.6854848065396344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,1439,28,0.62 [0.35-1.10],0.1020102549052938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,1676,36,1.06 [0.75-1.50],0.7462777091666856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YWHAQ,14-3-3 protein theta,1471,29,1.02 [0.64-1.64],0.9177417933227424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YY1,Transcriptional repressor protein YY1,1444,28,0.90 [0.23-3.49],0.8847823773297981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,1444,28,1.65 [0.84-3.22],0.1449087857874934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,1675,38,1.30 [0.89-1.90],0.1687518754179101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,1692,39,1.69 [1.05-2.74],0.0313172448476728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,1439,28,0.92 [0.48-1.74],0.7938494291832325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,1478,29,1.03 [0.70-1.53],0.8758938919665701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,1486,27,0.42 [0.09-2.05],0.2824462725798862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF174,Zinc finger protein 174,1444,28,1.40 [0.63-3.13],0.4073250268646211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF75D,Zinc finger protein 75D,1475,30,0.62 [0.31-1.27],0.1917079610802939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF830,Zinc finger protein 830,1490,30,1.00 [0.66-1.53],0.990339758747228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRD2,Protein ZNRD2,1478,29,0.88 [0.53-1.44],0.6061478584854094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1490,30,0.72 [0.36-1.44],0.3522716609253027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,1461,30,1.05 [0.92-1.20],0.4964324078428724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,1438,27,0.82 [0.24-2.74],0.7445407675362086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,1432,28,0.83 [0.53-1.29],0.4008871739038352
